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Abstract 
Extended spectrum β-lactamases (ESBLs) are enzymes produced by bacteria that 
confer resistance to cephalosporins, antibiotics that are widely used to treat 
infections in animals and humans. The emergence of plasmid-borne ESBL 
resistance in humans and animals, especially poultry, is of particular concern. Avian 
pathogenic E. coli (APEC) cause colibacillosis, an economically important disease of 
poultry, but have also been linked to human disease. Of growing concern is the 
potential transfer of ESBL-producing plasmids between E. coli isolates and their 
impact on the host bacterium. Thus, the aim of this study was to characterise ESBL 
plasmids in APEC isolated from UK poultry and examine their impact on host 
bacterial fitness and virulence.  
Plasmid profiling and genome sequencing revealed that all three APEC isolates 
harboured at least two plasmids, belonging to the IncF and IncI replicon types. The 
ESBL plasmid was identical in each isolate, being of 105,610 Kb in size, belonging to 
the IncI1-Iy family and carrying the blaCTX-M-1 allele. Upstream of blaCTX-M-1 
gene was an ISEcp1 insertion element, which likely contributes to the transmissibility 
of the element. The plasmid also carried genes coding for tetracycline resistance that 
were co-transferred with the β-lactamase genes. The APEC isolates also harboured 
a large virulence plasmid of similar size, but belonging to the IncF replicon type. 
Competitive growth studies in rich or minimal media found no significant differences 
in the growth of CTX-M-1 plasmid-harbouring and plasmid-cured derivatives. 
However, the presence of the CTX-M-1 plasmid in APEC O78 was beneficial to their 
growth in iron-limited media, but caused a greater fitness burden at low pH. When 
present as the only plasmid in APEC, the ESBL-containing derivatives produced 
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more biofilm at human and chicken body temperatures and were better able to 
invade and survive in human (THP-1) and chicken (HD11) macrophage cell lines 
than the cured isolates. Finally, the substrate utilisation profiles of the plasmid-
containing derivatives differed to that of the parent strains, indicating that the plasmid 
may influence the metabolic capability of the organism. The studies presented here 
indicate that ESBL plasmids of the IncI1-1Y type spread readily to unrelated APEC 
isolates and can influence the fitness of APEC under certain conditions. 
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1 .Introduction 
 
1.1 Introduction 
Escherichia coli is a Gram negative rod-shaped bacterium that belongs to the family, 
Enterobacteriaceae. Originally called Bacterium coli, the organism was renamed E. 
coli in honour of the German pediatrician “Theoder Escherich” who originally 
identified it from the faeces of healthy individuals (reviewed in Shulman et al., 2007).   
 While most E. coli are considered harmless and colonise the colon of infants soon 
after birth, some strains are pathogenic and capable of causing a range of intestinal 
and extra-intestinal infections.  
 Pathogenic E. coli are classified into several distinct groups or pathotypes 
based on the presence of certain virulence factors and the type of disease they 
cause. Intestinal pathogenic E. coli (IPEC) such as Enteropathogenic E. coli (EPEC), 
Enteroaggregative E. coli (EAEC), Enterohaemorrhagic E. coli (EHEC), 
Enteroinvasive E. coli (EIEC) and Enterotoxigenic E. coli (ETEC) colonise the 
intestinal tract and cause diarrheal disease (reviewed in Croxen & Finlay, 2010). 
Conversely, extraintestinal pathogenic E. coli (ExPEC) such as urinary pathogenic E. 
coli (UPEC) and neonatal meningitis-associated E. coli (NMEC) are groups of 
pathogenic E. coli that cause infections at sites outside of the intestinal tract (Kaper 
et al., 2004). Grouped with ExPEC are the avian pathogenic E. coli (APEC), which 
can cause respiratory disease in poultry and constitute a growing health concern to 
humans (Antão et al., 2009). 
   Recent studies suggest that APEC may be zoonotic and linked to human 
ExPEC (Johnson et al., 2007; Ewers et al., 2007; Lima-Filho et al., 2013). In addition 
to similarities in their chromosomal attributes, APEC and human ExPEC both 
2 
 
harbour similar large, conjugative plasmids, which carry antibiotic resistance genes. 
In particular, carriage of genes coding for the production of extended spectrum beta-
lactamases (ESBLs) which confers resistance to current frontline antibiotics such as 
the 3rd and 4th generation cephalosporins, is common. Whether carriage of the 
plasmids confers a benefit to the organism over and above that attributed to 
antibiotic resistance, is not clear. While several studies have examined the impact of 
ESBL-plasmids in the context of human infections (Dubois et al,. 2009 ; Lavigne et 
al., 2006; Aoki et al., 2004), less is known about the properties and impact of ESBL-
producing plasmids in APEC. This represents a significant gap in knowledge and is 
the focus of the work presented in this thesis.   
1.2 Escherichia coli strains associated with extra intestinal diseases 
Extra-intestinal pathogenic E. coli (ExPEC) differ from intestinal pathogenic E. coli 
(IPEC) pathotypes in that they are genetically diverse and exhibit a dual 
extracellular/intracellular infectivity (Köhler & Dobrindt, 2011). Like all E. coli, ExPEC 
can be found in the intestinal tract of both humans and animals.  However, these 
organisms are able to escape the gut and multiply at sites distal from the intestine 
including the urinary tract, bloodstream and respiratory tract (Kaper et al., 2004). 
While UPEC and NMEC are probably the most widely known ExPEC pathotypes, 
several other groups that cause disease outside of the intestine in animals have 
been described. Of these, infections caused by APEC are responsible for significant 
morbidity and mortality in domestic and wild birds and can have devastating effects 
on the global poultry industry.  
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1.3 Avian Pathogenic E.coli (APEC):  
1.3.1 Impact of APEC infections on poultry and the poultry industry 
Colibacillosis is an economically important disease of poultry associated with extra-
intestinal infections of avian pathogenic E. coli (APEC)  (La Ragione and Woodard, 
2002; Dziva & Stevens, 2008). APEC can cause infections in all ages of birds 
producing a variety of disease manifestations including acute septicaemia and death 
(reviewed in Lutful Kabir, 2010).The most commonly isolated pathogenic E. coli in 
poultry belong to O serogroups, O78, O1, O2, O15 and O55 (Ewers et al., 2003).  
APEC have been isolated from a number of different sites in poultry such as 
the intestine, on skin and feathers, and in the upper respiratory tract (reviewed in 
Lutful Kabir, 2010). However, the route of APEC infection is not clearly established, 
with the oral and respiratory tract considered the most likely modes of entry (as 
reviewed by Dziva & steven, 2008). From these sites, the organism is thought to gain 
access to the bloodstream and colonize specific internal organs causing local and 
systemic infections (Nakazato et al., 2008). The most common disease associated 
with colibacillosis are airsacculitis, pericarditis and perihepatitis although in some 
cases the infection results in syndromes like egg peritonitis, salpingitis, 
caligranuloma, omphilitis, cellulitits, osteomyelitis or artheritis (reviewed in 
Vandekerchove et al., 2004). 
In addition, infection by APEC can show different manifestations when the 
infection occurs in combination with other infectious agents such as turkey 
rhinotracheitis virus in chicken, which leads to swollen head syndrome (reviewed in 
Dziva & Steven, 2008). The infection of the yolk sac by APEC is the major cause of 
early mortality in young broilers (Khan et al., 2004). Experimental infection studies 
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have demonstrated that yolk sac infections develop when bacteria were able to cross 
the gut wall (as reviewed by Khan et al., 2004; Fuller and Jayne-Williams (1968)). 
Outbreaks of colibacillosis have also been reported in laying hens. APEC-induced 
septicemia, pericarditis and perihepatitis, with peritonitis and polyserositis were 
commonly found at necropsy and O78 strains were the most prominent E. coli 
serogroup associated with disease (Vandekerchove et al., 2004). 
These diseases have a negative impact on the avian industry and can be 
associated with significant economic losses. For example, air sacculitis frequently 
presents in birds of 14 days of age, with mortality rates reaching approximately 20% 
(Nakazato et al., 2008). Swollen head syndrome often accounts for decline in egg 
production of 2 to 3% and mortality rates of 3 to 4% (Nakamura et al., 1997). 
Infections with coligranuloma, which is identified by the presence of granulomata in 
the liver, caeca and duodenum, can cause high rates of mortality reaching up to 75% 
of the affected flock (as reviewed by Lutful Kabir, 2010).  It has been estimated that 
mortality in the first week of life can lead to more than 50% of total flock losses 
(Yassin et al., 2009). Economic losses can also be linked to decreased hatching 
rates, lower egg production or increases in the costs of treatment. Despite the high 
prevalence of colibacillosis, available data regarding the true economic burden of 
this infection to the industry is difficult to assess (Barnes et al., 2008). 
 
1.4 APEC pathogenicity  
Evidence is increasing that APEC are well-adapted pathogens in poultry and may 
also exhibit zoonotic potential.  Thus, infections caused by APEC may not always 
arise as secondary infections or a consequence of other predisposing factors 
(Barnes et al., 2008).  A number of studies have indicated that APEC have unique 
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repertoire of virulence genes and experimental studies have indicated that APEC are 
capable of causing primary infections in otherwise healthy birds. 
 APEC are characterised by the presence of virulence genes that distinguishes 
them from commensal avian E. coli (Barnes et al., 2008). These virulence genes 
may be located on chromosomal or plasmid DNA (Janben et al., 2001). Acquisition 
of virulence genes or plasmids contribute to APEC pathogenicity within the host 
which leads to the development of disease symptoms (Mellata et al., 2012). 
 As mentioned in the previous section, the routes of infection for APEC have 
not been clearly defined, although the oral and respiratory routes of infection are 
widely regarded as the main modes of entry (as reviewed by Dziva & Steven, 2008). 
Regardless of the route of infection, columnar epithelial cells likely represent the first 
host cells encountered by the organism as it colonises the host. As a consequence, 
adherence and invasion factors likely constitute key mediators of APEC virulence. 
Virulence factors associated with APEC adherence include type 1 and P fimbriae, 
lipopolysaccharide (LPS), K1 capsular antigen, temperature-sensitive hemagglutinin 
(Tsh).  Some of these factors have been documented to be important in protecting 
APEC against the bactericidal effect of phagocytes, especially heterophils (Mellata et 
al., 2003). As such, they become important when APEC invades and survives in the 
bloodstream, leading to localised (e.g. lesions on multiple internal organs) and 
systemic infections (e.g. septicaemia), and potentially sudden death of the birds 
(Ewers et al., 2003).   
 
1.4.1.1 Adherence and invasion factors 
Several types of adhesion factors have been identified in APEC and shown to be 
important in colonisation of the host. For example, numerous types of fimbriae, thin 
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thread-like projections protruding from the cell surface, have been identified in APEC 
including AC/1, F1, F11, Stg and curli (Dho-Moulin & Fairbrother, 1999).  Expression 
of F1 fimbriae was found to be important during APEC colonisation of tracheal 
epithelial cells (Dozois et al., 1994; La Ragione et al., 2000) whereas P fimbriae 
were expressed during colonisation of the lower respiratory tract and organic tissues 
such as the liver, spleen and kidney (Dho-Moulin & Fairbrother, 1999). Also, 
temperature-sensitive haemagglutinin (tsh), an autotransporter protein encoded by 
some APEC strains and first identified by Provence and Curtiss (1994), has been 
shown to play an important role in the early stages of colonising the chicken 
respiratory tract (Dozois et al., 2000).  
In addition to fimbriae, several invasion factors have been identified in APEC 
including IbeA (an invasion associated protein) and OmpA (outer membrane protein 
A) (Germon et al., 2005). More recently, the ibeR gene which is located on the same 
genomic island (GimA) as the IbeA gene has been shown to have an important role 
in APEC invasion capacity of DF-1 cells, brains and cerebrospinal fluid (CSF) in vitro 
and in vivo (Wang et al., 2015). 
How APEC crosses the epithelial cell barrier and enters the blood stream is 
poorly understood (as reviewed by Dziva & Steven, 2008).  In vitro studies show that 
APEC is able to invade non-phagocytic cells such as the fibroblast cell line, CEC32, 
which suggests that APEC may also be able to invade epithelial cells of the avian 
respiratory tract in vivo (Matter et al., 2011). Moreover, experimental infection studies 
show that APEC were able to survive within macrophages, resisting the processes of  
opsonisation and phagocytosis (Pourbakhsh et al., 1997). Occasionally APEC were 
also found in the connective tissue, indicating that they had spread to the internal 
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organs. Thus, this study concluded that the lung and air sac are important sites of 
invasion into the blood stream.  
1.4.1.2 Avoidance of host defense mechanisms   
Survival of APEC in the blood stream and internal organs requires avoidance of host 
defense mechanisms, including complement-mediated lysis and opsonisation. 
Increased serum survival (Iss) protein was one of the first factors linked to increased 
resistance to serum in APEC (Binns et al., 1979). It is thought to act by preventing 
the deposition of the membrane attack complex of complement, thereby enabling 
APEC to resist the bactericidal effects of complement. The gene iss codes a protein 
that is more often found in APEC strains than in commensal E. coli strains isolated 
from healthy birds (Johnson et al., 2008) and is usually located on large ColV and 
ColBM plasmids (Mellata et al., 2009).  
The surface expressed O- and K-antigens also help APEC avoid lysis and 
death when inside the host cell. Both the O78 lipopolysaccharide and the K1 capsule 
have been linked to increased bacterial resistance to serum and colonization of 
internal organs (Mellata et al, 2003). These factors appear to reduce opsonisation by 
C3b complement and thus phagocytosis by neutrophils and macrophages 
(Pourbakhash et al., 1997). 
The ability of invasive bacteria to acquire iron from body fluids is a critical 
virulence mechanism (Gao et al., 2012a). Within host body fluids, APEC produces 
siderophores including enterobactin, aerobactin or yersiniabactin to sequester iron 
from host siderophores (Nakazato et al., 2009). Thus, genes encoding iron uptake 
systems are frequently found in APEC and can be carried on chromosomal or 
plasmid DNA (Johnson et al., 2008). The ColV and ColBM plasmids of APEC often 
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harbour multiple iron uptake systems including iroBCDN, sitABCD and iutA iucABCD 
(Mellata et al., 2009). 
  
APEC produce several toxins that are important in disease (Janben et al., 
2001; Ewers et al., 2009).These toxins include cytotoxins such as the heat labile (LT) 
toxin, heat stable (ST) toxin, neurotoxins and verotoxin (or Shiga toxin (Stx)), 
cytolethal distending toxin and cytotoxic necrotizing factor1 as well as haemolysins 
(Barnes et al., 2008; La Ragione et al., 2002). Some of these toxins are encoded on 
virulence plasmids such as hlyF, which is located on the ColV and ColBM plasmids 
(Mellata et al., 2009).  
1.4.2 APEC plasmids and virulence 
 APEC carry multiple large plasmids and many of their virulence factors are located 
on these mobile genetic elements. Plasmids belonging to different replicon types 
have been identified in APEC, with IncFIB being most commonly identified followed 
by IncI1, IncFIIA, IncP, IncB/O, IncN, and IncFIC (Johnson et al., 2007). Most of 
these plasmid’s replicon types were also found in isolates of E. coli from human 
origins (Johnson et al., 2007; (Johnson et al., 2011), suggesting that a common set 
of plasmids are circulating between human and avian populations.  As in other 
pathogenic E. coli, the plasmids are associated with carriage of virulence genes and 
antimicrobial resistance factors (Carattoli, 2013; Cantón et al., 2012; Johnson et al., 
2010).  
Colicin-encoding plasmids in particular ColV plasmids, have been associated 
with APEC virulence (as reviewed by Johnson & Nolan, 2009). Particular diseases in 
poultry such as swollen head syndrome have been found to be associated with 
strains producing colicin ( Silveira et al., 2002). Colicin expression by APEC strains 
9 
 
indicated that colicins Ia, Ib, E1, E2, E3, I, K, B and V are the most prevalent among 
these bacterial strains (Fantinatti et al., 1994). 
ColV and ColBM plasmids are the most well characterized plasmids found in 
APEC (Johnson et al., 2006a; Johnson et al., 2006b). Both are large, conjugative 
plasmids that belong to the same incompatibility group (IncFIB or IncFII/FIB types). 
The sequence of the ColV plasmid, pAPEC-O2-ColV, was completed in 2006 and 
came from an APEC isolate belonging to the O2 serogroup (Johnson et al., 2006). 
Analysis of its content revealed that the plasmid contains several virulence genes 
known to contribute to APEC pathogenesis. For example, genes coding for iron 
acquisition systems, manganese transport systems, outer membrane proteases, 
hemolysins, increased serum survival and hemagglutinin, were detected. Three 
years after release of the pAPEC-O2-ColV sequence, three large plasmids from an 
APEC O78 isolate were fully sequenced and characterized. These plasmids were 
found to belong to three different replicon types IncFIB, IncFIIA and IncFIC (Mellata 
et al., 2009). However, like pAPEC-O2-ColV, the plasmid pAPEC-1 which belonged 
to IncFIB, harboured most of the virulence genes. 
  These three large plasmids [pChi7122-1 (IncFIB/FIIA-FIC), pChi7122-2 
(IncFII), and pChi7122-3 (IncI2)]; and a small plasmid pChi7122-4 (ColE2-like) have 
been studied for their roles in APEC infections. The plasmids appeared to enhance 
biofilm formation, acid and bile tolerance as well as to encode other virulence genes 
such as an ABC iron transport system (eitABCD) and a putative type IV fimbriae 
(Mellata et al., 2012).  
Several APEC virulence genes were also found on a large conjugative R 
plasmid known as pTJ100. This plasmid was present in several different sero-
groups, but was more common in O78 and O2 groups (Rodriguez-Siek et al., 2004). 
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Several other plasmids have now been described including IncFIB: colicin encoding 
plasmid, IncHI2: encoding resistance to antimicrobial agents, pAPEC-01-Cryp1 and 
pAPEC-01-Cryp2 (Johnson et al., 2007). Recently, plasmids belonging to IncI 
replicon types and carrying multi-drug resistance have been increasingly detected in 
APEC (Cloeckaert et al., 2010; García-Fernández et al., 2008; Fischer et al., 2014; 
Accogli et al., 2013). Plasmid belonging to IncI are often described as conjugative, 
large in size and mostly found associated with resistance to extended spectrum 
cephalosporin (Johnson et al., 2011). 
Despite the prevalence of large plasmids in APEC, their role in the organism’s 
virulence is poorly understood. Most experimental studies are limited to a description 
of the virulence gene content, resistance profile and plasmid replicon type (Bortolaia 
et al., 2010; Accogli et al., 2013). Relatively few completed sequences with full 
characterization of plasmid gene content are available in the public databases (as 
reviewed by Johnson & Nolan, 2009) and this lack of knowledge has impaired an 
understanding of APEC plasmid biology and their contribution to virulence.  
1.4.3 APEC Epidemiology 
APEC most commonly linked to infections belong to the O1:K1, O2:K2 and O78:K80 
serotypes, although the number of serotypes linked to infection is still increasing 
(Ewers et al., 2003) and includes some untypeable strains (El-Sukhon et al., 2002). 
APEC O78 are considered the most frequent serogroup associated with colibacillosis 
which might be due to this strain’s ability to acquire virulence mechanisms 
(Collingwood et al., 2014).   
Epidemiological studies have found that APEC are widespread globally. For 
example, out of 216 E. coli strains isolated from chicken and environmental 
specimens in Korea, APEC were found in 31% of layers and 14% of broilers (Kwon 
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et al., 2008).  In the UK, approximately 50 % of 70 E. coli strains isolated from an 
colibasillosis outbreak in a layer breeder flock belonged to the same clonal group 
(Timothy et al., 2008).  
 In Germany, 50% of 150 APEC isolated from septicaemic poultry were found 
to belong to O1, O2 and O78 serogroups (Ewers et al., 2004). In contrast, sero-
group O6 was more prevalent in Brazil followed by O2, O8, O21, O46, O78, O88, 
O106, O111, and O143 (Knöbl et al., 2011). In Bangladesh the highest levels of 
avian colibacillosis were recorded in the summer and occurred in all age groups of 
chicken but particularly in adult layer birds (37%) (MA et al., 2004). In Belgium an 
epidemiological study of 20 flocks affected by colibacillosis indicated that the O78 
serotype was the predominant type associated with the outbreak, followed by O1 
and O2 (Vandekerchove et al,. 2004). Recent study of APEC in outbreaks in 
Netherlands revealed that E. coli peritonitis syndrome (EPS) in layer and breeder 
chickens was associated with one or two dominant E. coli genotypes in each case  
(Landman et al., 2014).  
In summary, although many studies show that serotypes O78, O1 and O2 are more 
frequently associated with disease, these serogroups are genotypically diverse and 
strains can show different cellular responses during in vitro assays (Kabir, 2010).    
1.4.3.1 APEC prevention and control 
Several important factors which contribute to outbreaks of avian colibacillosis have 
been described in the literature. Direct or indirect contact with other animals or 
faeces can expose the poultry flocks to new strains (as reviewed by Barnes et al., 
2008). This may include carriage of APEC by rodents and flies. Contaminated water 
supplies have also been associated with the spread of  disease on several farms 
(Dhillon & Jack, 1996). It is believed that colibacillosis outbreaks are also linked with 
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low quality housing conditions including insufficient ventilation, the build-up of 
ammonia which can affect respiratory function, and inhalation of excessive dust 
which may contain large populations of E. coli (Bermudez, 2008). The distance 
between farms, and the amount of space per hen in the cage were also significantly 
associated with colibacillosis outbreaks (Vandekerchove et al., 2004b). For example, 
the incidence of colibacillosis was decreased six-fold with every 1 km increase in 
distance to the nearest poultry farm; a  factor that enables better control of the 
disease during outbreak scenarios (Vandekerchove et al., 2004b). 
There are several recommendations to reduce infections by APECs and other 
pathogenic bacteria. These include venting the incubators and hatchers to the 
outside, keeping a low number of breeders per unit area, fumigating eggs, and 
discarding any cracked eggs or eggs contaminated with faecal material. Good 
hygiene and avoiding possible sources of APEC are key measures to control APEC 
infections (Kabir, 2010).        
 
1.5 Links between APEC and human ExPEC 
A number of studies have indicated that APEC may be zoonotic with human 
infections potentially occurring through contact with poultry or poultry products.  
However, the identification of ExPEC strains (including APEC) from commensal E. 
coli can be challenging because unlike IPEC, these organisms harbor many different 
virulence factors (Köhler & Dobrindt, 2011).  Several studies reported that there is 
similarity between the virulence factors carried by APEC and human ExPEC.   
Comparative genomic analysis revealed that “ExPEC and non-pathogenic E. coli 
share a large genomic  fraction”  (Köhler & Dobrindt, 2011), with only 4.5% of the 
APEC O1 genome not found in three human ExPEC genomes (Johnson et al., 
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2007). Over the last decade, many studies have highlighted the genetic similarities of 
avian and human ExPEC that causes sepsis (Johnson et al., 2007; Bauchart et al., 
2010). Similarities have been noted in the organism’s virulence gene content, 
phylogenetic group and even in plasmids which carry virulence and resistance genes 
(Ewers et al., 2007).  
 Both groups of organisms exhibit similar antimicrobial suspectibility profiles 
and harbor similar drug resistance elements (Ajiboye et al., 2009). A study 
conducted by Johnson et al. (2010) found that 58 % of neonatal meningitis E. coli 
(NMEC) population  harbored ColV-type plasmids that are also found in APEC, and 
that 26% of these plasmids carried drug resistance genes similar to that of pAPEC-
O103-ColBM found in APEC. Gao et al. (2012a) indicated that no significant 
differences were found between mutants lacking the iron acquisition system and wild 
type strains of APEC O1 and UPEC during invasion and intracellular survival of the 
chicken macrophage-like cell line, HD11. All these findings may suggest that APEC 
in poultry act as a source of virulence and resistance genes for human ExPEC 
strains.  
Finally, recent studies have raised the possibility that APEC might act as a 
zoonotic agent (Johnson et al., 2007; Knobl et al., 2011). Experimental studies have 
now confirmed that APEC can cause disease in mammalian infection models similar 
to human ExPEC infections such as ascending urinary tract infection (UTI) (Fricke et 
al., 2009).  Conversely, human ExPEC strains appear to have the ability to cause 
disease in avian disease models (Jakobsen et al., 2012).  
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1.6 Antimicrobial agents 
Antibiotics are defined as molecules that kill or inhibit the growth of microorganisms. 
Depending on their mode of action and target in the cell, antibacterial agents are 
divided into five main groups (Tenover, 2006). These include molecules that inhibit 
1) cell wall synthesis, 2) protein synthesis, 3) nucleic acid synthesis, 4) metabolic 
pathways, as well as those that 5) disrupt the cytoplasmic membrane.  
1.6.1 Use of antimicrobial agents 
Antimicrobials are used in humans and animals for several reasons, including 
disease treatment, prevention, and control, as well as historically for growth 
promotion (as reviewed by Marshall & Levy, 2011). In England, the β-lactams and 
tetracycline are the most commonly used drugs in hospitals or communities, 
representing 49% and 16% of the drugs used to treat systemic infections, 
respectively (Figure 1).Similarly, these two antibiotics represent 80% of the antibiotics 
sold in veterinary medicinal products in the UK, which suggests that there is a high 
consumption of these drugs in animal livestock production systems (Figure 2).      
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Figure 1. Antimicrobial consumption in the community and hospitals in UK during 2013. 
 
Distribution of antimicrobial consumption of Antibacterials for Systemic Use (ATC group J01) 
in the community and hospital sector in United Kingdom, reporting year 2013 (adapted from 
European Centre for Disease Prevention and Control website, 2015). 
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 Figure 2. Quantity of antibiotic products used in animals in the UK between 2009 and 2013. 
(Adapted from UK veterinary antibiotic resistance and sales surveillance,                             
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/440744/VARSS.
pdf). 
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One of the biggest threats to human health is the emergence and spread of 
pathogenic bacteria that are resistant to antibiotics, which make infections caused by 
these organisms hard to treat. Although this is frequently blamed on the poor use of 
antibiotics in the treatment of human infections, it is also believed that the use of 
antibiotics as growth promoters in animal production systems has contributed to the 
emergence of resistance bacteria (as reviewed by Marshall & Levy, 2011).     
1.6.2 Types of antibiotic  
Antibiotics are grouped based on their mode of action and target within the cell (Kanj 
& Kanafani, 2011). The β-lactam family of antibiotics includes penicillin, 
cephalosporins, carbapenems, monobactams and glycopeptides, and are 
distinguished by the presence of a β-lactam ring (Bradford, 2001). All are bactericidal 
and exhibit various spectrums of activity against Gram positive and Gram negative 
bacteria. For example, penicillin is active against Gram positive bacteria that do not 
produce beta-lactamase, Neisseria and some anaerobes whereas cephalosporin has 
broad spectrum activity against many Gram positive and Gram negative bacteria.  
Inhibition of the cell wall synthesis by these agents occurs when the β-lactam ring 
binds to the penicillin binding proteins, which are essential components involved in 
the synthesis of the peptidoglycan layer in bacteria (Tenover, 2006). 
Inhibition of protein synthesis by aminoglycosides occurs via binding to the 
30S ribosomal subunit which subsequently prevents formylmethionyl-transfer RNA 
(fmet-tRNA) from binding to the ribosome (Bradford, 2001). All antimicrobials 
belonging to this class are bactericidal and have broad spectrum of action against 
Gram positive and Gram negative bacteria. They are often used in combination with 
β-lactam antibiotics to treat severe bacterial infections (Kotra et al., 2000).  
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Tetracycline and chloramphenicol are bacteriostatic and also interfere with 
protein synthesis. However, these drugs bind to the 50S ribosomal subunit where 
they prevent the aminoacyl transfer RNA action and peptide bond synthesis 
respectively (Doi & Arakawa, 2007; Connell et al., 2003). Macrolide antibiotics like 
erythromycin, are also bacteriostatic and have the same mode of action as 
tetracycline by binding to the bacterial 50S ribosomal subunit but their spectrum of 
activity mainly against Gram positive cocci  (Roberts, 2008).  
Fluroquinolones are bactericidal synthetic agents able to deactivate 
deoxyribonucleic acid (DNA) gyrase and topoisomerase IV, disrupting DNA 
replication (Blondeau, 2004). Rifampicin is another bactericidal agent that is able to 
inhibit the synthesis of messenger RNA (mRNA) by binding to DNA – dependent 
RNA polymerase. It is primarily used against Gram positive and some Gram 
negatives. It is also used in combination with other drugs to treat tuberculosis and 
used as prophylaxsis to treat carriers of N.meningitides (Campbell et al., 2001). Both 
fluroquinolones and rifampicin have higher affinity for their site target in bacterial 
cells than in mammalian cells (Blondeau et al., 2004).                    
Sulfonamides and Trimethoprim also known as co-trimoxazole, are 
bactericidal and consist of one part of trimethoprim to five parts of sulfamethoxazole. 
They are both able to block the synthesis of tetrahydro folic acid (THFA), which is 
essential for producing purines and pyrimidines, principal components of DNA 
(Sköld, 2001). Sulfonamides /Trimethoprim are mainly described for treatment of  
urinrary tract infections (UTIs), otitis media in children and chronic bronchitis in 
adults (Connor ,1998). 
The last mechanism of action is the disruption of the cytoplasmic membrane 
by polymyxins or lipopeptides. Polymyxin A, B, C, D and E are all bactericidal and 
18 
 
have free amino groups which disrupt the phospholipid structure of the bacterial cell 
membrane (Landman et al., 2008), whereas lipopeptides act by depolarizing the 
bacterial cytoplasmic membrane (Yeaman & Yount, 2003). Both have narrow 
spectrum activity against Gram negative bacteria associated with UTI, blood, CSF 
and eye infections (Landman et al., 2008). Polymyxin can be used in combination 
with other drugs against infections caused by resistant Pseudomonas and Klebsiella 
pneumoniae (Landman et al., 2008).  
1.6.3 Emergence of resistance to antibiotics  
It is widely believed that the use and mis-use of antibacterial agents in humans and 
animals has contributed to the increase in resistance among pathogenic bacteria 
(Angulo et al., 2004). Organisms may acquire resistance as a result of mutations in 
chromosomal genes or through the exchange of resistance genes between 
microorganisms. Mobilization of antibiotic resistance genes by mobile genetic 
elements has contributed to the spread of resistant bacteria. Key mobile genetic 
elements include i) plasmids, which play a role in the emergence of multidrug 
resistant bacteria by translocating several resistance genes from one host cell to 
another via conjugation (Stokes & Gillings, 2011); ii) conjugative transposons, which 
contribute to the spread of antibiotic resistance genes in a manner similar to that of 
plasmids but by first excising the mobilized genes and transferring a copy of itself by 
conjugation to another bacterium where it integrates to its genome (Salyers et al., 
1995); and iii) integrons, which transfer resistance genes that are inserted one after 
another, by a site specific mechanism which involves specific site attachment and 
integrase (Mazel, 2006). Transposons and integrons are both found in plasmids and 
in the bacterial chromosome; mutations in these elements enable the 
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microorganisms to rapidly adapt to changing environments (Henriques Normark & 
Normark, 2002).  
Resistance to antimicrobial agents can occur via several different mechanisms. 
These include producing enzymes that inactivate the antimicrobial agent, producing 
alternative enzymes that are insensitive to the enzymatic activity of the drug, 
mutation in the drug’s target site, altering of permeability of the outer membrane, and 
activating efflux pumps to remove the drug from the cell (Tenover, 2006). 
 
1.7 Resistance to β-lactam Antibiotics: 
Beta-lactam antibiotics are one of the most widely used antimicrobial agents (Kanj & 
Kanafani, 2011), therefore the emergence of resistance at high levels has been 
reported in many countries (Tenover, 2006). There are three possible mechanisms 
bacteria use to become resistant to beta-lactams. Firstly, by alteration in the target 
site, resistant bacteria are able to avoid the beta-lactam activity. For example, the 
mecA gene in methicillin-resistant Staphylococcus aureus (MRSA) synthesizes a 
new penicillin binding proteins (PBPs) that has a lower affinity to beta-lactams (Rice, 
2006). Other organisms such as Haemophilus Influenzae and Neisseria gonorrhoeae 
have also achieved their resistance by the same mechanism (Bradford, 2001). 
Alteration in access to the target site is the second mechanism that such 
resistant bacteria can use for beta-lactam resistance. This is mostly described in 
Gram negative bacteria where the impermeability of the outer membrane is 
increased in order to prevent the accumulation of the drug inside the cell. This 
occurs as a result of mutations in the porins (protein channels) located in the outer 
membrane (Blondeau et al., 2004). The permeability barrier of the outer membrane 
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is a major factor in the resistance of Pseudomonas aeruginosa to many β-lactam 
antibiotics (Tenover, 2006). 
 
The third and most important mechanism of resistance is by the production of β-
lactamases, enzymes that hydrolyze the beta-lactam ring of certain antibiotics 
(Therrien & Levesque, 2000). The genes coding for β-lactamases are mostly found 
on plasmids (Tenover, 2006). There are several classes of β-lactamases (see 
below), and many of these have now been reported from countries around the world 
(Bradford, 2001; Li et al., 2007).  
1.7.1 Classification of ESBLs 
The classification of β-lactamases was proposed on the basis of two types of 
categories, molecular structure and amino acid sequences (Ambler et al., 1991; 
Bush & Jacoby, 2010). In the Ambler classification, β-lactamases were divided into 
four classes (A, B, C and D) depending on their amino acid sequence.  Ambler 
initially identified two classes; A, which has a serine residue in the active site of the 
β-lactamase and B, which has the Zn ion at its active site (Ambler, 1980). The 
following year, a new class of serine B-lactamases (designated as class C) was 
reported, which was found to bear less similarity to the known sequences in class A 
(Jaurin & Grundström, 1981). Lastly, class D comprising a another group of serine β-
lactamases was identified, which appeared to be distinct from either class A or C 
(Ouellette et al., 1987).  
Bush and Jacoby scheme uses the β-lactamases substrate and inhibition 
profiles (a functional classification) to classify the enzymes (Bush et al., 1995). More 
recently, the two classification schemes have been integrated to include the newly 
emerging β-lactamase (see Table 1;(Bush & Jacoby, 2010)). Serine containing β-
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lactamases are subdivided based on their response to the B-lactamase inhibitor, 
clavulanic acid.  Extended- spectrum beta-lactamases (ESBLs) are classified in the 
molecular class A and belong to group 2be that are able to hydrolyze oximino-
cephalosprins but are inhibited by clavulanic acid (Braford, 2001). ESBLs have been 
reported in different species of the Enterobacteriaceae particularly in E. coli and 
Kelbsiella pneumoniae. They are also described in other non-fermentative Gram 
negative bacteria, for example in Acinetbacter baumanni and Pseudomonas 
aeruginosa  (Falagas & Karageorgopoulos, 2009). 
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Table 1. Summary of β-lactamase classification based on Bush’s new scheme (Bush et al., 2010). 
 
 
 
 
 
Ambler 
class 
Bush-Jacoby 
scheme 
Active site Functional characteristics Inhibited by  
Clavulanic acid 
Representative enzyme 
families 
A 2a,2b,2be,2br,2b
er,2c,2ce 
Serine Penicillinase,cephalosporinases and 
carbapenemases 
Yes TEM,SHV,CTX-M,VEB 
B 3a,3b Metallo ion Broad-spectrum carbapenemases 
inhibited by EDTA 
No VIM,IMP,IND 
C I,Ie Serine Cephalosporinases No CMY. E.coli AmpC, FOX 
D 2d,2de,2df serine Oxacillinases,cephalosporinases and 
carbapenemases 
Yes OXA 
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1.7.2 Origins of ESBLs 
ESBLs are originally derived from TEM or SHV enzymes (Falagas & 
Karageorgopoulos, 2009; Heffron et al., 1975; Naas & Nordmann, 1999; Tzouvelekis 
& Bonomo, 1999). These historically comprise the largest two families of plasmid–
encoded beta-lactamases that are prevalent in resistant bacteria of human origin, 
mainly in K. pneumoniae and E. coli (Li et al., 2007). The first ESBL-producing strain 
was reported in Germany in 1983 when strains of Klebsiella pneumoniae were found 
to exhibit resistance to cefotaxime and ceftazide,  mediated by SHV-1 (Knothe et al., 
1983). Two years later in 1984, K. pneumoniae with a similar resistance spectrum 
was identified in France and found to contain a variant of the broad spectrum TEM-2 
β-lactamase (as reviewed by Cantón et al., 2008). Since then, both enzymes have 
become prevalent worldwide and today more than 200 variants have been described 
(www.lahey.org). The ability of these enzymes to become prevalent was based on 
point of mutations in its amino acid sequences (as reviewed by Cantón et al., 2008). 
In the early 1990s, another type of ESBLs known as CTX-M, emerged. The CTX-M 
enzymes are able to hydrolyze cefotaxime (CTX) to a greater extent than ceftazidime 
(Bradford, 2001). There are many types of beta-lactamases in the family of CTX-M 
and it is believed that this family was originally mobilized by the insertion of 
chromosomally-encoded β-lactamases from Kluyvera ascorbata (Livermore & 
Hawkey, 2005). 
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1.7.2.1 Types of ESBLs 
1.7.2.1.1 SHV type 
SHV-1 was the first beta-lactam enzyme discovered in K. pneumoniae in Germany. 
SHV stands for sulphydyl variable which refers to the biochemical properties of the 
enzyme    (Tzouvelekis & Bonomo, 1999).  SHV family of β-lactamases are believed 
to be derived from Klebsiella spp. SHV-1 showed nucleotide sequence homology to 
LEN-1, which is a chromosomally encoded β-lactamase found in K. pneumoniae  
(Heritage et al., 1999). SHV enzymes belong to the molecular class A of serine β-
lactamases and share extensive functional and structural similarity with TEM β-
lactamases (Bush et al., 2010). The first SHV enzymes identified in E. coli was in 
USA in 1993 (Bradford et al., 1995). The gene was carried by a plasmid and 
conferred broad spectrum resistance to the second generation cephalosporins. The 
SHV β-lactamases accounts for up to 20% of plasmid-mediated ampicillin resistance 
in E. coli and K. pneumoniae (Tzouvelekis & Bonomo, 1999). Nowadays, more than 
200 of SHV varieties are known (http://www.lahey.org/Studies/webt.asp#SHV, as of 
September 2015). 
1.7.2.1.2 TEM type    
The TEM family of β-lactamases are derivatives of TEM-1 and TEM-2. According to 
the Bush-Jacoby-Medeiros classification scheme it belongs to group 2b and class A 
(Bush & Jacoby, 2010). TEM-1 was the first enzyme of the TEM family reported in 
1965 from an E. coli isolate (Datta & Kontomichalou, 1965). These enzymes are 
mostly detected in Gram negative bacteria particularly E. coli and Klebsiella spp.  
and are often found on plasmids or transposons  (Heffron et al., 1975). In E. coli, 
90% of ampicillin resistance is due to the production of TEM-1 enzyme (Cooksey et 
al., 1990). TEM-1 is able to deactivate penicillins and first generation cephalosporins, 
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but are not able to hydrolase clavulanic acid or extended spectrum cephalosporins. 
TEM-2 differs from TEM-1 by single point mutation in their amino acid sequence 
(Bradford, 2001), but this did not change the activity of the enzyme until the first 
report of TEM-3 in 1988  by which time the isolates showed extended spectrum beta 
lactamase activity  (Sougakoff et al., 1988). Since then, over 200 derivatives of TEM 
enzymes have been reported (http://www.lahey.org/Studies/temtable.asp, as of 
September 2015).  .  
1.7.2.1.3 OXA type 
The OXA type β-lactamase differ from TEM and SHV enzymes as they  are 
classified to belong to group 2d and class D ( Bush et al., 2010). They were initially 
identified in Pseudomonas aeruginosa in Turkey (Paterson & Bonomo, 2005). These 
enzymes are characterized by their ability to hydrolyze oxacillin and cloxacillin 
(hence the name OXA) and are poorly inhibited by clavulanic acid (Bardfor, 2001). 
OXA enzymes are mostly detected in Gram negative bacteria particularly P. 
aeruginosa (Bradford, 2010). Unlike TEM and SHV, OXA genes are encoded by 
narrow host range of plasmids with different enzyme activities (Naas & Nordmann, 
1999). It is believed that the emergence of OXA enzymes coincided with the 
introduction of methicillin and fluoxacillin as a treatment therapy for Staphylococcal 
infections (Evans & Amyes, 2014). More than 400 of OXA derivative enzymes are 
reported and these are widely disseminated in Gram negative bacteria 
(http://www.lahey.org/Studies/ as of September 2015). 
1.7.2.1.4 CTX-M type 
The predominance of TEM, SHV and OXA enzymes has been replaced by the 
emergence of another group of ESBLs called CTX-Ms, which have been increasingly 
reported over the last two decades (Bonnet, 2004). CTX-M β-lactamases are 
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classified as belonging to class A and functional group 2be (Bush et al., 2010). 
These enzymes are not closely related to the SHV and TEM enzymes, in fact they 
show only approximately 40% amino acid identity with these commonly detected β-
lactamases (Tzouvelekis et al., 2000).  
The first enzyme discovered capable of hydrolyzing cefotaxime but with 
sensitivity to ceftazidime, was isolated in Japan in 1986 from E. coli. The enzyme 
was detected in a fecal sample obtained from a dog used to study cephalosporin 
pharmacokinetics, and was first named as FEC-1(Matsumoto et al., 1988). The first 
human isolate with cefotaximase activity was identified in E. coli  recovered from an 
ear swab sample taken from a 4-month-old child in Germany in 1989; it was named 
CTX-M-1 (Bauernfeind et al., 1990). CTX-Ms are able to hydrolyze broad spectrum 
beta-lactam antibiotics and they hydrolyze cefotaxime (CTX) more effectively than 
ceftazidime, and hence the group acquired its name CTX and M from Munich 
(Bradford, 2001). In the same year, cefotaximase activity was identified in 
Salmonella Typhimurium from a patient with meningitis, septicemia and enteritis in 
Argentina (Bauernfeind et al., 1992). This enzyme had a different isoelectronic point 
(PI value) than that found for CTX-M-1. However, comparison of amino acid 
sequences showed that it had 84% homology to CTX-M-1 and so it was named 
CTX-M-2 (Bauernfeind et al., 1996). Since that time the emergence of CTX-Ms 
enzymes have become prevalent worldwide and now more than 172 subtypes are 
recognized (http://www.lahey.org/Studies/other.asp#table1, as of September 2015). 
CTX-M enzymes have been categorized into five different clusters based on their 
differences in amino acid sequence: CTX-M-1, CTX-M-2, CTX-M-8, CTX-M-9 and 
CTX-M-25 (Smet et al., 2010). Isolates producing these enzymes are mostly Gram 
negative bacilli including E. coli, Klebsiella spp, Shigella spp, Citrobacter spp, 
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Acinetobacter spp, Serrtia marcescens, Enterobacter spp,  and Sallmonella spp 
(Shibata et al., 2006; Fujita et al., 2011). 
The spread of CTX-M genes is largely due to their dissemination by 
conjugative plasmids (Rossolini et al., 2008). The plasmids belong to different 
incompatibility types including IncI1, IncF, IncFII and IncA/C,  and range in size from 
between 7 and 160 kb  (Novais et al., 2012 ; Coque et al., 2008; Accogli et al., 
2013). Broad host range plasmids such as IncI1,IncN and IncL/M are also known to 
carry additional genes conferring resistance to tetracycline, aminoglycosides and 
fluroquinolones (Bonnet, 2004). Thus, multi-drug resistant organisms have become 
widespread in nature. 
Certain types of CTX-Ms enzymes such as CTX-M-9, CTX-M-14 and CTX-M-
15 are reported to be associated with plasmids belonging to certain Inc types. For 
example, CTX-M-15 has been linked with incompatibility group IncI1 and IncFII 
plasmids in E. coli strains isolated from different sources in human and animals 
(Smet et al., 2010).   
As well as plasmids, mobile genetic elements such as transposons and 
insertion sequences (IS), play a crucial role in the dissemination of the CTX-M allele. 
IS and transposons are pieces of DNA that are able to move between and around 
the bacterial chromosome using the transposon enzyme (Frost et al., 2005). One 
such factor has been  identified upstream of the CTX-M genes and is associated with 
their mobilization (Cantón et al., 2012).  ISEcp1, which was the first identified IS, is 
widely distributed and usually located 24 - 266 bp upstream of the blaCTX-M gene. It 
provides a high level expression promoter for the downstream located CTX-M genes 
(Zhao & Hu, 2012). Other insertion sequences like IScR and IS10, have mostly been 
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detected in strains containing CTX-M-2, CTX-M-9 and CTX-M-8 subtypes, 
respectively  (Cantón et al., 2012)(Figure 3). 
 
Figure 3. Insertion sequences (IS) involved in the mobilization and expression of 
blaCTX-M genes. 
 
 
Insertion sequence (IS) surrounding blaCTX-M genes within different CTX-M groups (CTX-M-1, 
CTX-M-2, CTX-M-9 ,and CTX-M-25). (Adapted from Cantón et al., 2012).    
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1.7.3 Epidemiology of ESBLs   
Beta lactam-CTX-Ms are now ubiquitous and have been reported in isolates 
recovered from many sources, including humans, animals, food and sewage 
(Livermore & Hawkey, 2005). The rise of bla-CTX-M within hospitals may not be 
linked simply to the spread of resistant bacteria but could also be due to acquisition 
of resistant organisms from the wider community (Cantón & Coque, 2006). 
The prevalence of CTX-Ms among clinical isolates varies from country to 
country and from hospital to hospital (Figure 4). As illustrated in Figure 4, resistance 
mediated by CTX-M alleles is found worldwide and has now reached a high level 
(Hawkey & Jones, 2009). The level of ESBL-producing E.coli strains in Asian 
countries ranges between less than 10% in Australia and Japan to more than 30% in 
Singapore and China. CTX-M-15 is widely prevalent across the world and 
predominates in the UK over CTX-M-14.               
Figure 4. Graph showing the distribution of CTX-M types and their relative proportions 
in each area. 
 
Adapted from Hawkey and Jones (2009). 
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In USA, in a sample of more than 5000 isolates from 72 US hospitals 
collected in 2012, the highest rate of ESBLs was found in K. pneumoniae (16%), 
followed by E. coli (12%), K. oxytoca (10%) and Proteus mirabilis (5%) (Castanheira 
et al., 2014). In this study CTX-M belonging to CTX-M group1, 8, 9, 25 and in 
particular group 15, were the most common ESBL enzymes identified. In Europe, 
during the last four years (2010-2013) the level of resistance to third cephalosporins 
has increased significantly for E. coli, mostly in the south and east countries (Figure 
5). Closer examination of clinical isolates in the UK revealed that 75 % of ESBL-
positive isolates were associated with the production of CTX-M enzymes, of which 
CTX-M group1 and CTX-M group 9 predominated in E.coli  and CTX-M-9 in 
K.pneumoniae (Enoch et al., 2012).   
In northern European countries, several studies also report high levels of 
ESBL-producing strains. In Denmark, CTX-M-15 and 9 predominated among E.coli 
isolates (Kjerulf et al., 2008). A Norweigian study found that CTX-M was the most 
common ESBL enzyme present in clinical E.coli isolates with reduced susceptibility 
to oxyimino-cephalosporins. Nearly 90% of E. coli isolates examined carried the 
CTX-M allele, of which CTX-M-15 and CTX-M-9 were the most prevalent types 
(Tofteland et al., 2007).  In a Swedish study, CTX-M-15 was found to be the 
dominant resistance gene and was present in 58% of ESBL-producing E. coli 
isolates between 2007 and 2012 (Brolund et al., 2014). 
 In southern European countries, the detection of CTX-M producing strains 
was more prevalent in E. coli strains. In Spain, CTX-M-9 (27%) and 14 (20%) were 
the prominent alleles found in inpatients, outpatients as well as health workers 
(Hernández et al., 2005). In Portugal, surveillance study in individual hospitals found 
that of 181 E. coli isolates, 66 % ESBL producers of which 90% carried CTX-M-15 
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and 8% carried CTX-M-14 (Mendonça et al., 2007). An Italian study of ESBL 
production among Enterobacteriaceae isolated from 10 health centers found that the 
CTX-M allele was mostly identified in E. coli isolates, of which CTX-M-15 (60%) and 
CTX-M-1 (35%) were prevalent (Mugnaioli et al., 2006).   
 
 
Figure 5. Proportion of invasive E.coli isolates with resistant to third-generation 
cephalosporin in Europe.  
 
 
ECDC Annual Report, 2013 (Adapted from ECDC). 
 
 In France, the prevalence of CTX-M ESBLs was reported in different 
hospitals. CTX-M enzymes were most common in E. coli isolates and CTX-M-15 
(57%) was the most common ESBL type (Lavigne et al., 2007). 
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In European countries, all published studies have confirmed that the 
prevalence of ESBL-producing isolates in northern countries is low compared to that 
found in eastern countries (Adriana et al., 2012). The prevalence of ESBL-producing 
isolates is estimated to be more than 10% in Hungary, Poland, Russia and Turkey 
with K. pneuminae being among the most common ESBL producers and CTX-M-3 
being the most wide spread in hospitals (Adriana et al., 2012). This could be due to 
the poor implementation of infection control protocols within the hospitals in these 
countries, which help eliminate the resistant bacteria.  
1.7.4 ESBL in avian pathogenic E.coli (APEC) 
APEC isolates with multidrug resistance have now emerged worldwide (Overdevest 
et al., 2011; Zhao et al., 2005; Jakobsen et al., 2010). Avian ESBL–producing E. coli 
isolates have been increasingly reported worldwide. Poultry to human dissemination 
of resistant bacteria either via direct contact or via the food products, has been 
reported (Leverstein-van Hall et al., 2011). 
Carriage of multidrug resistance by both pathogenic and non-pathogenic E. 
coli isolates has been reported in poultry (van den Bogaard et al,. 2002 ; Costa et al., 
2009). Lambie et al., (2000) found that approximately 50% of E. coli isolated from 
diseased birds were resistant to 9 of 11 selected drugs, including aminoglycoside, β-
lactam and sulfamethoxazole-trimethoprim. In another study, Zhao et al. (2005) 
reported that multidrug resistance in APEC included resistance to cephalothin, 
ampicillin, amoxicillin/clavulanic acid, cefoxitin, tetracycline, nalidixic acid, 
sulfamethoxazole, streptomycin, and gentamicin, and mostly occurred in isolates 
belonging to the O78, O15 and O53 serotypes. 
The carriage of resistance in APEC have been mainly reported in isolates 
harboring resistant plasmids (Zhao et al., 2005; Fricke et al., 2009; Platell et al., 
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2011). The plasmids belong to different replicon groups including  IncX, IncN, IncFI, 
IncFIB and IncI (Carattoli, 2011), and are generally described as large and 
conjugative plasmids, which also carry resistance genes to heavy metals (Caudry & 
Stanisich, 1979). In poultry, plasmids harbouring the CTX-M genes were found to 
belong to a variety of incompatibility groups like A/C, P/F, I1-Ү, F, FIA and K, and the 
most common CTX-M types identified were 1, 3,14,15 and 55 (Randall et al., 2010). 
Recent studies have detected highly similar ESBL-producing E. coli in human 
and chickens (Accogli et al., 2013; Leverstein-van Hall et al., 2011). In the 
Netherlands, 35% of human isolates containing ESBL genes were similar to those 
found in chickens (Leverstein-van Hall et al., 2011).  CTX-M-1 was the most 
predominant gene found in this study corresponding to 86 % and 78% of human and 
chicken isolates, respectively. It was also noted that 19 % of ESBL genes detected in 
humans were carried by plasmids belonging to IncI1 type that were genetically 
identical to those found in poultry.  
A chinese study examined the patterns of antimicrobial resistance found in 
more than 700 isolates of E. coli isolated from chickens between 1970 and 2007 (Li 
et al., 2010). This study revealed that the detection rate of narrow spectrum β-
lactamase genes declined from 71% in 1970 to 29% in 2007, while the detection rate 
of third generation cephalosporin resistant strains increased to 18% between 2004 
and 2007. This corresponded to the period when CTX-M genes became globally 
distributed and increased worldwide.  
The prevalence of ESBLs in E.coli isolated from poultry in the UK was 
examined over a three year period between 2006 and 2009 (Randall et al., 2011). 
The study found that CTX-M genes were the main ESBL type present in 55% of 
E.coli isolates and the IncI1 plasmid type was the most common carrier of the gene. 
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The main zoonotic risk is likely associated with horizontal transfer of broad-host-
range IncI1 plasmids carrying blaCTX-M from avian E. coli to other zoonotic human 
pathogenic Enterobacteriaceae such as Salmonella. In addition, the broad host 
range of some strains belonging to certain sequence type complex, such as ST10, is 
worrying as this sequence type is found in both humans and healthy poultry 
(Bortolaia et al., 2011). However, characterizing plasmid relatedness among 1000 E. 
coli isolates of avian, human and poultry meat origin revealed that plasmids 
belonging to IncFIB replicon type is the most prevalent followed by IncI1 regardless 
of isolate origin (Johnson et al., 2007). Moreover, IncFIB and IncI1 plasmid types 
were the most frequent plasmid types found in APEC and retail poultry E. coli 
(RPEC) rather than in uropathogenic E. coli (UPEC), human and avian fecal 
commensal E. coli.  In fact, most virulence and resistance genes found in APEC 
particularly the O78 serogroup, are located on IncFIB plasmids such as pAPEC-1 
(Mellata et al., 2009).  
 
1.8 Resistant-plasmids and their impact on host bacterium 
The importance of plasmid biology was first realized by Ledberg and Tatum in 1952 
after identification of sex factor (F), as the transmissible agent mediating conjugation 
in E. coli (Johnson and Nolan, 2009). Bacterial plasmids are viewed as self-
replicating pieces of DNA smaller in size than the bacterial chromosome, which 
generally do not possess essential genes for bacterial cell growth but contain genes 
essential for the plasmid's replication, stability and transfer (Johnson and Nolan, 
2009). A number of research studies on plasmids and their properties have now 
been carried out in both Gram negative and Gram positive bacteria which has 
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increased understanding of plasmid behavior (reviewed in Garcillán-Barcia et al., 
2011).   
Many plasmids contain additional genes that add specific traits to the host bacterium 
(Frost et al., 2005). The fitness of bacteria within a specific ecological niche may be 
enhanced by acquiring traits that are not found in other competing strains (Hacker 
and Carniel, 2001). For example, it has been found that conjugative plasmids like R 
plasmids increase the fitness of newly transformed cells, even when acquired by 
different species (Dionisio et al., 2005). Notable fitness advantages have been 
reported. For example, the R1 plasmid which belongs to the IncFII group, carries 
genes conferring resistance to six antibiotics. Carriage of this plasmid significantly 
enhanced the fitness after 420 generations of resistant strains compared to the 
plasmid-free ancestral cells. To understand how evolved bacteria gain an advantage 
after propagation with the naïve plasmid for several hundred generations, Lenski et 
al.( 1994) examined fitness by deleting specific resistance genes from the plasmid. 
Using this approach, the authors showed that the tetracycline resistance gene 
increased the fitness of plasmid carriage in the evolved hosts. Another study also 
reported that fitness advantages were enhanced by apramycin resistance wild-type 
plasmids from non-pathogenic E. coli to new host suggesting that the plasmids may 
have evolved in these commensal hosts (Yates et al., 2006). 
The impact of the plasmids containing resistance genes and whether they 
enhance or are a burden to the bacterium in vivo has been also examined in strains 
of E. coli harboring plasmids confering resistance to fluroquinolones (Michon et al., 
2011). The authors found out that plasmids carrying qnrA3 genes enhanced bacterial 
fitness. This would suggest that the acquisition of resistance genes may enhance E. 
coli fitness even in environments where exposure to antibiotics are absent.   
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Plasmids of different Inc groups including IncN (pVE46, R46 and N3) and IncP (RP1 
and PUB307) on different E. coli host strains showed variable results in fitness 
impact in vitro and in vivo experiments. Derivatives of these plasmids carry 
expressed and partially silent resistance genes have been recently investigated by 
Humphrey et al. (2012). These plasmids contain genes blaoxa-2, sul1, aadA1 and tet 
(A) in the IncP groups or blaTEM-2, sul1, aadA1, tet(A) and aphA in the IncN group that 
confer resistance to first generation of cephalosporins, tetracyclines and other 
antimicrobial agents. In their study it was reported that PUB307 conferred a slight 
fitness cost compared to Rp1 in in vitro experiments, but in vivo neither plasmid 
showed an effect on bacterial colonization of the pig gut compared to the plasmid-
free strains. Similar results were obtained with R46, however N3 which belongs to 
the same group, showed a fitness advantage in both laboratory assays and in 
colonization of the pig gut.  The contrasting results for R46 and N3, which belong to 
the same Inc group and are of approximately the same size, could be related to the 
effect of extra genes that carried by the two plasmids. Although the researchers have 
highlighted this may explain this difference, they did not mention that the difference 
in fitness cost could be the result of R46 harboring a beta lactamase gene (blaoxa-2) 
whereas N3 does not.  
Plasmids contribute significantly to the pathogenesis of APEC O78. Strain 
x7122 has been used as a model APEC strain for the O78 serogroup (Mellata et al., 
2012 ; Gao et al., 2012 ; Provence & Curtiss, 1994). A study carried by Mellata et al., 
(2010) found that  curing x7122 of its’ three major plasmids attenuated the virulence 
of the strain in chickens. Thus, the fitness impact associated with large plasmids 
harbored by APEC has been generally based on plasmids that have been previously 
characterized and annotated (Mellata et al., 2009).   
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  IncI1 plasmids were recently observed in isolates of pathogenic E. coli and 
Salmonella spp. from poultry and human origin and were found to be associated with 
ESBL genes particularly the CTX-M-1 allele (Cloeckaert et al., 2010).  However, the 
positive or negative impact of plasmids carrying the CTX-M β-lactamase in APEC 
has not been studied in detail. This is a significant gap in knowledge given that these 
plasmids are often associated with ExPEC strains of human origin. Despite the 
extensive molecular characterization in ESBL-producing isolates around the world, 
few studies have focused on their ‘cost’ to the host bacterium and/or their role in the 
virulence of avian pathogenic E. coli isolates. 
 
1.9 Project aims and hypothesis 
The ESBL family of β-lactamases confers resistance to most β-lactams and are often 
carried on large promiscuous plasmids, which have become increasingly prevalent 
within animal and human bacterial isolates. However, there is a paucity of 
information regarding the ‘cost’ of ESBL plasmid carriage on the host bacterium, 
usually an E. coli isolate. Thus, the overall aim of this study was to investigate the 
impact of ESBL-containing plasmids on the fitness of avian pathogenic E. coli 
(APEC), an important pathogen of poultry and potential zoonotic threat to humans. 
Examining this question will enable testing of the underlying hypothesis that in the 
absence of antibiotic selection pressure ESBL plasmids confer a burden to the host 
bacterium which influences the fitness of the host bacterium. 
Main aims of the project: 
 To genotypically and phenotypically characterise ESBL-producing avian 
pathogenic E. coli (APEC) using plasmid profiling, PCR and next generation 
sequencing. 
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 To determine the transmissibility of the ESBL-producing plasmids to other 
avian or laboratory E. coli strains in vitro and ex vivo using a model of the 
chicken caeca. 
 To generate ESBL plasmid transconjugates and produce ESBL plasmid-free 
isolates in order to examine the impact of plasmid carriage on host cell 
phenotypes including growth and ability to form biofilms.  
 To determine the metabolic profile of ESBL-producing and non-ESBL-
producing isolates in order to investigate the link between plasmid carriage 
and bacterial metabolism. 
 To assess the impact of ESBL plasmid carriage on APEC interactions with 
eukaryotic cells and on their ability to produce an infection in the Greater 
Waxmoth larvae (Galleria mellonella) model. 
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2. Materials and Methods 
 
2.1  Bacterial strains and routine growth media 
Three E. coli isolates obtained from a survey examining the prevalence of ESBLs in 
broiler chicken and turkey flocks in the UK were examined in this thesis (Randall et 
al., 2011) and one strain non-resistant avian pathogenic E. coli strain was provided 
by Professor Roberto La Ragione. The three presumptive ESBL-producing strains 
(herein called SAP44, SAP45 and SAP46) were originally selected following growth 
on CHROMagar containing 1 µg /L cefotaxime and were presumed to be E. coli. The 
fourth isolate, herein called SAP24, a non-ESBL-producing E. coli isolate was 
included for comparative analysis. Strains were confirmed as E. coli (see section 
2.2.1) and verified where appropriate as ESBL producers (see section 2.2.2) prior to 
the start of any experiments. In addition, laboratory E. coli K-12 strain NEB 10-beta 
was used as a recipient bacterium in some of the conjugation assays.  
All media and media supplements were obtained from Oxoid (Basingstoke, UK) 
unless stated otherwise. Media were prepared using reverse osmosis water and 
sterilised by autoclaving at 121°C, 15lb in-2 for 15 min. All antibiotics were obtained 
from Sigma-Aldrich® (UK). All prepared media was stored at 4°C for a maximum of 2 
weeks until required. 
For routine bacterial culture, strains were grown in Luria-Bertani (LB) broth or 
LB broth solidified with 1.5% bacteriological agar.  LB broth was prepared by adding 
5 g of tryptone, 2.5 g of yeast extract and 5 g of NaCl to 0.5 L of distilled water and 
adjusting to pH 7.0 with 1 N NaOH prior to autoclaving. When needed, LB broth or 
LB agar was supplemented with 1 µg/mL cefotaxime in order to provide a selective 
media for the ESBL-producing isolates.  
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For long term storage, bacterial isolates were stored in MicrobankTM (Pro-
Lab Diagnostics, UK) vials at -80 oC until required. Strains were routinely grown from 
frozen stocks in LB broth or LB agar. Cultures grown on solidified media were 
incubated at 37°C for 16 - 18 h whereas liquid cultures were incubated with shaking 
at 150- 200 rpm under the same conditions. 
For competitive growth assays, strains were grown in Davis minimal broth 
(Carlton and Brown 1981), supplemented with 25 mg/L glucose. Davis minimal broth 
was prepared by adding 3.5 g of potassium phosphate (diabasic trihydate) (K2HPO4), 
1.0 g of potassium phosphate (monobasic anhydrous) (KH2PO4), 0.5 g of ammonium 
sulfate (NH4)2 SO4) and 0.25 g of sodium citrate (Na3C6H5O7 (H2O)2) to 500 mL of 
distilled water. After autoclaving, 125 µl of 10% glucose, 500µl of 10% magnesium 
sulfate (MgSO4) and 500µl of 0.2% Thiamine (vitamin B1) was added.  
For bacterial survival assays, bacteria were grown in M9 minimal media, 
supplemented with single carbon sources or iron sulfate (FeSO4), as appropriate. M9 
minimal media was prepared by adding 3 g of sodium phosphate (Na2HPO4), 1.5 g 
of potassium phosphate (Na2PO4), 0.5 g of sodium chloride (NaCl) and 1 g of 
ammonium chloride (NH4Cl) to 500ml of water. After autoclaving, 500 µl of 1M 
magnesium sulfate (MgSO4), 500 µl of 0.1M calcium chloride (CaCl2) and 5 ml of 10 
%( w/v) glucose (or another carbon source) was added. 
Viande Levure (VL) media was used in the in vitro chicken gut model in order to 
provide nutritional support for the microflora obtained from the chicken caecum 
(Nisbet et al., 2000). To 1 L of citrate buffer (prepared by adding 118 ml of 0.1 M 
citric acid and 382 ml of 0.1 M sodium citrate and adjusting the pH to 5.8), the 
following compounds were added prior to autoclaving: 2.5 g of beef extract, 5 g of 
42 
 
yeast extract, 2.5 g of glucose, 10 g of tryptone, 5 g of NaCl and 0.6 g of L-cysteine 
HCl.    
  
2.2 Confirmation of species and phenotypic properties of isolates 
2.2.1 Species identification using API20E 
API20 E test strips, which contain 20 miniaturised biochemical reactions, were used 
to verify the species identity of the strains (bioMerieux, UK). The strips were 
inoculated with bacterial suspensions according to the manufacturer’s instructions 
and incubated at 37oC for 18h. The following day, any colour changes evident in 
each well were compared to the index book and the most likely species for each 
isolate determined. 
2.2.2 Antibiotic susceptibility testing 
The avian E. coli isolates were tested for their sensitivity to different antimicrobial 
agents in accordance to the guidelines described by the British Society for 
Antimicrobial Chemotherapy (BSAC, 2012). Bacterial antimicrobial sensitivity assays 
were performed using Iso-sensitet agar (ISA) (Iso-Sensitest™ Agar CM0471, Oxoid), 
prepared by 15.5 g of ISA agar to 500 ml of water as stipulated by the manufacturer. 
Bacterial suspensions were spread on petri dishes containing ISA agar and when 
dry, discs impregnated with different antibiotics (Table 2) were carefully placed on 
the surface of the media. Plates were incubated for 18 hr at 37˚C.  The following day, 
the zone of inhibition around each disc was measured and resistance or sensitivity 
determined based on the BSAC guidelines. In these assays, E. coli NCTC 10418, 
which is a susceptible strain, was used as a negative control to ensure all discs 
contained an active antimicrobial. All antimicrobial discs and chemicals were 
obtained from Sigma-Aldrich (UK). 
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Table 2. Antibiotic disc content and accepted zones of inhibition (mm) around E. coli 
NCTC10418, a suspectible control strain.   
Antimicrobial agents Disc content 
(g) 
Zone of 
inhibition 
(mm) 
Amikacin 30 24-27 
Gentamicin 10 21-27 
Ampicillin 10 21-26 
Cefotaxime 30 36-45 
Cefoxitin 30 28-33 
Cefpodoxime  10 29-36 
Ceftazidime 30 32-40 
Cefotaxime-clavulanic acid  30/10A 39-44 
Ceftazidime-clavulanic acid 30/10 31-39 
Ciprofloxacin 1 31-40 
Nalidixic acid 30 28-36 
Tetracycline 10 23-29 
Chloramphenicol 10 21-27 
Sulphamethoxazole 
/Trimethoprim 
25 28-36 
The susceptible E. coli NCTC10418 control strain was grown in the presence of antibiotic 
discs containing the following antibiotic content. Zones of inhibition are provided by the 
manufacturer and represent typical values that can be used to indicate the susceptibility or 
otherwise of test isolates grown under the same conditions. All plates were incubated at 35-
37˚C in air for 18-20 h.  
Footnote: A, two values are given for performing β-lactamase tests and for screening and confirmatory 
tests for ESBLs.  
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2.2.3 Phenotypic confirmation of ESBL production 
In order to confirm ESBL production in the avian E. coli isolates, the combination 
disc diffusion method was performed according to BSAC standards (BASC, 2012). 
Discs containing cefotaxime (30 μg) or ceftazidime (30 μg), with or without the β-
lactamase inhibitor, clavulanic acid, were placed on Iso-sensitet agar that had been 
spread with bacterial suspensions. Strains were considered ESBL producers when 
the zone of inhibition around the disc containing either cefotaxime or ceftazidime and 
clavulanic acid, was 5 mm or more than that around either cefotaxime or ceftazidime 
alone.  
 
2.3 Genetic characterisation of avian E. coli isolates  
The phylogenetic group, O-antigen type and virulence gene content of the avian E. 
coli isolates was assessed using various single and multiplex PCR (see below). For 
all PCR assays, template DNA was prepared by suspending one bacterial colony in 
1 ml of nuclease-free water and subjecting the cell suspension to heating at 95oC for 
10 min. Two µl of the resulting cell lysate was added to each PCR reaction. PCR 
products were separated by mixing with an appropriate volume of loading dye 
(Promega) and loading into 0.7 - 1.2 % (w/v) agarose gels made with 1x TAE (Trise-
Acetate-EDTA) or 1x TBE (Trise-Borate-EDTA) buffer.  A 50X stock of TAE buffer 
was made as mixing 242g Tris-base, 57.1 mL acetic acid and 100 mL of 0.5M 
sodium EDTA and making the solution up to 1 L with water.  A 10X TBE stock was 
made by mixing 108 g of Tris base, 55 g of boric acid and 40 mL of 20mM EDTA (pH 
8.0) and making the solution up to 1 L with water. To stain nucleic acids present in 
the gel, 5 µl of RedSafe DNA staining solution (iNtRON biotechnology, Korea) was 
added to 100 ml of molten agarose prior to pouring into the gel tray. DNA ladders 
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containing fragments corresponding to 1 kb or 100 bp scaled ladders were used to 
estimate the size of any products. Gel electrophoresis was performed at 95V for 90 
min in a Model H5 tank (BRL, USA) and an image of the gel was captured under UV 
light using GeneFlash (Syngene, UK). 
2.3.1 Multiplex PCR for phylogenetic group 
Multiplex PCR was used to determine the phylogenetic group of each isolate as 
previously described (Clermont et al., 2000). Phylogenetic group classification was 
based on the combination of these genes: group A (chuA−, TSPE4.C2−, yjaA+), 
group B1 (chuA−, TSPE4.C2+,yjaA−), group B2 (chuA+, TSPE4.C2−/+, yjaA+) and 
group D (chuA+,TSPE4.C2−/+, yjaA−). E. coli negative for all products were 
assigned to group A0 (Kemmett et al., 2014). 
  The sequences of the primers and the expected amplicon sizes for each 
reaction are listed in Table 3 . PCR amplification reactions were performed in a total 
volume of 25 µl, made up of 12.5 µl of 2X Qiagen Multiplex PCR Master Mix (Qiagen 
GmbH, Hilden, Germany), 0.5 µl of 10 µM primer solution (final concentration 0.2 
µM) and 2 µl of DNA template. The cycling parameters were as follows: an initial 
denaturation at 95°C for 15 min; followed by 30 cycles of 94°C for 30 s, 62°C for 90 
s, and 72°C for 60 s; and with a final extension at 72°C for 10 min. The amplified 
PCR products were subjected to electrophoresis in a 1.5% agarose gel in 1X TAE 
buffer. Positive control strains were available in-house (from Elie Salim, personal 
communication) and nuclease-free water was used as a negative control. 
 
 
 
 
46 
 
Table 3. Primers and amplicon sizes used in phylogenetic typing.  
Primers name Primer sequence Size 
 
ChuA 
F- GACGAACCAACGGTCAGGAT  
279 R- GCCGCCAGTACCAAAGACA 
 
YjaA 
F- TGAAGTGTCAGGAGACGCTG  
211 R- ATGGAGAATGCGTTCCTCAAC 
 
TspE4C2 
F- GAGTAATGTCGGGGCATTCA  
152 R- CGCGCCAACAAAGTATTACG 
Taken from Clermont et al. (2000). 
 
2.3.2 PCR-based O-antigen typing of avian E.coli isolates 
To further characterise the isolates, O-antigen typing was performed by PCR as 
previously described (Clermont et al., 2011). The primer sequences of all available 
O-antigen alleles and the expected amplicon sizes are given in Table 4. Single PCR 
amplification reactions were performed in a total volume of 25 µl, made up of 12.5 µl 
of 2X Qiagen Multiplex PCR Master Mix (Qiagen GmbH, Hilden, Germany), 0.5 µl of 
10 µM primer solution (final concentration 0.2 µM) and 2 µl of DNA template. The 
cycling parameters were as follows: an initial denaturation at 95°C for 15 min; 
followed by 30 cycles of 94°C for 30 s, 62°C for 90 s, and 72°C for 60 s; and with a 
final extension at 72°C for 10 min. The amplified PCR products were subjected to 
electrophoresis in a 1.5% agarose gel in 1X TAE buffer. 
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Table 4 Primers and amplicon sizes used for O-antigen typing.   
Primer 
designation 
Primer sequence Target Size of PCR 
product (bp) 
 
gndbis.f 5’-ATACCGACGACGCCGATCTG -3’    
rfbO1.r 5’-CCAGAAATACACTTGGAGAC-3’ rfbO1 189  
rfbO2.r 5’-GTGACTATTTCGTTACAAGC-3’ rfbO2 274  
rfbO4.r 5’-AGGGGCCATTTGACCCACTC-3’ rfbO4 193  
rfbO6a.r 5’-AAATGAGCGCCCACCATTAC-3’ rfbO6 584  
rfbO7.r 5’- CGAAGATCATCCACGATCCG -3’ rfbO7 722  
rfbO8a.r 5’-GAACAATATTGTAAGGTCGCC-3’ rfbO8a 227  
rfbO15.r 5’-TGATAATGACCAACTCGACG-3’ rfbO15 536  
rfbO16.r 5’-GGATCATTTATGCTGGTACG-3’ rfbO16 450  
rfbO17.r 5’-CGGTGTTAAAGGTGCTGCTA-3’ rfbO17 302  
rfbO18.r 5’-GAAGATGGCTATAATGGTTG-3’ rfbO18 360  
rfbO21.r 5’-CAGTAAGAGCTCTTGCTAAG-3’ rfbO21 250  
rfbO25a.r 5’-GAGATCCAAAAACAGTTTGTG-3’ rfbO25a 313  
rfbO25b.r 5’-TGCTATTCATTATGCGCAGC -3’ rfbO25b 300  
rfbO26.r 5’-GTATGAGCAAAATGGTGAGC-3’ rfbO26 329  
rfbO45a.r 5’-GCGCAATAAATGGCTGACTG-3’ rfbO45a 312  
rfbO45b.r 5’-TGCGAGTAGACTATCTCAAG-3’ rfbO45b 436  
rfbO55.r 5’-AATTTAGGTCCGGCAGCAAG -3’ rfbO55 675  
rfbO75.r 5’-GTAATAATGCTTGCGAAACC-3’ rfbO75 419  
rfbO78.r 5’-GCACTGCCATTGGTATTTACG-3’ rfbO78 464  
rfbO81.r 5’-GAGCAGTATATATTACTGGTG-3’ rfbO81 383  
rfbO83.r 5’-TTCCTTCACGACAACTAAGG-3’ rfbO83 219  
rfbO86.r 5’-CGTTGTTAATAATTCTGAATGCG-3’ rfbO86 361  
rfbO88.r 5’-AAGGAAAAACGCTGGGAGAG-3’ rfbO88 494  
rfbO103.r 5’-GAACTTGGATGGAAAGCCTG-3’ rfbO103 242  
rfbO104.r 5’-TGGCTTAGGATACTTGCAGC-3’ rfbO103 410  
rfbO111.r 5’-TTGAGTTCTGAGTGGGAAGG-3’ rfbO111 522  
rfbO127.r 5’-ACGTCAATTCATGTGCGACG-3’ rfbO127 554  
rfbO128.r 5’-AACTCGGAGAGTTCCCTATG-3’ rfbO128 319  
rfbO150.r 5’-TAACGCTAGTGGCAGCAATG-3’ rfbO150 602   
rfbO157.r 5’-TACGACAGAGAGTGTCTGAG-3’ rfbO157 672  
Taken from Clermont et al. (2011).   
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2.3.3 PCR-based determination of Virulence gene content 
While no single virulence gene defining APEC, the presence of several virulence 
genes (iss, ibeA,iucD etc.) is widely recognised as confirmation of E. coli belonging 
to the APEC pathotype (Köhler & Dobrindt, 2011). Thus, the avian E. coli test 
isolates used in this thesis were examined for the presence of 14 common virulence 
genes using two separate multiplex PCRs.  Table 5 lists the primers and sizes of the 
expected amplicons of the five plex and nine plex PCR reactions, respectively. In the 
five plex PCR, the presence of the following genes was examined: iroN, ompT, hylF, 
iss and iutA. The reaction tube contained 0.3 µl of Taq (Promega), 0.5 µl of each 
primer, 1 µl of dNTPs (Promega),2 ul of MgSO4, 5 µl of Taq buffer, 3 µl DNA and 
was made up to 25 µl with dH2O. The PCR reaction conditions consisted of a 5 min 
denaturation step at 95oC, followed by 35 amplification cycles of 30s at 95oC, 30s at 
55oC and 40s at 72oC, with a 7 min elongation step at 72oC. Samples were run on a 
3% gel and analysed for amplicon content.  
In the nine plex PCR, the presence of the following genes was examined: 
astA, irp2, papC, iucD, tsh, vat, cvi/cva, ibeA and sitA. The reaction tube contained 
0.3µl of GoTaq, 0.5µl  of each primer, 1µl  of dNTPs, 2µl  of MgCl2, 5µl of GoTaq 
buffer, 3µl of DNA and was made up to a 25µl total volume with dH2O. The PCR 
reaction conditions consisted of a 5 min denaturation step at 95˚C, followed by 35 
amplification cycles of 30s at 95˚C, 30s at 55˚C and 2 min at 72˚C, with a 10 min 
elongation step at 72˚C.  Samples were electrophoresed on a 2% agarose gel and 
analysed for amplicon content.  
. 
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Table 5. Primers used for the detection of virulence genes in APEC.
Gene Forward primer (5’-3’) Reverse primer (5’-3’) size 
(bp) 
Function 
Five plex PCR primers (Johnson et al., 2008) 
iroN  AATCCGGCAAAGAGACGAACCGCCT GTTCGGGCAACCCCTGCTTTGACTTT 553 Siderophore receptor 
ompT  TCATCCCGGAAGCCTCCCTCACTACTAT TAGCGTTTGCTGCACTGGCTTCTGATAC 496 Outer membrane protein 
hlyF GGCCACAGTCGTTTAGGGTGCTTACC GGCGGTTTAGGCATTCCGATACTCAG 450 Hemolysin 
iss CAGCAACCCGAACCACTTGATG AGCATTGCCAGAGCGGCAGAA 323 Serum survival 
iutA  GGCTGGACATCATGGGAACTGG CGTCGGGAACGGGTAGAATCG 302 Siderophore receptor 
Nine plex PCR primers (Arabi et al., 2013; Momtaz et al., 2013;  Zhao et al., 2009 ; wers et al., 2007 ; Schouler et al., 2012 ; Kwon et al., 2008) 
astA TGCCATCAACACAGTATATCC TCAGGTCGCGAGTGACGGC 116 Toxin 
irp2  AAGGATTCGCTGTTACCGGAC AACTCCTGATACAGGTGGC 413 Iron acquisition 
papC TGATATCACGCAGTCAGTAGC CCGGCCATATTCACATAA 501 Adhesin 
iucD ACAAAAAGTTCTATCGCTTCC CCTGATCCAGATGATGCTC 714 Iron acquisition 
tsh ACTATTCTCTGCAGGAAGTC CTTCCGATGTTCTGAACGT 824 Adhesin 
vat TCCTGGGACATAATGGTCAG  GTGTCAGAACGGAATTGT 981 Toxin 
cvi/cva  TGGTAGAATGTGCCAGAGCAAG GAGCTGTTTGTAGCGAAGCC 1181 Colicin V operon 
ibeA AGGCAGGTGTGCGCCGCGTAC TGGTGCTCCGGCAAACCATGC  171 Invasion 
sitA AGGGGGCACAACTGATTCTCG TACCGGGCCGTTTTCTGTGC 608 Binding protein 
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2.3.4 PCR-based identification of ESBL and CTX-M enzyme type 
 PCR was used to identify the type of ESBL present in the ESBL-producing avian E. 
coli isolates. The presence of blaSHV, blaTEM, blaCTX-M, and blaOXA-type resistant genes 
was assessed using a previously published multiplex PCR assay (Fang et al., 2008). 
The primer sequences and the expected amplicon size for each gene are listed in 
Table 6. PCR amplification reactions were performed in a total volume of 25 µl, made 
up of 12.5 µl of 2X Qiagen Multiplex PCR Master Mix (Qiagen GmbH, Hilden, 
Germany), 0.5 µl of 10 µM primer solution (final concentration 0.2 µM) and 2 µl of DNA 
template. The cycling parameters were as follows: an initial denaturation at 95°C for 
15 min; followed by 30 cycles of 94°C for 30 s, 62°C for 90 s, and 72°C for 60 s; and 
with a final extension at 72°C for 10 min. The amplified PCR products were subjected 
to electrophoresis in a 1.5% agarose gel in 1X TAE buffer.  A pathogenic E. coli strain 
known to be positive for the 4 tested genes was included as a positive control 
(available from Elie Salim, personal communication).  
 
                    Table 6 Primers and amplicon sizes used for the detection of different β-            
lactamase genes by multiplex PCR. Taken from Fang et al. (2008). 
Primers and Amplicon sizes 
Gene Primer sequence Size bp 
SHV blaSHV-F CTT TAT CGG CCC TCA CTC AA  
blaSHV-R AGG TGC TCA TCA TGG GAA AG 
237 
TEM blaTEM-F CGC CGC ATA CAC TAT TCT CAG AAT GA  
blaTEM-R ACGCTCACC GGCTCC AGA TTT AT 
445 
CTX blaCTX-M-F ATG TGC AGY ACC AGT AAR GTK ATG GC  
blaCTX-M-R TGG GTR AAR TAR GTS ACC AGA AYC AGC GG 
593 
OXA blaOXA-F ACA CAA TAC ATA TCA ACT TCG C  
blaOXA-R AGT GTG TTT AGA ATG GTG ATC 
813 
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Strains that were positive for the presence of the CTX-M genes were subject to further 
characterisation to identify the specific CTX-M group type by multiplex PCR (Woodford 
et al., 2005). The PCR assay distinguishes between CTX-M genes belonging to the 5 
CTX-M groups: group 1, 2, 8, 9 and 26. The primers and sizes of the expected 
amplicon products for each group are listed in Table 7. 
 
                                        Table 7  Primers and amplicon sizes of different CTX-M groups using a 
multiplex PCR. Taken from Woodford et al. (2005).  
Primer name  
 
Primer Sequence (5'-3') 
 
Product size 
 
 
CTX-M group 1 
F- AAAAATCACTGCGCCAGTTC 
415-bp R- AGCTTATTCATCGCCACGTT 
CTX-M group 2 
F- CGACGCTACCCCTGCTAT T 
552-bp R- CCAGCGTCAGATTTT TCAGG 
CTX-M group 9 
F- CAAAGAGAGTGCAACGGATG 
205-bp R- ATTGGAAAGCGTTCATCACC 
       CTX-M group 26 – F F- GCACGATGACATTCGGG 327-bp 
          CTX-M group 8/26 – R R- AACCCACGATGTGGGTAGC 327-bp or 666-bp 
          CTX-M group 8 F- TCGCGTTAAGCGGATGATGC 666-bp 
  
2.4 Characterisation of plasmid content of avian E.coli isolates 
2.4.1 Plasmid profile of avian E.coli isolates 
In order to determine the plasmid content of the avian E. coli isolates, plasmid DNA 
was extracted from broth cultures and analysed by gel electrophoresis. Plasmids in 
the different bacterial strains was prepared by the method of Kado and Liu (Kado & 
LIU, 1981). The method uses the molecular properties of the plasmid DNA to separate 
it from chromosomal DNA.  As the covalently closed circular DNA, which is released 
from the bacterial cells under conditions where the bacterial genome is denatured by 
using alkaline sodium dodecyl sulphate (pH 12.6) at an elevated temperature.  
Isolates were grown with shaking at 37˚C for approximately 18 h in 3 ml of LB broth. 
The following day, broth cultures were centrifuged at 13,000 rpm for 5 minutes. The 
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supernatants were discarded and the cell pellets re-suspended in 20 µl of suspension 
buffer (50 mM Tris-HCl, 1 mM EDTA, pH 8.0). To lyse the cells, 150 µl of lysis buffer 
(3% SDS, 50 mM Tris, pH 12.5) was added to the suspension and the resultant 
solution incubated for 30 minutes at 55˚C.  After incubation, 150 µl of phenol-
chloroform-isoamyl (25:24:1) was added to denature proteins and inactivate RNAases. 
The suspension was then centrifuged at 13,000 rpm for 10 minutes and the upper 
aqueous phase containing the plasmid DNA, transferred into fresh microtube for 
analysis by gel electrophoresis. Plasmid DNA (35 µl) was loaded together with 7 µl  of 
loading dye into an 0.8% agarose gel, to which Redsafe stain had been added. The 
gel was electrophoresed at 95 V for 1 hour and the banding pattern visualised under 
the Ultra-Violet transilluminator system. E .coli 39R strain was used a reference strain 
in this method as it contains several plasmids of known sizes. The E.coli 39R strain 
was obtained from Animal and Plant Health Agency (APHA, Weybridge, UK).  
2.4.2 Plasmid DNA extraction, sequencing and annotation 
Plasmid DNA for sequencing was extracted from the avian E. coli isolates using the 
large-construct Plasmid DNA extraction kit (Qiagen, location) according to the 
manufacturer’s instructions. Plasmid DNA was assessed for quantity and purity based 
on the A260/A280 ratio using a NanoDrop (Thermo scientific, UK). Purified plasmid DNA 
was sent to the Animal and Plant Health Agency (APHA, Weybridge, UK) for next 
generation sequencing using an Illumina sequencer. Illumina sequencing raw data 
was assembled de novo using sequence analysis software such as VELVET (version 
1.2.10) or CLC Main Workbench (version 7.5.1). The quality of the assembled 
sequence data was examined using VELVET and FastQ software. The generated 
contigs were ordered by aligning them against a reference fully-sequenced plasmid, 
pC49-108 (accession no: KJ484638) and annotated using CLC Main Workbench 
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(version 7.5.1). To close the gaps in plasmid sequence following alignment, PCR 
primers were designed using Primer3 software (http://simgene.com/Primer3) (Table 8) 
and PCR reactions performed using standard reaction conditions. The PCR products 
were sent to Beckman Coulter Genomics, UK for PCR primer walk sequencing. The 
new sequence data was then inserted in to fill the gaps in the plasmid DNA backbone.  
The newly closed plasmid DNA backbone was subsequently aligned against two 
reference plasmids pC49-108 (accession no: KJ484638) and R64 (accession no: 
AP005147) using the Artemis comparison Tool (Sanger, UK). For the pFIB44 plasmid, 
the reference pAPEC-1 plasmid DNA (accession no: CP000836) was used for 
comparative analysis. 
 
     Table 8 Primers used to close the gap in Inc1I and IncFIB plasmids 
Plasmids  Forward primer (5’-3’) Reverse primer (5’-3’) 
pSAP44 (IncI plasmid) ACCTTTGATGGTGGCGTAAG 
 
GGCTGAAAATCACCACCACT 
 
pFIB44 (IncFIB plasmid) TCCATTCCTGGTCTACTGCC TACCAGAAATGCGAAGACCC 
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2.5 Whole genome sequencing, assembly, annotation and analysis 
The genome sequences of SAP44 and SAP24 strains were selected for comparison 
because both strains belonged to the same phylogenetic and O-antigen group, but 
differed in their ESBL status. Moreover, strains within this grouping (CP004009; O78) 
represent a major cause of colisepticemia, an invasive infection caused by APEC  
(Schouler et al., 2012). It was postulated that genomic comparisons could provide 
insights into whether ESBL plasmid carriage influenced host genome structure. In this 
case, SAP44 is an ESBL-producing avian E. coli while SAP24 is the naïve, non-ESBL-
producing avian E. coli belonging to the same serogroup. 
     For genomic sequencing, the ArchivePure DNA Purification kit (5PRIM, UK) 
was used to extract and purify genomic DNA from the avian E. coli isolates according 
to the manufacturer’s instructions. Following extraction, DNA quantity and purity (ratio 
A260/A280 nm) were determined using a NanoDrop (Thermo scientific, UK). Genomic 
DNA was sequenced by next generation sequencing by the Animal Health Trust (AHT, 
location) using an Illumina sequencer. Illumina sequencing raw data was de novo 
assembled using VELVET version (1.2.10). The quality of the sequence reads was 
assessed using FastQC software (version 0.10.1). A preliminary annotation of each 
genome was generated using the automated annotation software RAST(Aziz et al., 
2008). Phage-associated gene clusters within the genomic scaffolds were initially 
identified using the PHASTserver(Zhou et al., 2011).  Genomic scaffolds with positive 
PHAST hits were further verified to be phage-associated in the RAST annotation 
output. Single nucleotide polymorphisms (SNP) was examined using snpTree 1.1, a 
web-based on-line server for SNP analysis (Leekitcharoenphon et al., 2012). Multi 
locus sequence typing (MLST) was performed in order to determine the clonality of the 
strains using the free access server provided by the University of Warwick 
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(http://mlst.warwick.ac.uk/mlst/). IslandViewer software (Dhillon, 2015) was used to 
identify putative genomic islands (GIs). IslandViewer is a tool server that integrates 
three different genomic island prediction methods: IslandPick, IslandPath-DIMOB, and 
SIGI-HMM. Comparative analysis of the core scaffolds of each whole genome 
sequence was performed using Mauve software (version 2.3.1).  
The genomes of APEC O78 (CP004009), APECO1 (PC000468), APEC O2 
(PC005930) and Uropathogenic E. coli (UPEC O6, AE014075.1) obtained from the 
NCBI GenBank database were analysed alongside the genomic data of SAP44 and 
SAP24.  These genome sequences were included in this analysis as out-groups to 
confirm the validity of the comparison methods used in this study. 
 
2.6 Generation of ESBL-producing transformants and cured derivatives of avian E.coli 
isolates. 
In order to study the impact of ESBL plasmid carriage on the bacteria, two sets of 
derivatives were obtained. First, the ESBL plasmid was transferred to naïve non-
ESBL-producing E. coli isolates. Second, the ESBL plasmid was removed from the 
original ESBL-producing isolates to obtain cured (or plasmid-free) derivatives. 
Serendipitously during this process, derivatives that had lost one or both of the large 
plasmids present in SAP44 were obtained (see section 2.6.2).  
2.6.1 New ESBL-producing derivatives 
ESBL plasmids were transferred to naïve, non-ESBL-producing laboratory and avian 
E. coli isolates using electroporation or conjugation, respectively. Electroporation was 
used to transfer the plasmid to the laboratory E. coli NEB 10-beta strain (herein 
referred to as SAP59) (see below). Once these new ESBL-producing E. coli K12 
derivatives were obtained, the strains were used to move the ESBL plasmid via 
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conjugation to a naïve non-ESBL-producing avian E. coli isolate (SAP24). Plasmids 
from each of the native ESBL-producing APEC isolates (SAP44, SAP45 and SAP46) 
were subject to these manipulations.   
 
2.6.1.1 Electrocompetent cells preparation 
NEB 10 - beta E. coli electrocompetent cells were prepared as described by Wu et al., 
(2010). Bacterial cells were streaked out onto LB agar and grown for 18 h at 37oC.  A 
single colony was inoculated into 10 ml of LB broth and the culture incubated for 18 h 
at 37 oC in a shaking incubator. Two and half millilitre of bacterial culture was then 
transferred to 500 ml of LB medium and incubated at 37ºC with vigorous shaking at 
300 rpm till the cell density reached an OD between 0.5 – 0.7 at 600nm 
(approximately 4 hours). The culture flask was then chilled in ice for 30 min. Then, the 
cells were collected by centrifugation and subjected to 15 ml of 10% ice-cold glycerol 
in order to wash the cells free of salts.  Washed cells were resuspended in 10% ice-
cold glycerol and left on ice for 10 min before pipetting 100 ul aliquot into each 
cryovial. The cell aliquots were either directly applied for electroporation of plasmid 
DNA or immediately transferred to the -80 ˚C freezer. 
2.6.1.2 Electrotransformation of  E.coli NEB 10-beta (SAP59) 
The electroporation protocol was performed as follows: previously prepared 
electrocompetent cells were placed on the ice for about 10 minutes to thaw. The cells 
were mixed gently prior to 25 µl being transferred to a chilled microcentrifuge tube. To 
the cells, 1 µl of plasmid DNA was added. The cells/plasmid DNA mix was transferred 
into a chilled 1 mm electroporation cuvette. Electroporation was carried out at the 
following settings: 2.kV, 200 ῼ and 25 µF. The typical time constant was 4.8 to 5.1 
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milliseconds using a Bio-Rad Gene Pulser Electroporator (Bio-Rad, USA). 
Immediately after electroporation, 975 µl of SOC media (0.5% Yeast Extract, 2% 
Tryptone, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 mM MgSO4, 20 mM Glucose) 
was added and the entire contents of the cuvette transferred to a 15 ml falcon tube. 
The cells were incubated with gentle shaking for 1h at 37˚C.  As a negative control, 1 
µl of nuclease-free water was used instead of plasmid DNA. The cells were then 
diluted and100-200 µl spread on a pre-warmed LB plates containing 1ug/ml of 
cefotaxime to select for the transformants that had taken up the plasmid. Putative 
transformants were screened using the ESBL combination disc test, tested for 
amplification of the CTX-M gene by PCR and their plasmid profile was assessed in 
order to confirm that they harbored the CTX-M plasmid. Following confirmation of 
plasmid transfer, the strains were named SAP56 (contains ESBL plasmid from 
SAP44), SAP57 (contains ESBL plasmid from SAP45) and SAP58 (contains ESBL 
plasmid from SAP46), respectively. 
2.6.1.3 Transfer of ESBL plasmids by conjugation to avian E.coli (SAP24) 
Bacterial conjugation was used to transfer the ESBL plasmids from the newly 
generated ESBL-producing E. coli K12 derivatives, SAP56, SAP57 and SAP58 (see 
above) to the avian E. coli isolate (SAP24).  Conjugation was performed by mixing 
approximately equal numbers of stationary phase cells of the donor and recipient 
strains. Bacteria were grown in 3 mL of LB broth for approximately 18 h prior to 
centrifugation and re-suspension in 1 ml of fresh LB broth. Thereafter, 100 µl of the 
donor and recipient strain were mixed to give a final volume of 200 µl, which was 
spotted onto a nitrocellulose filter disc placed on top of a LB agar plate and incubated 
for 4 hours at 37 ˚C. 
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After incubation, the entire filter disc was transferred using sterile forceps to 25 ml of 
1X M9 media and placed in a vigourously shaking incubator for 10 minutes to re-
suspend the attached cells. Next, the cell suspension was centrifuged at 4,500 rpm for 
10 minutes and the supernatant was discarded. The cell pellet was re-suspended in 1 
ml of fresh 1X M9 salts and after gentle pipetting to resuspend the cells, 100 µl  was 
plated on LB agar plates containing 1µg/ml of cefotaxime and 80 uM/ml of X-gal.  X-
gal was added to the selection plates in order to provide a selective marker and 
enable discrimination between SAP24 and SAP59 strains. While SAP 24 is able to 
cleave X-gal giving rise to blue-coloured colonies on the plate, SAP59 does not 
harbour this enzymatic function, and thus grows as white-coloured colonies. As 
mentioned above, all putative transconjugants were confirmed for ESBL production, 
PCR amplication of the CTX-M allele and plasmid content. Following confirmation of 
plasmid transfer, strains were denoted as SAP140, SAP141 and SAP142.  
 
2.6.2 Generation of cured derivatives 
Curing the original avian E. coli isolates their ESBL plasmid offers another approach to 
experimentally study the contribution of the plasmid to the host bacterium. Curing was 
performed using a plasmid curing vector (pIFM27), which is a derivative of pCURE 
(Hale et al., 2010) and was developed by Irene Martin (PhD thesis, University of 
Surrey). This method avoids using stress or chemical detergents which may have a 
mutational effect on chromosomal DNA (Hale et al., 2010). Curing is based on using 
plasmids with the same incompatibility group and antisense RNA as the target plasmid 
so that the curing vector displaces the ESBL plasmid from the cell (see Figure 6). 
Plasmid pIFM27 was introduced by electroporation into electro-competent ESBL-
producing APEC cells and putative transformants selected by plating on LB agar 
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containing 50 µg/ml kanamycin.  The plates are incubated for 18 h at 37oC. The 
following day, putative transformants are checked for loss of the target plasmid by 
examining kanamycin-resistant colonies for their plasmid profile and gene content (by 
PCR). In order to remove the curing vector plasmid, transformants were grown for 18 
h with shaking at 37˚C in 5 ml of LB broth containing 50 µg/ml kanamycin. The 
bacterial cultures were then serially diluted in PBS to 10-6 and 100 µl of the 
appropriate dilution spread on LB agar plates and LB agar plates supplemented with 
5% sucrose. Only cells from which the vector plasmid has been removed, will grow on 
the sucrose-containing plates. Any colonies will be tested for the presence or absence 
of both plasmids by examining their susceptibility to kanamycin and cefotaxime as well 
as checking for loss of the CTX-M gene by PCR (summarized in Figure 7).  
 
 
 
                  Figure 6 .plFM 27 curing vector which was used to remove the Inc1I ESBL 
plasmid.   
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Figure 7. Summary of the plasmid curing procedure. Taken from (Hale et al., 2010). 
 
2.6.3 Plasmid Inc/rep typing of ESBL plasmids: 
The properties of the CTX-M plasmids were further characterized by examining their 
origins of replication. SAP59 derivatives (SAP56, SAP57 and SAP58) were selected 
for these assays in order to avoid cross-contamination with other plasmids present in 
the avian E. coli isolates. Strains were examined for the presence of 18 plasmid 
replicons types using five multiplex PCR reactions and three simplex PCR reactions 
as previously described (Carattoli et al., 2005). The primers and expected amplicon 
sizes following PCR amplification are listed in Table 9. PCR amplification reactions 
were performed in a total volume of 25 µl, made up of 12.5 µl of 2X Qiagen Multiplex 
PCR Master Mix (Qiagen GmbH, Hilden, Germany), 0.5 µl of 10 µM primer solution 
(final concentration 0.2 µM) and 2 µl of DNA template. The cycling parameters were 
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as follows: an initial denaturation at 95°C for 15 min; followed by 30 cycles of 94°C for 
30 s, 62°C for 90 s, and 72°C for 60 s; and with a final extension at 72°C for 10 min. 
The amplified PCR products were subjected to electrophoresis in a 1.5% agarose gel 
in 1X TAE buffer. All E.coli control strains were grown with 50 ug/ml ampicillin except 
where stated in the E. coli culture database. 
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Table 9 Primers and amplicon sizes used in PCR-based Inc/rep typing of plasmids.
Inc group Forward primer (5’-3’) Reverse primer (5’-3’) size (bp) 
Multiplex PCR (1)  
HI1 (multiplex 1) 5’-GGAGCGATGGATTACTTCAGTAC 5’-TGCCGTTTCACCTCGTGAGTA 471 
HI2 (multiplex 1) 5’-TTTCTCCTGAGTCACCTGTTAACAC 5’-GGCTCACTACCGTTGTCATCCT 644 
I1-Iγ (multiplex 1) 5’-CGAAAGCCGGACGGCAGAA 5’-TCGTCGTTCCGCCAAGTTCGT 139 
Multiplex PCR (2)  
X (multiplex 2) 5’-AACCTTAGAGGCTATTTAAGTTGCTGAT 5’-TGAGAGTCAATTTTTATCTCATGTTTTAGC 376 
L/M (multiplex 2) 5’-GGATGAAAACTATCAGCATCTGAAG 5-CTGCAGGGGCGATTCTTTAGG 702 
N (multiplex 2) 5’-GTCTAACGAGCTTACCGAAG 5’-GTTTCAACTCTGCCAAGTTC 242 
Multiplex PCR (3)  
FIA (multiplex 3) 5’-CCATGCTGGTTCTAGAGAAGGTG 5’-GTATACCTTACTGGCTTCCGCAG 462 
FIB (multiplex 3) 5’-GGAGTTCTGACACACGATTTTCTG 5’-CTCCCGTCGCTTCAGGGCATT 402 
W (multiplex 3) 5’-CCTAAGAACAACAAAGCCCCCG 5’-GGTGCGCGGCATAGAACCGT 242 
Multiplex PCR (4)  
Y (multiplex 4) 5’-AATTCAAACAACACTGTGCAGCCTG 5’-GCGAGAATGGACGATTACAAAACTTT 765 
P (multiplex 4) 5’-CTATGGCCCTGCAAACGCGCCAGAAA 5’-TCACGCGCCAGGGCGCAGCC 534 
FIC (multiplex 4) 5’-GTGAACTGGCAGATGAGGAAGG 5’-TTCTCCTCGTCGCCAAACTAGAT 262 
Multiplex  PCR (5 )  
A/C (multiplex 5) 5’-GAGAACCAAAGACAAAGACCTGGA 5’-ACGACAAACCTGAATTGCCTCCTT 465 
T (multiplex 5) 5’-TTGGCCTGTTTGTGCCTAAACCAT 5’-CGTTGATTACACTTAGCTTTGGAC 750 
FIIAs(multiplex 5) 5’-CTGTCGTAAGCTGATGGC 5’-CTCTGCCACAAACTTCAGC 270 
Simplex PCR  
F (simplex) 5’-TGATCGTTTAAGGAATTTTG 5’-GAAGATCAGTCACACCATCC 270 
K (simplex) 5’-GCGGTCCGGAAAGCCAGAAAAC 5’-TCTTTCACGAGCCCGCCAAA 160 
B/O (simplex) Forward primer same as used for K simplex 5’-TCTGCGTTCCGCCAAGTTCGA 159 
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2.7 Impact of ESBL plasmids on bacterial growth and metabolism 
The impact of the ESBL plasmids on the growth and metabolism of avian E. coli was 
assessed by comparing the response of wild type isolates to that of the cured 
(plasmid-free) derivatives. In addition, the response of some newly-transformed 
ESBL-producing derivatives was compared to that of the naïve host strain.  
 
2.7.1 ESBL plasmids and bacterial growth 
2.7.1.1 Single strain growth curves: 
In order to examine the impact of the avian E. coli plasmids on bacterial growth, 
single strain growth experiments were performed in LB broth, a nutrient-rich media. 
ESBL-producing and plasmid-free derivatives of E. coli were grown in LB broth with 
gentle agitation at 37˚C for 16 hours. The following day, a 100 µl of the culture was 
used to inoculate 100 ml of pre-warmed LB broth. Growth was monitored by 
measuring the absorbance of the culture solution at 600nm using a 
spectrophotometer (Helios Alpha,UK) as well as by enumerating the number of 
viable bacteria by serial dilution and plating. Growth curves were typically run over 8 
h and samples were analysed every hour. The Miles and Misra technique was used 
to accurately quantify the number of viable bacteria present at each time point. 
Bacterial suspensions were serially diluted 10-fold using maximum recovery diluent 
(MRD). Three 20 μl volumes of the cell suspension at each dilution were pipetted 
onto a suitable solidified growth medium. Where spread plates were also used due 
to the low numbers of viable bacteria, 0.1 ml of the bacterial suspension was spread 
on the surface of the media using a sterile plastic spreader. The growth of each 
bacterial strain was performed using at least three biological replicates. 
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2.7.1.2 Competitve growth studies and long term competitive growth assays 
Competitive growth experiments, where equal numbers of two differentially marked 
strains are grown together in the same medium usually offers a more sensitive way 
to identify differences in growth. Pair-wise competition growth experiments were 
performed for the naïve avian E. coli isolate (SAP24) and the ESBL-producing 
derivative (SAP140) in Davis minimal medium supplemented with 25 mg/ml glucose 
(aka DM25) as described previously (Enne et al., 2005). Strains were separately 
cultured for approximately 18 h in nutrient broth (NB) and inoculated singly at a 
dilution of 1:104 into DM25. The following day, the individual cultures were diluted at 
a ratio of 1:100 into fresh DM25 and incubated with shaking for another 24 h at 37˚C. 
Following this second period of growth, the absorbance of the cultures was 
measured and adjusted such that equal densities of cells were mixed together, in a 
1:1 ratio. This mixture was then diluted at 1:100 into a fresh DM25 and incubated 
with shaking at 37˚C for 24 h. After 24 h, the culture was then transferred at a 
dilution of 1:100 into fresh DM25 and this process was repeated 6 times in total.  The 
input culture and at each subsequent subculture step, 100 µl samples were plated 
out on nutrient agar plates with and without 1µg/ml of cefotaxime. Three independent 
repeats of the competitive growth experiments were performed. The fitness impact of 
the ESBL plasmid was determined using the following formula as previously 
described: 
W = In (Rf/Ri) / In (Sf/Si). 
Where Ri and Si refer to the number of resistant and susceptible cells at baseline, 
and Rf and Sf to the number of resistant and susceptible cells at endpoint of the 
study, respectively (Gagneux et al., 2006). 
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A parallel experiment using a streptomycin resistant SAP24 derivative (SAP24Strr) 
instead of SAP140 as a recipient, was performed to estimate the rate of ESBL 
plasmid transfer during the competitive assay. Such a transfer event could confound 
the outcome of the competitive experiments. SAP24Strr was obtained by daily 
subculturing SAP24 on nutrient broth (NB) agar containing increasing concentrations 
of streptomycin.  Cultures from the competive growth experiment were  plated out on 
NB agar plates supplemented with 100 µg/ml streptomycin as well as those 
supplemented with both 100 µg/ml streptomycin and 1 µg/ml  of cefotaxime.   
 
2.7.1.3 Growth under iron limiting conditions 
To investigate the impact of ESBL plasmid carriage on APEC growth under iron 
limiting conditions, bacteria were cultured in M9 minimal media supplemented with 
glucose as the sole carbon source and 1.5 µM of ferric sulphate (FeSO4) as an iron 
source. Iron-free media was made by adding the iron chelator, 2,2 dipyridyl (100 µM) 
to the media.  Bacterial strains were grown in LB broth, with shaking for 18 h at 37 ˚C 
and the following day, the OD of the cultures was adjusted to be the same for all 
strains. Cultures were centrifuged at 4,500 rpm for 10 minutes, the supernatant 
discarded and cell pellet washed 2x with PBS. Washed cells were then diluted 1:100 
into 50 ml of M9 minimal media. At time zero, the number of viable bacteria of each 
strain was determined using the Miles and Misra technique, and thereafter the 
bacteria were enumerated every 24 hours for 7 days.   All assays were repeated in 
triplicate. Depending on the number of strains being compared, data were analyzed 
by one-way analysis of variance (ANOVA), followed by Tukey’s multiple-comparison 
test (GraphPad Prism software, version 6.0) or using  an unpaired, two-tailed student 
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t test. The levels of significance (P values) are reported and values P < 0.05 were 
taken to be significant. 
2.7.2 ESBL plasmids and bacterial metabolism 
2.7.2.1 Phenotypic microarray assays 
The metabolic utilization profiles of newly transformed ESBL-producing E. coli strains 
were compared to those of the naïve host using Biolog, a phenotypic microarray 
consisting of microtiter plates containing single carbon, nitrogen or other nutrient 
sources (Bochner, 2009). In these studies, the laboratory (SAP59) and naïve avian 
(SAP24) E. coli strains were compared to their respective ESBL plasmid-containing 
derivatives (SAP56) and (SAP140), respectively. Biolog plates PM1 to 4 were used 
according to the manufacturer’s instructions. All PM plates were inoculated with 
bacterial suspensions at 100 µl per well. Suspensions were prepared by picking 
bacteria colonies from media plates using a sterile cotton swab and resuspending 
the cells in 15 ml of IF-0 fluid (supplied by manufacturer). The turbidity of the solution 
was adjusted to 85% transmittance (t) using the Biolog turbidimeter. When needed, 
disodium succinate (20mM) and ferric citrate (2uM) were added to the PM3 and PM4 
plates, which measures N, P, and S utilization. All plates were incubated for 48 h at 
37oC in the Omnilog plate reader (Biolog Inc, USA) and color changes resulting from 
reduction of the tetrazolium violet (dyeA) in the wells were recorded automatically 
every 15 minutes. Kinetic respiration data were analyzed with Omnilog PM Software. 
All strains were tested in triplicate for each PM plate.  
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2.7.2.2 Single strain growth on different carbon sources 
To confirm some of the findings obtained in the phenotypic microarray assays (see 
above), bacteria were grown in DM25 minimal media supplemented with a single 
carbon source. In each case, the final concentration of the carbon source was 
adjusted at 10 µg/ml, consistent with that used in the Biolog assays. All selected 
strains were cultured with shaking for 18 h in LB broth and inoculated at a dilution of 
1:100 into DM25 media. Cultures were incubated with shaking at 37˚C for 24 h.  
Changes in the growth of each strain was determined using Miles and Misra to 
enumerate the number of viable bacteria at the start (t=0) and at 24 h intervals over 
the 6-day experiment. The number of bacteria present were quantified on LB agar, in 
the presence and absence of 1 µg/ml cefotaxime.  Three replicates of each assay 
were performed and the number of cells over time used to calculate the specific 
growth rate of each strain.  The growth rates, of otherwise isogenic, plasmid-
containing and plasmid-free strains were compared using the unpaired Students t 
test.  
 
2.8 Impact of pH on APEC growth and transfer of ESBL plasmids 
2.8.1 Acid tolerance assay 
 To assess if ESBL plasmid carriage modifies the acid tolerance of the host 
bacterium, acid tolerance assays were performed as described previously (Mellata et 
al., 2012). For these experiments, the optical density of liquid bacterial cultures 
grown for 18 h at 37˚C, were adjusted to give OD600 = 1.0 The cell suspension was 
centrifuged to pellet the cells and the cells were washed twice with PBS before finally 
being diluted 1:1000 in 50 ml of LB, adjusted to pH 2.5 with 1M HCL. The bacterial 
cultures were incubated at 37˚C with gentle shaking (50 rpm) and samples removed 
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at 8 h, 24 h and 36 h for enumeration by serial dilution and plating on LB agar plates.  
Assays were repeated in three independent experiments and data compared using 
oneway ANOVA followed by Tukey’s multiple comparison test.  
2.8.2 Plasmid mobility in different pH conditions 
Like most E. coli, APEC encounter changes in acidity as they pass through the 
chicken intestine. In addition to affecting the survival of the isolates, low pH may alter 
the rate of ESBL plasmid transmission to other bacteria thereby promoting the 
spread of the resistance determinant. In order to investigate this further, conjugation 
experiments were set up to assess the transfer of the ESBL plasmid following 
exposure of the bacterium to different pH levels.  In these experiments, donor (those 
carrying an ESBL plasmid) and recipient (lacking ESBL plasmids) strains were first 
grown in a range of pH conditions (pH 4.0, 5.0, 6.0 and 7.0) before being mixed in 
equal proportions and conjugation assays performed.  
Donor and recipient strains were grown in LB broth for 18 h at 37˚C. Following 
growth, cells were washed and diluted in PBS to give a final optical density (OD600nm) 
of 0.1. Then 200 µl aliquots of the OD = 0.1 suspension were inoculated into LB 
broth, adjusted to the pH mentioned above using 1M HCL or 1M NaOH. After 
overnight incubation, the stressed cells were once again washed and diluted with 
PBS to a cell density equivalent to OD600nm = 0.1. The donors and recipient strains 
were then mixed in equal amounts and 200 µl of the mixture was spotted onto filter 
paper, placed on top of LB agar, adjusted to the same pH value. The conjugation 
assays were carried out in triplicate in three independent experiments for each pH 
condition. As a control, the equivalent non-stressed cells (grown in LB pH 7) were 
included. Plasmid transfer rates were calculated as the number of trans-conjugants 
per number of recipients. 
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2.8.3 Plasmid mobility in a chicken gut model 
While pH-adjusted media provides one way to study APEC behavior in low pH 
conditions, a better approach would involve more closely replicating the natural 
chicken intestinal environment. For example, the presence of host compounds and 
the normal chicken microbiota may have profound effects on APEC growth and 
plasmid transmission rates. In vivo studies were beyond the scope of this thesis, 
however, attempts were made to develop an in vitro chicken gut model which used 
natural chicken microbiota to try and address this question.  
             To mimic the filling and emptying of the caeca in the bioreactor (Nisbet et al., 
2000) (Figure 8) , a cyclic fed batch model was adopted in which the bioreactor (200 
ml Duran) containing 50 ml of inoculum would fill with media at a flow rate of 0.30 ml 
per minute to 100 ml and then every 8 hours, 50 ml of the contents would be 
pumped out into a collecting Duran from which samples would be taken for pH 
testing. PH testing was carried out using a non-bleeding pH-indicator strip (range 0 – 
6.0; Merck Millipore). The remaining 50 ml provided a starting inoculum for the 
following cycle. 
Citrate buffered custom VL media was pumped in to provide nutrition and pH 
balance at a pre-determined flow rate of 0.30ml per min. The temperature of the 
bioreactor was maintained at 42 ˚C in an incubator. A low motility was induced in the 
contents by the use of a small flea and magnetic stirrer set to a low voltage. The flea 
was autoclaved inside the bioreactor and the bioreactor was placed atop the stirrer in 
the incubator. To ensure an anaerobic environment was maintained the headspace 
of the vessel was flushed with nitrogen at a low flow rate. The inoculum was 5 ml of 
chicken faecal contents injected directly into the bioreactor via a syringe at the start 
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of the experiment. The faecal contents inoculum constituted of 5 ml faecal content 
paste, made from faecal droppings and reagent grade water, and 45ml of VL media 
to make a 10% starting inoculum. Samples from the bioreactor were obtained 
according to the following sampling protocol: one sample was taken directly from the 
starting inoculum (0 h time point); the second at 8h, after the first cycle; the third at 
24h, after the completion of the third cycle. Immediately after the 24h sample was 
collected, the bioreactor was inoculated with 2 ml of a suspension of the donor strain 
(APEC harbouring the ESBL plasmid) and the recipient strain (streptomycin resistant 
mutant of SAP24) and a final sample (8h + ) was taken 24 hours after the addition of 
the suspension (i.e. after one cycle was completed). The bioreactor was run for a 
total of 7-8 days (3, 8 hour cycles), in which every 24 hours the sample was collected 
for analysis. 
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Figure 8. Schematic of the chicken gut bioreactor model.  
 
The chicken gut bioreactor model consisted of a bioreaction chamber (200 duran), a 
collecting chamber (500ml Duran), a reserviour to supply fresh media and a supply of N2 
gas to maintain a reduced oxygen atmosphere. Chicken caecal samples were added to 45 
mls of VLA media and samples were collected every 8 hours for analysis of the number of 
donor, recipient and transconjugant cells.  
 
 
 
2.9 ESBL plasmids and bacterial virulence  
While APEC lack any definitive single virulence factor, the ability of strains to 
colonise the host and avoid detection by the immune system are likely to be 
important virulence strategies (Pourbakhsh et al., 1997). Thus the impact of the 
ESBL plasmid on the ability to strains to form biofilms, adhere to intestinal and 
macrophage cells, and multiply in the Galleria mellonella infection model was 
examined. 
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2.9.1 Biofilm formation assay 
 To assess the effect of ESBL plasmid carriage on biofilm formation, the crystal violet 
microtitre plate biofilm assay was performed as described previously (Mellata et al., 
2012). Stationary phase cultures of bacteria grown in LB broth were diluted 1:100 
into fresh LB broth supplemented with 0.1% glucose. Thereafter, 200 µl aliquots of 
each test strain were dispensed into a 96-well microtitre plate. Each strain was 
tested in quadruplicate and negative control wells containing uninoculated medium 
were also included on each plate. The microtitre plates were sealed with parafilm to 
prevent evaporation losses and incubated without shaking at 30 ˚C, 37 ˚C and 42 ˚C 
for 5 days. After incubation, the contents of the plates were removed and the plates 
were washed twice with copious amounts of sterile double distilled water (ddH2O). 
Biofilms formed on the microplates were stained with 200 µl of 1.0 % crystal violet for 
30 min, before the plates were washed four times with ddH2O to remove any excess 
stain, and air dried for 1 h. After drying, the dye present in adherent cells was 
solubilized by adding 200 µl of 30% acetic acid to each well. Finally, the optical 
density (OD) of the solution in each well was measured by reading the absorbance 
of the solution at 570 nm (OD570nm). All tests were carried out in triplicate, and the 
results were averaged.   
2.9.2 Adhesion and invasion assays using HD11, THP-1 and Caco-2 cells. 
2.9.2.1 Macrophage-like cells 
The ability of avian E. coli isolates to adhere and invade chicken or human 
macrophage-like cells was assessed using two different cell lines, HD11 and THP-1, 
respectively. HD11 cells, a chicken macrophage-like cell line, was obtained from 
APHA (Weybridge, UK). HD11 cells were cultured in RPMI1640 medium containing 
73 
 
20 mM L-glutamine (Gibco), 2.5% newborn calf serum (Autogen Bioclear), 2.5% 
chicken serum (Sigma), 10% tryptose phosphate broth(Sigma), 3% sodium 
bicarbonate (Sigma), 0.4% folic acid (Sigma), and 1% of penicillin and streptomycin 
(Gibco). Cells were routinely propagated in 75 cm2 flasks (BD falcon). For assays, 
HD11 cells were seeded at a density of 2 × 105 cells/ml in 24-well tissue culture 
plates and incubated at 37 ˚C for 2 days prior to use.  
THP-1 cells, a human monocyte-like cell line (ATCC® TIB-202™), were obtained from 
in-house stocks. THP-1 cells were cultured in RPMI 1640 medium supplemented 
with 5% 2 mM L-glutamine, 5% penicillin and streptomycin and 10% FBS.  Cells were 
routinely propagated into 75 cm2 flasks (BD falcon). For assays, THP-1 cells were 
seeded at a density of between 1x105 cells/ml to 1x106 cells/ml in 24-well tissue 
culture plates. To promote differentiation, cells were centrifuged and re-suspended in 
fresh media to a concentration of 2x105 cells per ml and treated with 100 nM Phorbol 
12-myristate 13-acetate (PMA) (P8139, Sigma). After treatment with PMA, 
immediately 1ml of cell suspension was added per well in a 24-well culture plates, 
and cells were incubated at 37 ˚C for 3 days prior to use. 
 
2.9.2.2 Intestinal epithelial cells 
In addition to testing the ability of avian E. coli isolates to adhere and invade 
macrophages, their interactions with human intestinal epithelial cells was also 
examined as entry via the intestine may occur. Caco-2 cells are human colon 
adenocarcinoma cells that exhibit similar properties as epithelial cells lining the small 
intestine (Natoli et al., 2012). Caco-2 cells were obtained from APHA (Weybridge, 
UK) and were routinely grown in Dulbecco’s modified Eagle medium (DMEM) 
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(Invitrogen) supplemented with 10 % (v/v) fetal bovine serum (FBS; Invitrogen) and 
1% of penicillin and streptomycin in 95 % air/5 % CO2 at 37 °C. For routine culture, 
propagated cells were seeded at approximately 106 cells cm–2 into 75 cm2 flasks (BD 
falcon). After 5 days of culture, cells were harvested by treating with 0.25% trypsin 
and once detached re-suspending in DMEM containing 10 % FBS. For assays, 
Caco-2 cells were seeded into 24-well plates at ~4×105 cells per well. The medium 
was changed daily until cells reached a confluent state and thereafter it was changed 
every second day. 
For the infection assays, bacterial were grown in 20 ml LB broth and 
incubated at 37 ˚C on shaking at 225 rpm for 16 h. The cells were then pelleted by 
centrifugation at 4000 rpm for 10 minutes at 20˚C.  The cells were re-suspended in 
PBS (pH 7.2) and the optical density of the cell suspension adjusted to OD540nm = 
1.2. Then the cell suspension was further diluted 1:20 in pre-warmed RPMI or 
DMEM media supplemented with 200mM L-glutamine and 1% (v/v) non-essential 
amino acids (NEAA) (Sigma). One ml of the bacterial solution was added to each 
well of the plate, giving an MOI of 100:1, unless stated otherwise. Eukaryotic cells 
were washed three times in Hank's balanced salt solution (HBSS)(Sigma) pre-
warmed to 37 ˚C prior to inoculation of the bacterial strains. The highly virulent S. 
Typhimurium SL1344 strain was used as a positive control in these studies.  
2.9.2.3 Incubation conditions and enumeration of adherent or invasive bacteria: 
All infected plates were incubated at 37Co in the presence of 5% of CO2. Bacterial 
association assays were incubated for 2 hours, whereas bacterial invasion and 
survival assays were performed after 4 and 8 hours, respectively. The gentamicin 
protection assay was used to determine the number of cells that had invaded 
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(Edwards & Massey, 2011).  Growth media containing 100 µg/ml gentamicin and 1% 
NEAA was added to the infected cells in order to kill any extracellular bacteria, 
Bacteria that are located inside the host cells are protected from the actions of 
gentamycin, and are quantified after removal of the gentamicin-containing media as 
described below. 
After each time point, microtitre plates were washed three times with HBSS 
and 1ml of 1% Triton was then added for 10 min to lyse the host cells and extract the 
bacteria. The lysates were serially diluted in PBS (pH 7.2) from 10-1 to 10-4 for 
association assays, and from 100 to 10-3 for invasion and survival assays. To 
determine the actual inoculum used in the assays, the initial inoculum was also 
serially diluted and plated on selective agar plates. 
For each tested strain, the assay was carried out at least in triplicate and in 3 
independent experiments. Data were analysed using Graphpad Prism (version 6.2, 
company and location) and differences between the mean percentage adherence, 
invasion or survival determined by one-way ANOVA, followed by Tukey’s multiple 
comparison post test. 
2.9.3 Galleria mellonella infection model: 
Greater waxmoth larvae (Galleria mellonella) have become a widely adopted insect 
model to study the pathogenesis of a range of pathogens including Listeria spp., 
Streptococcus pyogenes, Campylobacter jejuni, Yersinia pseudotuberculosis, as well 
as several pathogenic fungi (Mukherjee et al., 2010; Alghoribi et al., 2014; Senior et 
al., 2011). G. mellonella larvae are easily maintained and infected, and can 
withstand incubation at 37°C.  Thus, this infection model was used to assess if ESBL 
plasmids affect the ability of APEC to infect this non-mammalian model host. 
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G. mellonella larvae were purchased from Live Foods, UK and maintained on wood 
chips at 15 ˚C. Larvae infection were carried out as previously described (Champion 
et al., 2010). Using a Hamiliton syringe, 10 µl of a bacterial suspension (105 cfu) was 
injected into the haemocoel via the right foreleg. Larvae were then incubated at 37˚C 
and their survival and macroscopic appearance examined at various times post-
infection.  Normal healthy larvae appear cream-coloured and move readily around 
the Petri dish whereas unhealthy larvae turn brown and are unable to right 
themselves when placed on their back. No movement is detected in dead larvae. In 
these studies, uninfected controls and larvae receiving sterile PBS were included in 
each independent experiment. In each experiment, groups of ten G. mellonella 
larvae were infected.  
Intracellular growth assay: 
In addition to quantifying larvae survival, the number of bacteria present in the 
haemolymph was determined at various times post-infection. Thus, at 5 and 10 h 
p.i., haemolymph was extracted from three infected larvae as previously described 
(Harding et al., 2013). In order to release any intracellular bacteria, the haemolymph 
was incubated with 1 µl of 1% triton for 5 min at room temperature. Then, the 
resultant solution was serially diluted in PBS and plated onto LB agar or LB agar, 
supplemented with 1µg/ml cefotaxime. 
 
2.10 Data manipulation and statistical analysis 
Data including antimicrobial resistance profiles, gene content, bacterial counts 
(cfu/ml) and larvae survival were tabulated using Microsoft Excel (version 2010) and 
means and standard deviations calculated as necessary. Bacterial count data were 
log transformed in order to obtain normally distributed data prior to further analysis. 
Strain generation times were calculated from bacterial growth curves. Statistical 
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analyses including t-tests, were performed using GraphPad Prism 6. Unpaired two-
tailed Student’s t-test was used to compare two samples, whereas oneway or 
twoway ANOVA with Bonferroni’s Multiple Comparison post-hoc tests were used to 
compare two or more variables. In all cases, statistical significance was set at 
P≤0.05. 
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3 . Characterization of APEC strains and ESBL plasmids 
 
3.1 Background and aims 
Avian pathogenic E. coli (APEC) are considered as ExPEC and are associated with 
a range of mainly extra-intestinal infections of mild to severe disease severity in birds 
(Nakazato et al., 2009). Recent studies have indicated that APEC and human 
ExPEC share many common features such as virulence genes, serogroups, 
phylogenetic groups, and the possession of certain plasmids (Bauchart et al., 2010a; 
Johnson et al., 2007; Mellata, 2013). Thus, it is possible that APEC has the potential 
to be a human pathogen and to act  as  a virulence gene reservoir for human ExPEC 
strains, and vica versa (Mellata, 2013).  
Resistance to antimicrobials is widespread in the Enterobacteriaceae and the 
presence of resistance genes on APEC plasmids has been recognised as 
contributing to their potential risk in terms of food safety and human health (Lima-
Filho et al., 2013). The most prominent plasmids in APEC strains carrying virulence 
and resistance genes belong to different incompatibility groups including IncFIB, 
IncFIIA, IncI1 and IncN replicon types (Johnson & Nolan, 2009). Extended spectrum 
β-lactamases (ESBLs) are enzymes produced by resistant bacteria, that act to 
hydrolyse the β-lactam ring of extended-spectrum cephalosporins and 
monobactams, which are frontline antibiotics used in the treatment of infections  
(Livermore & Woodford, 2006). In the last decade, the ‘original’ ESBL enzymes, TEM 
and SHV have been rapidly replaced by the CTX-M allele as the most common 
resistance type (Carattoli , 2009). Their rapid spread within Gram negative bacteria 
has been associated with the presence of insertion sequences such as ISEcp1, 
which are also located on the plasmid (Cantón & Coque, 2006). CTX-M harbouring 
plasmids of different incompatibility types have been identified in isolates from 
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chickens, human and environmental origin (Livermore & Hawkey, 2005). Of these, 
plasmids belonging to IncI1 and IncF replicon types have been reported to be 
predominant in chicken and human isolates (Carattoli, 2009). Particular concerns 
have been raised since CTX-M has been frequently identified in the community and 
in food production animals (Bortolaia et al., 2011).      
Given the significant economic cost of APEC infection to the poultry industry, 
the potential risk of zoonotic transmission to humans and the fact that many of these 
organisms harbour resistance plasmids, a better understanding of APEC plasmid 
gene content and biology is warranted. Thus, the aim of this chapter was to 
characterise the genetic and phenotypic properties of several ESBL-producing APEC 
isolated from UK poultry and to generate plasmid-containing transconjugants as well 
as plasmid-free derivatives to enable study of the effect of ESBL plasmid carriage on 
host cell fitness. To this end, three cefotaxime-resistant and one cefotaximine-
sensitive APEC strain were selected for further investigation. These strains were 
randomly chosen from a collection of putative ESBL-producing E. coli UK poultry 
isolates (Randall et al., 2011).   
The objectives of this chapter were to:      
 Characterise the genetic background and virulence gene content of wild type 
APEC in order to determine whether the strains belonged to the same 
phylogenetic group and to assess their pathogenic potential. 
 Determine the size, number and origin(s) of replication of plasmids present in 
the host strains in order to further characterise the plasmid content of APEC. 
 Generate ESBL transconjugants and plasmid-cured strains in order to study 
the impact of the ESBL plasmid on host bacterium biology. 
 Determine the antibiotic resistance profiles of wild type APEC and the ESBL-
producing transconjugants in order to accurately describe their resistance 
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patterns and ascertain which resistance genes and alleles are located on the 
conjugative plasmids. 
 
3.2    Results 
3.2.1  Species and isolate characterisation  
Four strains of avian pathogenic E. coli SAP24, SAP44, SAP45 and SAP46 were 
used in this study. Three of these strains (SAP44, SAP45 and SAP46) were 
originally among strains isolated by Randall and colleagues to study the presence of 
virulence genes in isolates of CTX-M producing E. coli from broiler chicken and 
turkey flocks in UK (Randall et al., 2011). The sensitive non-ESBL wild type strain, 
SAP24, was kindly provided by Professor Roberto La Ragione, and was originally 
obtained from a clinical case of avian colibacillosis in the UK.  
 Prior to the start of experiments, the species identity of the four strains was 
confirmed using the commercially-available API 20E test kit, a miniaturised 20-
chamber strip that contains individual test media. Based on the pattern of 
biochemical reactions obtained for each of the four test isolates, the bacteria were 
positively identified as E. coli.  
 
3.2.1.1  PCR-based phylogenetic and O-antigen typing  
In order to examine whether APEC isolates were derived from the same 
clonal group, phylogenetic typing of the strains was performed based on the chuA, 
YjaA and TspE4C2 genes as previously described (Clermont et al., 2000). The 
results of the phylogenetic typing showed that the three APEC strains belonged to 
different phylogenetic groups. SAP44 and the wild type isolate (SAP24) belonged to 
the same group (A1) as they harboured yjaA genes (Figure 9). In contrast, no 
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amplicons were generated for SAP45 placing this isolate in group A0, whereas 
SAP46 was found to amplify the chuA amplicon, making this isolate a member of 
group D1. 
To further characterize the APEC strains, the O-antigen type was determined 
using allele–specific PCR (Clermont et al., 2011). Both wild-type APEC isolates 
SAP44 and SAP24 were classified as having the same O- antigen type (O78), 
whereas, the other APEC isolates, SAP45 and SAP46, were found to have different 
O antigens, corresponding to O7 and O15, respectively (Figure 10). These findings 
indicate that the two APEC isolates, SAP44 and SAP24, are potentially ancestrally 
related. 
        
Figure 9. Phylogenetic analysis of wildtype APEC strains. 
 
Phylogenetic analysis of APEC isolates based on PCR amplification of yjaA, chuA and 
TspE4C2, as previously described (Clermont et al., 2000). The data indicates that SAP24 
and SAP44 strains were in the same phylogenetic group (A1) as both amplified the yjaA 
gene (211bp). No PCR amplicons were observed for SAP45, indicating that it is grouped as 
A0. SAP46 was positive for the chuA gene (279 bp) and thus, was placed in group D1. Lane 
N: negative control of nuclease-free water; Lane P: positive control strain that harbours all 
three genes; Lane L: 1 kb DNA ladder. 
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Figure 10. O-antigen typing of wildtype APEC strains. 
 
O-antigen typing of APEC isolates based on PCR amplification of several common O-
antigen types (Clermont et al., 2011). An O78 strain was included as a positive control. 
SAP24 and SAP44 both amplified the same O-antigen type (O78; 464 bp), whereas SAP45 
and SAP46 amplified fragments belonging to different O- groups, O7 (722bp) and O15 
(536bp), respectively. Lane N: negative control of nuclease-free water; Lane L: 1 kb DNA 
ladder. 
 
3.2.1.2  Antimicrobial suspectibility profiles 
The sensitivity of the APEC isolates to various antimicrobial agents was assessed 
using the disc diffusion assay in accordance with BSAC methods (BSAC, 2012). The 
antibiogram profiles are presented in the table (Table 10).  All APEC isolates were 
resistant to ampicillin. More importantly, with the exception of SAP24, the APEC 
isolates showed full resistance to first and second generation of cephalosporins 
(ampicillin, cefotaxime and cefpodoxime) and tetracycline but were sensitive to 
aminoglycosides, fuluroqoinilones, chloramphenicol and sulphanilamid/trimethoprim.  
Based on these findings, the production of ESBLs was confirmed by the combination 
disc method according to the BSAC standards.  ESBL-producer strains were 
considered positive if the zone of inhibition around the combination disc (cefotaxime 
plus clavulanic acid) was 5 mm or more than that present around cefotaxime alone. 
All APEC strains (SAP44, SAP45 and SAP46) that demonstrated full resistance to 
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cephalosporin also showed a zone of inhibition around the combination disc that was 
more than 5mm greater than that present around the cefotaxime only disc. Thus, the 
APEC isolates SAP44, SAP45 and SAP46 were confirmed as ESBL-producing 
bacteria while SAP24 was confirmed as being sensitive to most β-lactam antibiotics. 
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Table 10. Antimicrobial resistance profiles of APEC isolates. 
 
 
 
 
Strains and their   
derivatives 
                                                                                                     Antimicrobial agents 
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Cut off points (in mm) R<14   
S>15 
R<12 
S>13 
R<23  
S>30 
R<23 
S>28 
S>23 R<19 
S>20 
R<22 
S>27 
R<16 
S>20 
R<17 
S>18 
R<20 
S>21 
R<13 
S>14 
R<15 
S>16 
R<15 
S>19 
R<16 
S>20 
R<13 
S>14 
Original strains                
SAP44 R S R R S R R S S S R S S S S 
SAP45 R S R R S R R S S S R S S S S 
SAP46 R S  R R S R R S S S R S S S S 
SAP24 R S S S S S S S S S S S S S S 
R and S stand for resistant and sensitive. Antibiotics are abbreviated as follows: AMP: ampicillin, AMC: amoxycilin, CTX: Cefotaxime, CEF: Ceftriaxone, FOX: Cefoxitin, 
CPD: Cefpodoxim, CAZ: Ceftazidime, CIP: Ciprofloxacin, NA: Nalidixic acid, C: Chloramphenicol, TE:Tetracycline, SXT: Sulpha/Trim, AK; Amikacin, GC: Gentamin, 
APR: Apramycin. 
 
APEC isolates were tested as sensitive (S) or resistant (R) to the anitbiotics listed above using a disc 
diffusion assay (BSAC). SAP44, SAP45 and SAP46 were resistant to first and second generation 
cephalosporins, whereas SAP24 was susceptible to all antibiotics except amplicillin.   
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3.2.1.3  PCR-based identification of ESBL enzyme types  
In section 3.2.1.2, three of the APEC isolates were found to be resistant to first and 
second generation cephalosporins and confirmed as ESBL-producing bacteria. The 
identification of the ESBL gene conferring resistance was determined using a 
previously published multiplex PCR that enabled the detection of blaSHV, blaTEM, 
blaOXA and blaCTX-M genes (Fang et al., 2008). With the exception of SAP24, all 
isolates were found to carry the blaCTX-M gene (Figure 11). To further characterise the 
type of CTX-M enzyme present in these isolates, PCR specific primers to each of the 
main CTX-M groups were used (Woodford et al., 2005). All APEC isolates used in 
this study were found to harbour the blaCTX-M-1 group allele (Figure 12 ). 
Figure 11. Beta-lactam gene typing in wildtype APEC strains. 
 
 APEC isolates were assessed for the presence of the common β-lactam genes using PCR 
(Fang et al., 2008). The blaCTX-M, blaOXA, blaSHV and blaTEM genes were detected based on 
the expected amplicon size: CTX-M (593 bp), OXA (813 bp), SHV (237 bp) and TEM (445 
bp). Strains tested are APEC strains, SAP44, SAP45, and SAP46. SAP24 was included as a 
negative control strain. Lane L: 1 kb DNA ladder, Lane N: negative control of nuclease-free 
water and Lane P: positive control strain that contains all four bla types. 
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Figure 12. CTX-M group determination in ESBL APEC strains. 
 
 
Wild type APEC isolates contain β-lactam enzymes that belong to CTX-M group1. Plasmid 
DNA was tested against primers specific for CTX-M group1 (expected size 415pb), include 
others. Only a fragment specific to the CTX-M group1 was amplified. Strains tested include 
wild type APEC isolates (SAP44, SAP45 and SAP46), one derivative strain of SAP59 
(SAP56). 
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3.2.1.4  PCR-based assessment of virulence gene content 
The pathogenicity of the APEC isolates was investigated using several multiplex 
PCR assays that allowed the detection of 14 virulence genes that are usually 
associated with APEC (iutA, iss, hlyF, ompT, iroN, astA, ibeA, irp2, papC, sitA, iucD, 
tsh, vat, and cvi/cva). The virulence genes are associated with adhesins, toxins, iron 
uptake systems and resistance to host serum.  
Previously established criteria indicates that isolates are considered as APEC 
if they are associated with 5 or more virulence associated genes (Ewers et al., 2009) 
however, the specific set of virulence factors possessed by APEC has not been 
clearly established (Dho-Moulin & Fairbrother, 1999; Johnson et al., 2008).  The 
studies presented here indicated that all the original test E. coli strains were 
classified as APEC strains (see Table 11). Although there was variability in the 
number of virulence genes present, two virulence genes (sitA and iss) were found in 
all four APEC isolates used in this thesis, indicating that their presence is not 
associated with carriage of the ESBL plasmid (Figure 14). Two additional virulence 
genes (hlyF and ompT) were only found in the ESBL-producing isolates (SAP44, 
SAP45 and SAP46) (Figure 13).  It was interesting to find that SAP44 (O78) was the 
only APEC isolate to possess the tsh gene, which is commonly found in APEC 
(Köhler & Dobrindt, 2011) . The variable virulence gene content of APEC as evident 
here reflects the difficulty of developing specific markers for the APEC pathotype 
based on their virulence gene content.  
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Figure 13. Multiplex PCR detection of iutA, iss, hlyF, ompT and iroN in APEC.. 
 
A 5-gene multiplex PCR assay was used to detect the presence of iutA, iss, hlyF, ompT and 
iroN in APEC (Johnson et al., 2008) . The expected amplicon sizes were iutA (302 bp), iss 
(323 bp), hlyF (450 bp), ompT (496 bp) and iroN (533 bp). Strains tested included APEC 
strains SAP24, SAP44, SAP45 and SAP46. PCR products were run on 2% agarose gel. L: 1 
kb DNA ladder and N:  negative control of nuclease-free water. 
 
Figure 14. Virulence genes determination in APEC strains (Multiplex PCR for 9 genes). 
 
Multiplex PCR analysis of the virulence genes in wild type APEC and its derivatives.  
Primers specific for astA (116bp), ibeA (171bp), irp2 (413bp), papC (501bp), sitA (608bp), 
iucD (714bp), tsh(824bp), vat(981bp) and cvi/cva (1181bp) were used. Strains tested are 
APEC strains SAP24, SAP44, SAP45 and SAP46 . N stands for negative control of nuclease 
free water. 
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Table 11  Virulence-associated genes in APEC strains and derivatives 
 
Virulence genes 
APEC strains 
SAP24 (O78) SAP44(O78) SAP45(O7) SAP46(O15) 
iutA     
Iss + + + + 
hlyF  + + + 
ompT  + + + 
iroN  + +  
astA     
ibeA    + 
irp2 +  + + 
papC   +  
sitA + + + + 
iucD + + +  
Tsh  +   
Vat     
cvi/cva     
total no. genes 4/ 14 7 / 14 8 / 14 6 / 14 
Virulence genes detected in ESBL- harbouring wild type APEC strains and  wild type non ESBL plasmid pathogenic 
strain (SAP24). 
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3.2.2  Plasmid content of APEC isolates  
In order to further analyse the genetic background of APEC, the plasmid content of 
the different isolates was determined using plasmid profiling. Purified plasmid DNA 
from each of the isolates was subject to gel electrophoresis and the relative size and 
number of plasmids determined. As shown in Figure 15, all ESBL-producing APEC 
strains possessed at least one large plasmid of just less than 148 kb, based on the 
migration of plasmids of known size in the reference strain E. coli 39R. SAP44 
appears to harbour a single large plasmid (likely encoding the blaCTX-M gene), 
whereas strain SAP45 harbours two plasmids of size 63.4 and 148 kb, respectively. 
Interestingly, the intensity of plasmid DNA extracted from SAP44 was much brighter 
than for any of the plasmids extracted from the other isolates. Strain SAP46 
harboured four plasmids, ranging in size between ˂ 6.8 kb to approx. 148 kb. With 
the exception of SAP44, these findings are consistent many other studies  (Johnson 
et al., 2007; Mellata et al., 2009) which show that APEC harbours multiple, large 
plasmids, and this is a defining feature of the pathotype.     
Figure 15. Plasmid profiling of ESBL-producing APEC isolates 
               
ESBL-producing APEC isolates (SAP44, SAP45 and SAP 46) were subject to plasmid profiling.  
Plasmid DNA was extracted from each strain and subject to gel electrophoresis on 0.7% agarose gel. 
The gel shows that SAP44 appears to harbour a single large plasmid (CTX-M plasmid), whereas 
strain SAP45 harbours two plasmids of size 63.4 and 148 kb, respectively. SAP46 contains four 
plasmids, ranging in size between ˂ 6.8 kb to approx. 148 kb. E. coli 39R is a reference strain that 
contains four plasmids of known sizes, corresponding to 148kb, 63.4kb, 36 kb and 6.8 kb. 
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3.2.3  Generation of ESBL-producing transconjugants in E. coli K12 and a naïve avian 
E. coli O78 isolate  
 
In order to investigate the metabolic burden and phenotypic effects attributed to 
carriage of the ESBL plasmid, two sets of plasmid–harbouring derivatives were 
constructed. Firstly, plasmid DNA from each of the ESBL-producing APEC was 
introduced into the laboratory E. coli K12 strain (herein named SAP59) by 
electroporation. The plasmid-containing E. coli K12 derivatives were selected 
following growth on LB agar supplemented with 1 µg/ml cefotaxime and designated 
as SAP56, SAP57 and SAP58 having been derived from SAP44, SAP45 and SAP46 
respectively. The presence of a band just less than 148 kb in each of these 
derivatives confirmed the transfer of a large plasmid (Figure 16). Growth on the 
selection plates and subsequent antimicrobial resistance profiling of the 
transconjugants (SAP56, SAP57 and SAP58) was consistent with the transfer of the 
CTX-M gene (Table 12). 
Secondly, the ESBL plasmids were introduced into the non-ESBL-producing 
avian E. coli O78 isolate (SAP24) by conjugation. SAP24 was used as it belonged to 
the same serogroup and phylogroup as one of the APEC isolates (O78). Plasmid 
transfer was mediated by bacterial conjugation using the SAP59 derivatives (SAP56, 
SAP57 and SAP58) generated above as donors and SAP24 as the recipient strain. 
The SAP59 derivatives were used for conjugation rather than the original APEC 
isolates because they only contain the ESBL plasmid, and thus transfer of other 
APEC plasmids was avoided. 
As shown in Figure 16, SAP24 normally harbours one large plasmid (< 63.4 
kb) and two smaller plasmids (both < 36 kb). Following conjugation, the SAP24 
transconjugates (SAP140, SAP141 and SAP142 derived from SAP56, SAP57 and 
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SAP58, respectively) were found to harbour an additional large plasmid (size just 
less than148 kb) indicating that the presence of the ESBL plasmid. The presence of 
the ESBL plasmid was also confirmed by the production of ESBL using the disc 
combination test (cefotaxime and clavulanic acid) that used to test the original APEC 
isolates (see section 3.2.1.2). Finally, the antimicrobial resistance patterns of the 
SAP24 transconjugants were found to be similar to that of the donor strain (SAP59 
derivative carrying the ESBL plasmid). Thus, the ESBL plasmid was able to express 
the resistance genes in E. coli of a different genetic background (see Table 12 ). 
Figure 16. Plasmid profiling of ESBL-producing transconjugants of laboratory E. coli 
K12 and the avian E. coli O78 isolate. 
 
Plasmid content of ESBL-producing E. coli K12 transconjugants (SAP56, SAP57 and 
SAP58) and the naïve avian E. coli O78 (SAP24) transconjugants (SAP140, SAP141 and 
SAP142).  Plasmid DNA was extracted ffrom each of the strains and subject to gel 
electrophoresis to verify plasmid content and size. Lanes: 39R-E. coli reference strain 
containing plasmids of known size, SAP24 – plasmid-free recipient, SAP56, SAP57 and 
SAP58 are E. coli K12 (SAP59) derivatives that contain the CTX-M plasmids originally 
isolated from the wild type strains; Lanes - SAP140, SAP141 and SAP142 are SAP24 
derivatives that contain the CTX-M plasmid as follows: SAP140 (SAP24 transconjugant from 
SAP56), SAP141 (SAP24 transconjugant from SAP57), SAP142 (SAP24 transconjugant 
fromSAP58.
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Table 12  Antimicrobial resistance profiles of laboratory E. coli K12 and avian E. coli (SAP24) after conjugation with ESBL-producing 
APEC donor isolates. 
 
 
 
Strains and their   
derivatives 
Antimicrobial agents 
A
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Cut off points (in 
mm) 
R<14   
S>15 
R<12 
S>13 
R<23  
S>30 
R<23 
S>28 
S>23 R<19 
S>20 
R<22 
S>27 
R<16 
S>20 
R<17 
S>18 
R<20 
S>21 
R<13 
S>14 
R<15 S>16 R<15 
S>19 
R<16 
S>20 
R<13 
S>14 
E. coli K12 (SAP59) and its derivatives 
SAP59 S S S S S S S S S S S S S S S 
SAP56  R S  R R S R R S S S R S S S S 
SAP57  R S R R S R R S S S R S S S S 
SAP58  R S R R S R R S S S R S S S S 
 Avian E. coli O78 (SAP24) and its derivatives 
SAP24 R S S S S S S S S S S S S S S 
SAP140  R S R R S R R S S S R  S S S S 
SAP141  R S R R S R R S S S R  S S S S 
SAP142  R S R R S R R S S S R  S S S S 
R and S stand for resistant and sensitive. (AMP: ampicillin, AMC: amoxycilin, CTX: Cefotaxime, CEF:Ceftriaxon, FOX:Cefoxitin,CPD;Cefpodoxim, CAZ;Ceftazidime, CIP: 
Ciproflloxacin, NA: Nalidixic acid, C: Chloramphenicol,TE.Tetracyclin, SXT: Sulpha/Trim, AK; Amikacin, CN: Gentamin,APR: Apramycin 
 
 
 
 
Antimicrobial suspectibility profiles of laboratory E. coli K12 (SAP59), avian E. coli O78 (SAP24) and their respective ESBL-producing 
transconjugants. The donor strains consisted of the ESBL-producing APEC isolates. The zone of inhibition around the various antibiotic discs 
was measured and compared to the BSAC guidelines to assign as sensitive (S) or resistant (R).  All transconjugants showed resistance to first 
and second generation of cephalosporins after acquisition of the ESBL plasmid.   
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To classify the ESBL plasmids, their origin of replication was determined using 
multiplex PCR that amplifies replicon-specific sequences as previously described 
(Carattoli et al., 2005). The E. coli K12 strains harbouring the ESBL plasmid (SAP59 
derivatives) were used as the source of plasmid DNA in order to avoid issues of 
contamination with other plasmids present in the wild-type APEC isolates. All 
plasmids were found to contain the Inc I1-IY replicon type (Figure 17). After 
determining the ESBL plasmid Inc type in the E.coli K12 transconjugants, it was 
possible to identify the non-ESBL plasmid types present in the wild type APEC 
isolates. All ESBL-producing APEC strains were also found to harbour the Inc FIB 
type plasmid. In addition, SAP45 and SAP46 also harboured Frep type plasmids Inc 
FIA and Inc FIA and F types respectively (Figure 18 and Figure 19). Interestingly, 
none of the 18 rep types was found in SAP24 (the non-ESBL avian O78 strain) even 
though plasmid profiling indicated the presence of more than one plasmid. 
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Figure 17. Inc/rep typing of ESBL plasmids in E. coli K12 transconjugants. 
 
Multiplex PCR was used to identify the Inc/rep type plasmid present in E. coli K12 
transconjugants. A strain containing HI1, HI2 and I1-IY orgins was used as a positive control 
with expected amplicon sizes of 471 bp, 644 bp and 139 bp respectively. Lanes: L - DNA 
ladder 100 bp, Lane 1 – positive control strain, lane 2, 3 and 4 are SAP59 derivative strains 
(SAP56, SAP57 and SAP58, respectively) and lane 5 - negative control (nuclease-free H2O). 
Based on amplicon size, all strains have I1-IY plasmid type. 
 
Figure 18. Inc/rep typing of plasmids in ESBL-producing APEC isolates. 
 
Multiplex PCR was used to identify the Inc/rep type of plasmids harboured by ESBL- 
producing APEC isolates (SAP44, SAP45 and SAP46). A positive control strain containing 
plasmids belonging to FIB (702 bp), FIA (462 bp) and W (242 bp) was included. Lanes: L- 
DNA ladder 100 bp, lane 1 - positive control, lanes 2, 3 and 4 contains SAP44, SAP45 and 
SAP46, respectively, and lane 5 - SAP24. 
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Figure 19. Simplex PCR to identify IncF plasmids in APEC strains. 
 
Simplex PCR was used to amplify the IncF (270 bp) plasmid type in the ESBL- producing 
APEC isolates (SAP44, SAP45 and SAP46). Lanes: L - DNA ladder 100 bp, lane 1 - positive 
control containing PCR products of known size IncF (270bp), lanes 2, 3 and 4 contain 
SAP44, SAP45 and SAP46, respectively and lane 5 contains SAP24.   
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3.2.4  Generation of plasmid-cured derivatives of the APEC isolates 
Curing the original APEC isolates of their respective ESBL-producing plasmids was 
essential in order to study the contribution of the plasmid to the phenotype of the 
host bacterium. Curing was performed using a plasmid curing vector (pIFM27) in 
order to avoid secondary mutations occurring as a result of manipulations based on 
stress or treating the bacterium with chemical detergents  (Hale et al., 2010). By 
having the same incompatibility group and antisense RNA as the target plasmid, the 
curing vector was able to cure the host strains of their ESBL plasmids (Figure 20). 
Plasmid profiling showed that a band of approximately 100 kb in size was still 
present after curing of SAP44 (Figure 20, lane 2 and 3). Subsequently, it was found 
that SAP44 harbours two plasmids of approximately the same size, one belonging to 
the Inc I1-1y replicon type (ESBL plasmid) and the other belonging to the Inc FIB 
replicon type. This was confirmed by PCR-based Inc typing of the strains (Figure 
18). Interestingly, screening of transformants after the curing process revealed that 
the FIB plasmid has been lost from one of the ‘cured’ colonies (herein named SAP44 
plasmidless). The FIB cured strain was complemented with ESBL plasmid (I1-IY) 
and renamed SAP44C, and both were used for further study (Figure 21 and Table 
13). Loss of the ESBL plasmid was also confirmed by PCR-based detection of the 
CTX-M gene and Inc I1-1y type, as well as the transformants phenotypic sensitivity 
to cefotaxime in growth media. 
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Figure 20. Plasmid profiling of cured strains (SAP44 and SAP45). 
 
Plasmid profiling gel of new cured strains. For strain SAP44, 1 is the original strain, 2 and 5 
are transformants carrying the curing plasmid, but which don’t seem to have lost the large 
plasmid although the band density colour become more fade in the presence of curing vector 
and after the vector was cured from the strain. For strain SAP45 the curing was successfully 
achieved. Lane 8 is the original strain. Lanes 9 and 12 are the transformants carrying the 
curing plasmid. Lanes 10, 11, 13 and 14 are the cured strains after vector removal. (gel 
profiling was performed by Irene Martin). 
 
 
Figure 21. Multiplex PCR of Inc/rep typing in SAP44 and its derivative strains. 
 
Multiplex PCR analysis of Inc/rep typing plasmids harboured by of ESBL- producing APECs 
SAP44 and its derivatives. L (marker ladder 100bp). Lane 1 is a positive control containing 
PCR products of known size FIB (702bp) and I1-IY (139bp). Lane 2, 3,4 and 5 are 
SAP44(the origin isolate), SAP44(cured of ESBL plasmid but still has FIB plasmid) and 
SAP44(cured of ESBL plasmid and lost the FIB plasmid) and SAP44 (complemented cured 
strain with ESBL plasmid), respectively. 
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Table 13. Summary of APEC isolate properties and that of their derivatives 
 
The table summarises most APEC genetic features that were found in the tested isolates in 
this chapter. It will be as a reference table for the subsequent studies in the next chapters.  
Footnote: A, Plasmid belonging to IncFIB replicon type was designated as pFIB44 and the 
SAP44 derivative harbouring pFIB44 as a single plasmid was designated as SAP44F. B, 
Plasmid belonging to IncI1 replicon type (ESBL) was designated as pSAP44 and the SAP44 
cured derivative strain which was complemented with pSAP44 was designated as SAP44C.   
 
 
 
 
 
 
 
 
 
 
 
 
Name Strain derivation O-type Phylogenic 
group 
Plasmid content 
SAP44 ESBL-producing APEC O78 A1 IncFIB, I1-Iy 
SAP44F 
SAP44C 
SAP44 cured of ESBL plasmid 
SAP plasmidless transformed 
with ESBL plasmid 
  IncFIBA 
I1-IyB 
SAP44 plasmidless SAP44 cured of ESBL and FIB 
plasmid 
  none 
SAP45 ESBL-producing APEC O7 A0 IncFIB, I1-Iy, IncFIA 
SAP45 cured SAP45 cured of ESBL plasmid   IncFIB, Inc FIA 
SAP46 ESBL-producing APEC O15 D1 IncFIB,I1-Iy,IncW 
SAP46 cured SAP46 cured of ESBL plasmid   IncFIB, IncW 
SAP24 Avian E. coli O78 isolate O78 A1 Non-type able plasmids 
SAP140 
 
SAP141 
SAP24 transformed with ESBL 
plasmid from SAP44 
SAP24 transformed with ESBL 
plasmid from SAP45 
O78 A1 Transformed with I1-Iy 
 
I1-Iy 
SAP59 E. coli K12 laboratory strain  A1 None 
 SAP59 derivative strains(SAP56)  A1 Transformed with I1-Iy 
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3.3 Discussion  
 
In this study, three ESBL-producing APEC originally isolated from broiler chicken 
and turkey flocks in the UK were examined for their genotypic and phenotypic 
properties. All three isolates (named SAP44, SAP45 and SAP46) showed high levels 
of resistance to the third generation beta-lactams as well as the broad spectrum 
antibiotic, tetracycline. The isolates belonged to different O-antigen serogroups, 
namely O78, O7 and O15, as well as different phylogenetic groups, namely A1, A0 
and D1, respectively. 
The isolation of ESBL-producing E.coli belonging to phylogenetic group A1 in 
poultry is concerning. Ciccozzi and colleagues found that avian and human E. coli 
isolates exhibiting multidrug resistance (MDR) and belonging to group A1 formed 
several tightly-related clusters compared to those belonging to either group B and D 
(Ciccozzi et al., 2013).  This led the authors to propose that human MDR E. coli 
strains belonging to phylogenetic group A1 were most likely descended from MDR 
E.coli clones found in poultry.       
Molecular characterisation of the ESBL-producing isolates showed that 
despite belonging to different sero- and phylogenetic groups, all possessed CTX-M-
containing plasmids of the same size and Inc type (I1-IY) (see Figure 15). In each 
case, the CTX-M gene belonged to CTX-M group 1. The blaCTX-M1 gene has  been 
detected in chicken isolates in the UK and several other European countries such as 
Germany and Netherlands (Schink et al., 2011; Leverstein-van Hall et al., 2011).  
Indeed, the CTX-M1 variant is one of the most commonly reported ESBL subtypes in 
the European Union for E. coli isolated from food-producing animals (EFSA, 2011).  
Moreover, genes coding for ESBLs have also been detected in avian E. coli isolated 
102 
 
from the faeces of healthy poultry, suggesting that poultry may act as a reservoir for 
the resistance genes (Asai et al., 2011).  
ESBLs of the CTX-M type have rapidly spread and have a wide distribution in 
both hospitals and community settings (Livermore & Hawkey, 2005). These enzymes 
have been reported from several sources including humans, animals, food and 
sewage. This wide distribution may help explain the increased detection of blaCTX-
M  within hospitals and  the emergence of resistant bacteria within the community 
(Cantón & Coque, 2006).  
Although several virulence genes have been linked with APEC pathogenicity 
(Janßen et al., 2001), no standard virulence gene profile has been identified for this 
pathotype (Schouler et al., 2012). The most common virulence genes associated 
with isolates causing avian colibacillosis include those coding for adhesins (F1, P, 
and Stg fimbriae and curli), anti-host defense factors (OmpA, Iss, lipopolysaccharide 
and K1 capsule), iron acquisition systems (aerobactin, Iro proteins, yersiniabactin, 
and the Sit iron acquisition locus), autotransporters (Tsh, Vat, and AatA), the 
phosphate transport system, sugar metabolism, and the invasion-associated IbeA 
protein (Schouler et al., 2012).  
In this study, it was found that the APEC isolates harboured different virulence 
gene profiles. At least six of the virulence genes tested were detected in the ESBL-
producing isolates (Table 11), confirming their assignation as APEC. In contrast, the 
non-ESBL-producing avian E. coli O78 isolate (SAP24) contained only 4 of the 
virulence genes, perhaps indicating that this bacterium is less virulent . 
  Common to all isolates is the presence of genes coding for two iron 
acquistion mechanisms, namely SitA (an iron transport system) and IucD (aerobactin 
system), as well as a gene promoting survival inside the host, namely Iss (increased 
serum survival). These genes have been well characterised and are mostly carried 
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on virulence plasmids belonging to the IncFIB type (Johnson et al., 2008). Other 
predominant virulence genes detected in the isolates were hlyF (haemolysin protein), 
and ompT (outer membrane protease T).  
Many studies have reported that APEC possesses virulence factors that 
contribute to the ability of the organism to colonize and invade tissues, which result 
in developing colibacillosis (Zhao et al., 2005; La Ragione & Woodward, 2002). Of 
these factors increased serum survival (iss) and temperature-sensitive haemaglutinin 
(tsh), are important. The iss gene was present in 3 of APEC (SAP44, SAP45 and 
SAP24) whereas tsh was only present in SAP44 (O78).    
In order to further study the ESBL-producing plasmids harboured by the 
APEC isolates, the plasmids were sequenced, annotated and compared to 
determine their gene content and genetic relationship to each other. Furthermore, 
the genome of the host bacterium was sequenced in order to examine if the genome 
harboured factors that may promote uptake of plasmid DNA.   
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Chapter 4  : Plasmid and genome DNA characterisation  
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4 . Plasmid and Genome DNA Characterisation 
 
4.1 Introduction: 
In chapter 3, three ESBL-producing APEC isolates were characterised and found to 
belong to different sero- and phylogenetic groups. Variability in O-antigen types can 
sometimes reflect genetic variability within the strains. However, it remains to be 
determined whether the strains harbour similar blaCTX-M1 expressing plasmids.  
In addition, most virulence plasmids in E. coli belong to the IncF family and 
have evolved in synergy with the host bacterium over time (Johnson & Nolan, 2009). 
In this study, each of the three APEC isolates carried both an ESBL-producing 
plasmid (IncI origin) and an IncFIB plasmid. Sequencing of the two plasmids may 
reveal links between carriage of IncI1 and IncFIB plasmids in the same host 
bacterium. The link between carriage of multi-drug resistance and plasmids made by 
researchers in the 1960s stimulated intense interest in plasmid biology and 
understanding the genetics of transmission in greater detail. However, much of this 
work was focused on single plasmids, and the impact of additional plasmids within 
the host bacterium was not extensively explored. Therefore, in this chapter, the 
sequence of the ESBL-producing plasmid from each APEC was sequenced and 
compared, together with the FIB plasmid from one of the isolates in order to gain 
insights into the gene content and clonality of the different genetic structures. 
Furthermore, the genomes of the ESBL-producing APEC isolate (SAP44) and the 
non-ESBL-producing avian E. coli (SAP24) were sequenced and subject to 
comparative analyses in order to identify host specific factors that distinguish the two 
isolates.  
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The specific objectives of this chapter were to: 
 Sequence and annotate the ESBL and FIB plasmids harboured by APEC in 
order to fully describe their genetic content.  
 Perform comparative analysis on the plasmid sequences in order to gain 
insights into common features and determine the relatedness of plasmids in 
ESBL-producing APEC. 
 Perform genomic sequencing of ESBL-producing and non-ESBL- producing 
APEC O78 strains (SAP44 versus SAP24) in order to identify host specific 
factors that distinguish these two organisms. 
 Perform comparative analyses against other known sequenced strains of 
APEC O78 in order to identify if harbouring ESBL plasmid has an effects on 
gene content.  
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4.2 Sequence analysis of ESBL plasmids from APEC isolates. 
The ESBL plasmids were extracted and sequenced from the three APEC isolates 
SAP44, SAP45 and SAP46, which belonged to O78, O7 and O15 serogroups, 
respectively. Preliminary analysis of the sequence data revealed that the plasmids 
were of identical size and exhibited 100% nucleotide sequence identity indicating 
that the same ESBL plasmid was present in each of the three APEC isolates. As a 
result of this finding, the ESBL plasmid from SAP44 (hereafter called pSAP44) was 
selected as representative of the other two ESBL plasmids. The gene content and its 
further characterisation are reported in this chapter.  
Plasmid pSAP44 was 105,610 bp in size and had an average GC content of 
51.1%. Consistent with rep/Inc typing by PCR (section 3.2.3), sequencing confirmed 
the presence of the IncI1 replicon type. Sequencing also revealed the plasmid 
encoded several genes that were known to be involved in conjugation, mobilisation, 
partitioning, antibiotic resistance as well as several hypothetical genes (Figure 22 
and Table 14), and these are discussed in more detail below.  
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  Figure 22. Circular map of pSAP44, an ESBL-producing plasmid isolated from APEC  
 
 
Circular genome of ESBL-encoding pSAP44 plasmid from APEC. The different rings 
represent (from outer to inner) all genes and insertion elements, which are color coded by 
functional group (rings 1 and 2), deviation from average G+C content (ring 3), and GC skew 
((G-C)/(G+C).The functions of genes are classified into 8 groups and genes in the same 
groups are indicated by the same colours, which are shown at the left side of the figure. Blue 
boxes indicates conjugation related genes; yellow, transposon genes; red, antibiotic 
resistance and virulence genes;orange, pil genes;green, maintenance and stability genes; 
pink, known function proteins; black, replication associated genes and light blue, 
hypothetical proteins.  
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Table 14. Features and/or open reading frames of pSAP44. 
Name Region Protein function  
TraC 176..586 IncI1 plasmid conjugative transfer protein TraC 
hypothetical protein 589..762 hypothetical protein 
hypothetical protein 759..1310 hypothetical protein 
 PilI 1472..1726 IncI1 plasmid conjugative transfer protein PilI 
hypothetical protein complement(1832..2050) hypothetical protein 
hypothetical protein 2067..2198 hypothetical protein 
hypothetical protein complement(2311..2442) hypothetical protein 
 PilK 2495..2788 IncI1 plasmid conjugative transfer protein PilK 
 PilL 2822..3889 IncI1 plasmid conjugative transfer protein PilL 
PilM 3889..4326 IncI1 plasmid conjugative transfer protein PilM 
 PilN 4340..6022 IncI1 plasmid conjugative transfer lipoproteinPilN 
 PilO 6015..7310 IncI1 plasmid pilus assembly protein PilO 
 PilP 7297..7749 IncI1 plasmid pilus assembly protein PilP 
 PilQ 7760..9313 IncI1 plasmid conjugative transfer ATPase PilQ 
 PilR 9326..10423 IncI1 plasmid conjugative transfer innermembrane 
protein PilR 
PilS 10441..11055 IncI1 plasmid conjugative transfer prepilinPilS 
 PilT 11065..11625 IncI1 plasmid conjugative transfer putativemembrane 
protein PilT 
 PilU 11661..12266 Type-IV sectretion leaderpeptidase/N-methyltransf 
erase, PilU 
PilV 12254..13690 IncI1 plasmid conjugative transfer pilus-tipadhesin 
protein PilV 
ISEcp1 14159..15421 ISEcp1 
hypothetical protein 15402..15524 hypothetical protein 
 CTX-M-1 15709..16584 Beta-lactamase, CTX-M-1 
Tryptophan synthase beta 
chain like 
complement(16631..16903) Tryptophan synthase beta chain like 
 Rci 17970..19157 Shufflon-specific DNA recombinase, Rci 
TraE 19308..20132 IncI1 plasmid conjugative transfer protein TraE 
 TraF 20217..21419 IncI1 plasmid conjugative transfer protein TraF 
 TraG 21479..22063 IncI1 plasmid conjugative transfer protein TraG 
hypothetical protein complement(22077..22226) hypothetical protein 
 TraH 22458..22916 IncI1 plasmid conjugative transfer protein TraH 
 TraI 22913..23731 IncI1 plasmid conjugative transfer protein TraI 
 TraJ 23728..24876 IncI1 plasmid conjugative transfer protein TraJ,related 
to pilus biogenesis/retracton protein 
TraK 24873..25163 IncI1 plasmid conjugative transfer protein TraK 
 Nuc 25178..25729 Plasmid conjugative transfer endonuclease 
 SogS/SogL 25818..29585 IncI1 plasmid conjugative transfer DNA 
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primase,SogS/SogL 
 TraL 29603..29950 IncI1 plasmid conjugative transfer protein TraL 
 TraM 29947..30639 IncI1 plasmid conjugative transfer protein TraM 
 TraN 30650..31633 IncI1 plasmid conjugative transfer protein TraN 
 TraO 31636..32925 IncI1 plasmid conjugative transfer protein TraO 
 TraP 32925..33629 IncI1 plasmid conjugative transfer protein TraP 
 TraQ 33635..34156 IncI1 plasmid conjugative transfer protein TraQ 
TraR 34207..34611 IncI1 plasmid conjugative transfer protein TraR 
 TraS 34675..34863 IncI1 plasmid conjugative transfer protein TraS 
 TraT 34847..35647 IncI1 plasmid conjugative transfer protein TraT 
 TraU 35737..38781 IncI1 plasmid conjugative transfer protein TraU 
 TraV 38781..39395 IncI1 plasmid conjugative transfer protein TraV 
TraW 39362..40564 IncI1 plasmid conjugative transfer protein TraW 
 TraX 40593..41177 IncI1 plasmid conjugative transfer protein TraX 
 TraY 41274..43442 IncI1 plasmid conjugative transfer integralmembrane 
protein TraY 
ExcA 43516..44166 surface exclusion protein, ExcA 
hypothetical protein complement(44238..44447) hypothetical protein 
hypothetical protein 44682..44810 hypothetical protein 
hypothetical protein 44839..45015 hypothetical protein 
hypothetical protein 45674..45925 hypothetical protein 
pndA complement(45997..46149) post segregation killing protein 
pndC complement(46004..46207) post-segregation killing protein 
TrbA 46441..47649 TrbA protein 
TrbB  47668..48738 TrbB protein 
TrbC  48731..51022 TrbC protein 
hypothetical protein complement(51059..53758) hypothetical protein 
Nickel ABC  complement(53769..54149) Nickel ABC transporter, periplasmicnickel-binding 
protein NikA 
hypothetical protein 54229..54345 hypothetical protein 
YggA  54335..54670 YggA protein 
YgfB  complement(54755..55603) YgfB protein 
hypothetical protein 55704..55982 hypothetical protein 
hypothetical protein 55952..56149 hypothetical protein 
YgeA 56183..56434 YgeA 
hypothetical protein complement(56465..56635) hypothetical protein 
YgdB complement(56697..57638) YgdB protein 
YgdA  complement(57703..57969) YgdA protein 
YgcA  complement(58061..58495) YgcA protein 
hypothetical protein 58600..58803 hypothetical protein 
hypothetical protein 58800..59084 hypothetical protein 
hypothetical protein complement(59097..59240) hypothetical protein 
 ArdA complement(59224..59739) Antirestriction protein ArdA 
hypothetical protein 59885..60025 hypothetical protein 
YgaA  complement(60187..60783) YgaA protein 
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PsiA  complement(60780..61499) PsiA protein 
PsiB  complement(61496..61930) PsiB protein 
YfhA  complement(61985..63943) YfhA protein 
Putative cytoplasmic protein complement(64002..64235) Putative cytoplasmic protein 
Ssb complement(64293..64820) Single-stranded DNA-binding protein, Ssb 
YffB  64941..65399 YffB protein 
YffA  complement(65590..65781) YffA protein 
YfeC  complement(65778..66200) YfeC protein 
YfeB complement(66247..66672) YfeB protein 
YfeA  66834..66974 YfeA protein 
YfdA  complement(67090..67911) YfdA protein 
YfcB complement(67911..68345) YfcB protein 
YfcA  complement(68357..68578) YfcA protein 
YfbB complement(68579..69262) YfbB protein 
hypothetical protein 69370..69495 'hypothetical protein 
hypothetical protein complement(69647..70573) hypothetical protein 
hypothetical protein 70806..70970 hypothetical protein 
ImpC 70967..71215 ImpC protein 
ImpA 71212..71649 ImpA protein 
ImpB 71649..72923 ImpB protein 
ParB complement(72925..73341) ParB protein 
ParA complement(73334..74314) ParA protein 
YegA complement(74728..75036) YegA protein 
YefA  complement(75123..75767) YefA protein 
 ResD complement(75947..76726) Resolvase, ResD 
hypothetical protein complement(76728..77141) hypothetical protein 
hypothetical protein 77255..77449 hypothetical protein 
hypothetical protein 77467..77580 hypothetical protein 
hypothetical protein 77673..78599 hypothetical protein 
hypothetical protein 78644..78898 hypothetical protein 
hypothetical protein complement(79204..79479) hypothetical protein 
hypothetical protein complement(79917..80918) hypothetical protein 
hypothetical protein complement(80923..81135) hypothetical protein 
hypothetical protein 81117..81284 hypothetical protein 
YdfA  81281..81526 YdfA protein 
hypothetical protein 81574..82116 hypothetical protein 
hypothetical protein complement(82164..82484) hypothetical protein 
Colicin Ib immunity protein 82603..82950 Colicin Ib immunity protein 
Colicin Ib protein complement(82968..84848) Colicin Ib protein 
hypothetical protein complement(84954..85118) hypothetical protein 
YagA  complement(85127..86473) YagA protein 
hypothetical protein 86551..86670 hypothetical protein 
YafB  86827..87429 YafB protein 
hypothetical protein 87446..87979 hypothetical protein 
hypothetical protein 87976..88245 hypothetical protein 
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hypothetical protein complement(88368..88490) hypothetical protein 
hypothetical protein 88499..88642 hypothetical protein 
YadA complement(88722..89195) YadA protein 
YacC complement(89312..90160) YacC protein 
YacB complement(90200..90460) YacB protein 
 Phd antitoxin complement(90478..90747) Prevent host death protein, Phd antitoxin 
Mobile element protein 91114..92250 Mobile element protein 
Phosphoglucosamine mutase complement(92426..92728) Phosphoglucosamine mutase 
Dihydropteroate synthase complement(92815..93630) Dihydropteroate synthase 
putative replication protein complement(93818..93961) putative replication protein 
Mobile element protein complement(94318..95007) Mobile element protein 
tnpA, IS26 complement(95113..95817) tnpA (transposase), IS26(insertion sequence) 
tnpA 96228..96429 Transposase  
tetR complement(96460..97137)  bacterial regulatory protein TetR  
tetA 97216..98415 tetracycline efflux protein 
pecM complement(98447..99331) hypothetical transmembrane protein 
hypothetical protein 99331..99603 hypothetical protein 
Mobile element protein 99584..100792 Mobile element protein 
hypothetical protein complement(100907..101083) hypothetical protein 
hypothetical protein complement(101334..101483) hypothetical protein 
replication initiation protein, 
repZ 
complement(101815..102891) replication initiation protein, repZ 
repY complement(102834..102923) replication protein repZ regulatory protein 
Inc 102938..103009 Inc 
hypothetical protein 103054..103173 hypothetical protein 
 TraA 104000..104287 IncI1 plasmid conjugative transfer protein TraA 
hypothetical protein 104601..104723 hypothetical protein 
 TraB 104729..105262 IncI1 plasmid conjugative transfer NusG-type 
transcription antiterminator TraB 
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Compared to other previously sequenced CTX-M1-encoding plasmids, 
pSAP44 exhibits 99% nucleotide identity and 96% query coverage to pC49-108 
(accession no: KJ484638).  pC49-103 was originally identified in a multidrug 
resistant (MDR) E.coli isolate obtained from a food producing- animal (Wang et al., 
2014). However, one key difference between the plasmids is in the organization of 
the class 1 integron (aadA5, dftA17, IntI1) and the insertion sequence Tn1722, which 
are absent in pSAP44 but present in pC49-108. Instead pSAP44 contains the genes 
coding for tetracycline resistance (about 3 kb) in this location (Figure 23).   
 
 
Figure 23.Sequence comparison of ESBL harbouring plasmid of APEC and MDR E.coli  
 
 
 
 
 
 
 
 
 
Artemis comparison Tool (Sanger, UK) was used to compare the complete 
DNA sequence of pSAP44 isolated from APEC (bottom-line) with the 
complete sequence of plasmid pC49-108 isolated from MDR E. coli (top 
line). Bands of color indicate homology between sequences, red lines shows 
sequence homology in the same confirmation. The resistance cassette 
which encodes the tetracycline resistance genes (tetR, tetA and Pem) in 
pSAP44 and the class 1 integron in pC49-108 are highlighted with a black 
box.  
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4.2.1  Key features of pSAP44  
1.1.1.1  Replication region: 
The first 1,000 bp of pSAP44  was identified as the replication region of the plasmid 
(with an IncI1 replicon type) and it showed high sequence homology (99% identity) to 
two plasmids, that of pC49-108 and R64 (accession no: AP0051457.1) (Figure 23 
and Figure 24). The R64 plasmid was originally identified in Salmonella Typhimurium  
(Komano et al., 1987). The replication region has three essential genes inc, repY 
and repZ, which were found to play important roles in replication maintenance and 
control the plasmid copy number in host bacterium (Sampei et al., 2010).  
 
Figure 24. Sequence comparison pSAP44, the ESBL-producing plasmid of APEC and 
plasmid R64 of Salmonella Typhimurium. 
 
 
 
 
 
 
 
 
 
Artemis comparison Tool (Sanger, UK) was used to compare the complete DNA 
sequence of pSAP44 ESBL (bottom-line) with the complete sequence of plasmid 
pR64 (top line). Bands of color indicate homology between sequences, red lines 
shows sequence homology in the same confirmation; blue lines show sequence 
inversion.  
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4.2.1.1 Resistance genes: 
The blaCTX-M1 gene has been reported frequently on plasmids belonging to the IncI1 
replicon type from E. coli isolated from human and animal sources (Carattoli, 2013). 
In pSAP44, the CTX-M1 gene was found to be located downstream of the insertion 
sequence ISEcp1 (Figure 25). The CTX-M1 gene has also been reported in plasmids 
belonging to different Inc types adjacent to ISEcp1, or to other insertion elements 
such as IS26, in IncF, IncB/O and IncN plasmids (Wang, 2015). Comparing the 
nucleotide sequence of ISEcp1 to the IS database (http://www-is.biotoul.fr/page-
is.html) , revealed that it was 100% identical to the IS1380 family of insertion 
elements. The IS1380 family are noted for their ability to mobilize easily and 
efficiently among different bacterial species, which may explain the high prevalence 
of CTX-M1 genes among different bacterial species (Jacoby, 2009).  
 
 
                Figure 25. Genetic map of the CTX-M1 region of pSAP44 and pC49-108. 
 
 
 
  
 
 
CLC main workbench version (7.5.1) was used to compare the genomic organization of the 
pSAP44 ESBL CTX-M-1 genes with those of pC49-108. The insertion sequence ISEcp1 is 
located upstream the CTX-M-1 gene.    
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Genes coding resistance to tetracycline were also identified in pSAP44.  
Resistance to tetracycline was also observed when pSAP44 was transferred to 
recipient E. coli strains (section 3.2.3) which suggested that the tetAR genes were 
co-transferable with the CTX-M1 gene and likely located on the same plasmid. The 
tetAR cluster contains the class A tetracycline efflux protein (TetA) and a repressor 
(TetR) with 100 % nucleotide sequence identity to the Inc1 plasmid pSC138 
(accession no:AY509004) isolated from a highly invasive strain of Salmonella 
enterica serovar Cholerasuis (Chiu et al., 2005). Although the genetic organisation of 
this cluster (pem-tetA-tetR) was highly similar to pSC138 as well as to plasmids of 
other Inc types e.g pH1038-142 (IncF-IncN) (accession no: KJ484634), the 
transposon TnpA gene located upstream of this loci was completely different and 
unique to pSAP44. This loci of organisation was not detected in the reference 
plasmid pC49-108, being disrupted by a mobile element Tn1721 and genes of the 
class 1 Integron module (IntI1-dfrA17-aadA5) (see Figure 26). It is believed that 
tetAR genes and the adjacent genes are linked with a direct repeat sequence 
(cgcccgcagca) which flanks the tetAR cluster and which might serve as a ‘hotspot’ 
location for the deletion and insertion of new mobile elements (Chiu et al., 2005). 
However the direct repeat sequence was lacking in pSAP44. Instead, analysis of the 
region flanking tetR, tetA and pecM, revealed inverted repeats of 7 bp (tatttgc-
ataaacg) in both pC49-108 and pSAP44 ESBL plasmid (see Figure 26). It is possible 
that this region also acts as a hotspot for gene exchange. 
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Genetic map of the tetracycline region (3kb) presents in pSAP44 ESBL and absent in pC49-
108 where class 1integron genetic organization is present. The genetic organization of both 
regions are flanked with inverted repeat sequence (ATTTGCA, TGCAAAT) indicated in a 
black box.  
 
 
 
 
Figure 26. Genetic map of the tetracycline region of pSAP44 ESBL vs. pC49-108 
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4.2.1.2 Transfer genes:  
Conjugative transfer is an important mechanism by which plasmids spread among 
different bacteria. The cluster of genes in the pSAP44 transfer region (39,447 kb) 
showed  homology to that found in R64 and pC49-108 except for the absence of two 
genes (traD and pilJ) in pSAP44. The pC49-108 plasmid also lacked these two 
genes. Comparison of the gene organisation in pSAP44 transfer region to that of 
R64 and pC49-108 plasmids revealed many conserved genes as indicated in Figure 
27. This included four major parts of the transfer region consisting of the traABC 
regulatory genes, traA and traB genes for conjugation, pil genes for type IV pilus 
biogenesis and the oriT operon for conjugation processing (Takahashi et al., 
2011).The traABC genes in all these plasmids are located upstream of the 
replication region consisting of the repYZ genes. 
 
 
Figure 27 . Sequence comparison of the transfer gene regions of pSAP44 and R64 
(AP005147) 
 
 
 
 
 
 
 
 
 
CLC main workbench version (7.5.1) was used to compare the genomic organization of the 
pSAP44 ESBL transfer genes with those of R64. The genomic organisation of the transfer 
genes shows high homology with only two genes, traD and pilJ are absent in pSAP44ESBL.    
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Thirteen of pil genes were found to be identical to those of the R64 plasmid, with 
exception of pilJ, which was missing in pSAP44. The pil genes are involved in the 
formation of the type IV pilus, which is important for conjugation (Sampei et al., 
2010). Notably, pilJ does not appear to be essential in the conjugation process as 
the absence of this gene in pSAP44 did not limit transfer of the plasmid to other E. 
coli strains.The ISEcp1 and CTX-M-1 genes are located between pilV gene and rci 
gene (shufflon- specific DNA recombinase) in pSAP44, but are not present in R64. It 
is possible that the sequence region between the pilV and rci genes acts to promote 
the insertion of new mobile elements. 
 
4.2.1.3  Miscellanous genes. 
The colicin 1b gene (colIb) was also identified in pSAP44 (see Figure 22). 
Comparing the colIb gene sequence to those present in the Genbank database 
(blast.ncbi.nlm.nih.gov) showed 100% nucleotide identity to the colIb gene located 
on other large conjugative plasmids, most of which belonged to different Inc types 
but also harboured antimicrobial resistance genes, such as blaCTX-M1. 
The stability genes, psiA and psiB, in pSAP44 were located downstream of 
the gene ardA coding for an anti-restriction protein. However, the stability region of 
the R64 plasmid presented as mck/kor genes is disrupted in pSAP44  by 
hypothetical proteins and only parAB (encoding for partitioning proteins) and resD 
(encoding for resolvase D protein) were detected (see Figure 22).  
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4.3 Key features of pFIB44, the FIB plasmid present in APEC isolate SAP44 
APEC virulence factors are commonly encoded on large plasmids, most of which 
belong to the IncFIB replicon type (Johnson. et al, 2006).  Previously in chapter 3, 
PCR-based replicon typing showed that all ESBL-producing APEC isolates used in 
this study also contained plasmids belonging to the Inc FIB type in addition to the 
ESBL IncI plasmid. Thus, the FIB plasmid was sequenced in order to determine its’ 
gene content and to better understand its relationship, if any, to the ESBL-producing 
plasmids of APEC.   
Sequence data analysis revealed that the plasmid belonged to the Inc FIB 
type (herein designated pFIB44), consistent with PCR-based rep typing in chapter 3. 
pFIB44 was 97.245 kb in size, contained 149 features and had an average of GC 
content of 60%. Like pSAP44, the plasmid contained several genes involved in 
conjugation, mobilisation, partitioning, virulence as well as some unknowns (Figure 
28). 
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Analysis of the DNA sequence of pFIB44 showed that it had 99% similarity at the 
nucleotide level to that of plasmid, pAPEC-1 (accession no:CP000836), which was 
also isolated from an APEC O78 isolate (Mellata et al., 2009).  A gap of about 600 
bp was missing from pFIB44. Closing the gap by PCR primer walking showed that 
the repA region found in pAPEC-1 was missing in pFIB44. The finQ and crnB genes 
found flanking the repA region in pAPEC-1, and also in the pAPEC-01-ColBM 
plasmid (accession no.BQ381420) were identical to that found in pFIB44 (Figure 29). 
In addition, one of two insertion sequences (IS30) located upstream of the crnB gene 
in pAPEC-1 was identical to that of pFIB44.  This was not the case however, in the 
ColBM plasmid where neither of the insertion sequences were similar to those found 
 
Circular representation of pFIB44 plasmid present ESBL-producing APEC. The 
different rings represent (from outer to inner) all genes and insertion elements, 
which are color coded by functional group (rings 1 and 2), deviation from average 
G+C content (ring 3), and GC skew ((G-C)/(G+C).Colors represent the following: 
red, virulence associated; yellow, mobile elements; dark blue, plasmid transfer; 
black, plasmid replication; green, plasmid maintenance; light blue, hypothetical 
proteins; and gray, transposons and insertion elements . 
Figure 28. Map of pFIB44 plasmid, the IncF plasmid of ESBL-producing APEC (SAP44).  
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in pFIB44 and pAPEC-1.The region flanking the missing repA cluster in pFIB44 
could act as a hotspot for the insertion or excision of foreign DNA. A complete list of 
the features based on the DNA sequence of pFIB44 are presented in Table 15. Key 
features in this plasmid are described in more detail below. 
 
Figure 29. DNA sequence comparison of p44FIB, pAPEC-1 and pAPEC-01-ColBM. 
 
Comparison of the genetic structure of the region flanked the repA cluster of the pAPEC-1 
and pAPEC-01 ColBM to that of pSAP44FIB. Colours represent the following: Black, known 
ORFs genes; white, hypothetical protein genes; hatched arrows, insertion sequence genes.  
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Table 15. Features and/or open reading frames of pFIB44. 
CODING  REGION COORDINATES      FUNCTION 
MM1_0001 44   334 conserved hypothetical protein 
MM1_0002           340   462 hypothetical protein 
MM1_0003           444  1079                     transposase, putative 
MM1_0004          1042  1161                    transposase, putative 
MM1_0005          1466  1600                    conserved hypothetical protein 
MM1_0006          1646  1774                    conserved hypothetical protein 
MM1_0008          1847  2116                    hypothetical protein 
MM1_0007          2113  2262                    hypothetical protein 
IROB 2315  3430                    IroB, glycosyltransferase 
IROC 3444  7229                    IroC, ABC transport protein 
IROD 7333  8562                    IroD, ferric enterochelin esterase 
IROE 8647  9603                    IroE, hydrolase 
IRON 9648 11825                    IroN, siderophore receptor 
AROH 12691 13725                  phospho-2-dehydro-3-deoxyheptonate aldolase 
MM1_0016         13743 13934                  hypothetical protein 
MM1_0017         13924 14070                  hypothetical protein 
MM1_0018         14285 14593                  conserved hypothetical protein 
MM1_0019         14692 14874                  conserved hypothetical protein 
MM1_0020         14871 15068 YacA, putative 
MM1_0022         15220 15342                  hypothetical protein 
MM1_0021         15328 15444                  hypothetical protein 
MM1_0023         15588 15746                  hypothetical protein 
CVAA 15750 17024                  colicin V secretion protein 
CVAB 17017 19113                  colicin V secretion/processing ATP binding protein 
CVAC 19283 19594                  colicin V synthesis protein 
CVI 19572 19808                  colicin V immunity protein 
MM1_0028         19690 19896                  hypothetical protein 
MM1_0029         19999 20370                  conserved hypothetical protein 
MM1_0030         20342 20746                  conserved hypothetical protein 
MM1_0031         20733 21017                  conserved hypothetical protein 
MM1_0032         21014 21994                  dimethylaniline monooxygenase 
MM1_0033         22061 22450                  Transposase 
MM1_0034         22447 22794                  transposase, putative 
MM1_0036         22844 24250                  Transposase 
MM1_0035         24235 24384                  hypothetical protein 
MM1_0038         24430 24687                  Resolvase 
DEF  24674 25126                  peptide deformylase 
MM1_0040         25080 25247                  hypothetical protein 
TSH 25235 29368                  temperature-sensitive hemagglutinin Tsh 
MM1_0041         29491 29913                  conserved hypothetical protein 
MM1_0042         29973 30377                  Transposase 
INSI1 30334 31464                  transposase InsI for insertion sequence element            IS30B/C/D 
MM1_0044          31508 32287                  transposase, putative 
SRNB 32688 32936                  Hok/Gef family protein 
MM1_0060         33105 33221                  endonuclease, putative 
MM1_0061         33455 33667                  conserved hypothetical protein 
FINO   33803 34363                  fertility inhibition protein 
    MM1_0063         34466 35326                  conserved hypothetical protein 
TRAX  35385 36131                   TraX 
TRAI    36151 38036                   TraI 
TRAK   38227 38955                   TraK 
TRAE    38942 39508                    type IV conjugative transfer system protein TraE 
TRAL 39530 39841                    type IV conjugative transfer system protein TraL 
TRAA     39856 40221                   fimbrial protein precursor 
TRAY   40254 40655                   TraY 
TRAJ 40748 41437                    TraJ 
TRAM   41624 42007                    TraM 
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MM1_0074         42340 42930                  Transglycosylase 
MM1_0075         42956 43090                  hypothetical protein 
MM1_0076         43109 43258                  hypothetical protein 
MM1_0077         43227 44156                 conserved hypothetical protein 
MM1_0078         44226 44498                 hypothetical protein 
MM1_0079         44542 44745                 hypothetical protein 
MM1_0080         44855 45087                 conserved hypothetical protein 
MM1_0081         45094 45249                  hypothetical protein 
HOK      45374 45490                          Hok protein 
MOK     45378 45590                          Mok
SOK     45576 45800                           Sok
PSIA       45812 46532                plasmid SOS inhibition protein A 
PSIB      46529 46966                PsiB 
MM1_0086           47018 47152               conserved domain protein 
YUBL    47243 47482                YubL 
SSB  47544 48083              plasmid-derived single-stranded DNA-binding protein 
MM1_0089           48109 48315              hypothetical protein 
MM1_0090           48317 48874             conserved hypothetical protein 
SOPB   49414 50385             SopB 
SOPA  50385 51560             SopA 
INSB  51851 52354             insertion element IS1 protein InsB 
MM1_0094            52365 52577             conserved domain protein 
MM1_0095            52619 52924             conserved hypothetical protein 
IUTA     53033 55231              ferric aerobactin receptor precursor 
IUCD 55316 56593              L-lysine 6-monooxygenase 
IUCC 56590 58332              IucC 
IUCB 58332 59279              IucB 
IUCA  59280 61061              IucA 
MM1_0101          60976 61095              hypothetical protein 
SHIF  61140 62333              transposon function, ShiF, putative 
MM1_0103          62449 62565              hypothetical protein 
CRCB  62713 63093             CrcB protein 
ENO  63434 63868             Enolase 
MM1_0106           64224 64370            hypothetical protein 
SITD 64336 65193           SitD 
SITC 65190 66047           SitC 
SITB    66044 66871           SitB 
SITA 66871 67785           SitA 
INSA 68142 68417           IS1 protein InsA 
MM1_0112           68336 68839           IS1 protein InsB 
IMPB  69019 69408             impB 
ISTA  69666 70022             transposase for insertion sequence element IS21 
MM1_0116         70244 70468             hypothetical protein 
MM1_0117         70605 70775             hypothetical protein 
REPB   70768 71745             rep FIB replication protein B 
MM1_0119         71821 71940             hypothetical protein 
INTM    72030 72770             site specific recombinase, putative 
MM1_0121         72927 73052             hypothetical protein 
MM1_0122         73453 74361             conserved hypothetical protein 
HYLF   74424 75533             hemolysin F 
MM1_0124         75783 75940             hypothetical protein 
OMPT  75973 76932             protease 7 
MM1_0126         77036 77425            conserved hypothetical protein 
MM1_0127         77564 77701            hypothetical protein 
MM1_0128         77793 78056            hypothetical protein 
MM1_0129         78205 78363            transposase, putative 
MM1_0130         78547 78873            IS629 taxon, putative 
MM1_0131         78873 79064            transposase for insertion sequence element IS629 
MM1_0132         79048 79747            transposase for insertion sequence element IS629 
MM1_0133         80019 80325            transposase, putative 
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MM1_0134         80347 80475            hypothetical protein 
MM1_0135         81085 81213            hypothetical protein 
ETSA   81219 82406            macrolide-specific efflux protein etsA 
ETSB     82403 84343             EtsB 
ETSC 84347 85717            outer membrane protein 
MM1_0139         85720 85848            hypothetical protein 
MM1_0140         85845 85988            hypothetical protein 
MM1_0141         86046 86234            conserved hypothetical protein 
MM1_0142         86336 86491            hypothetical protein 
MM1_0143         86514 87455           conserved hypothetical protein 
MM1_0144         87465 87653           hypothetical protein 
MM1_0145         87690 88076           conserved hypothetical protein 
MM1_0146         88213 89079           transposase, putative 
MM1_0147         89266 89577           conserved hypothetical protein 
MM1_0148         89594 89746           hypothetical protein 
MM1_0149         89716 90909          conserved hypothetical protein 
MM1_0150         91324 91548          hypothetical protein 
MM1_0151         91529 91648          hypothetical protein 
MM1_0152         91798 91962           Transposase 
MM1_0153         92151 92890          transposase insD for IS2 
MM1_0154         92940 93239          transposase insE for IS3 
MM1_0155         93236 94102          transposase InsF for IS3 
MM1_0156         94116 94316          Transposase 
MM1_0157         94274 94639          transposase insC for IS2 
MM1_0158         94870 94994          hypothetical protein 
MM1_0159         94995 95122          hypothetical protein 
ISS    95250 95567         Increased serum survival 
MM1_0161         95580 95872         conserved hypothetical protein 
MM1_0162         95887 96007         hypothetical protein 
MM1_0163         96076 96258         hypothetical protein 
MM1_0164         96453 96710         conserved hypothetical protein 
MM1_0165         96716 96838          hypothetical protein 
MM1_0166         96820 97243         conserved hypothetical protein 
 
 
4.3.1  Replication, partitioning and segregation regions 
The repFIB gene is located downstream of the insertion sequence element IS21 
between the sitABCD and etsABC gene clusters. In comparison to other FIB 
replicons, pFIB44 showed a similar homologous structure to the FIB replicons of 
pAPEC-1 and pAPEC-01-ColBM (accession no: DQ381420). Plasmid partitioning 
(sopA and B) and post-segregation systems (smB, and hok/sok) are located either 
side of smB of the tra region (see Table 15). This genetic organisation including the 
tra region clusters was identical to that of pAPEC-1. Although pSAP44 (the ESBL 
plasmid) was shown to transfer to other E. coli strains, the pFIB44 plasmid which co-
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exists in the same donor strain, was not detected in the recipient strains by PCR.  
Consistent with this observation, analyses the tra gene cluster in the pFIB plasmid 
revealed that several important tra genes are missing including traV, traU, traF, 
traW, traC, traH, traQ, and trbC, traD (controls DNA transfer), traT and traS (which 
mediate surface exclusion), as well as several others, including traR, trbG, trbH, 
trbF, trbD, and trbI. Given these gene omissions, it is perhaps not surprising that 
pFIB44 was not found in the recipient cell. 
 
4.3.2  Virulence gene content 
The pFIB44 sequence showed that 9 virulence gene clusters accounted for 
approximately 80% (80 kbp of 97 kbp) of the DNA sequence (Figure 28). These 
virulence mechanisms included three iron acquisition systems (iroBCDN, sitABCD 
and iutA iucABCD), a colicin V operon (cvi and cva ABC), temperature sensitive 
haemagglutinin (tsh), haemolysin protein (hlyF), macrolide resistant genes (etsABC), 
increased serum survival (iss), and the outer membrane protease (ompT). While 
detailed gene comparisons for pFIB44 were beyond the scope of this thesis, in 
general the sequence of the virulence genes identified in pFIB44 had similar 
homologous structures to that of pAPEC-1 and the pAPEC-01-ColBM plasmids. 
 
4.3.3  Comparison of pSAP44 and pFIB44  
The APEC strains used in this thesis were found to harbour two large plasmids 
approx. similar in size but belongin to different replicon types (Inc1 and IncFIB, 
respectively). While both plasmids encoded some virulence genes which likely 
conferred benefits to the host bacterium, the number of plasmid-coding for known 
virulence factors were markedly different. For example, pSAP44 carried resistance 
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genes (CTX-M1 and tetR) mediating resistance to antibiotics, whereas pFIB44 
harboured at least 9 virulence gene clusters, most of which are commonly reported 
in APEC. Interestingly, both plasmids carry genes coding for colicin proteins but of 
differing types, Col1 b and ColV, respectively. A striking feature of both plasmids was 
the number of unknown functional genes (hypothetical proteins) which represent 
14% and 17% of DNA in pSAP44 and pFIB44, respectively. Furthermore, 
comparison in the number and size of insertion sequence and transposons revealed 
that 12% of pFIB44 DNA was associated with mobile genetic elements (foreign DNA) 
whereas only this was accounted for only 4% in pSAP44. This may explain why so 
many common virulence genes are carried on plasmids belonging to the FIB 
replicon.  
   
4.4 Sequencing and genetic comparison of ESBL-producing (SAP44) and non-ESBL-
producing (SAP24) avian E. coli O78 isolates 
APEC belonging to the O78 serogroup are the most prevalent serogroup linked to 
diseases in poultry (Schouler et al., 2012). In chapter 2, two of the E. coli isolates 
were found to belong to the O78 serogroup, one of which harboured an ESBL 
plasmid while the other did not. These strains were selected for further study in order 
to determine whether the chromosomal content of ESBL-producing and ESBL-
negative isolates varies and/or may explain ESBL plasmid carriage. The fully closed 
genome sequence of APEC O78 (CP004009) was used as a reference strain, and 
ExPEC strains of different O-antigen types APEC O1 (PC000468), APEC O2 
(PC005930) and urine pathogenic E.coli (UPEC O6, AE014075.1) were included as 
‘out-groups’ in the analysis. These additional genomes were used to confirm the 
validity of the comparisons and included in the final phylogenetic tree to facilitate 
visualization of the relationships among E. coli populations.   
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De novo assembly of the SAP44 DNA sequence generated 203 scaffolds with 
a predicted genome size of 4,686,633 nucleotides. For SAP24, de novo assembly 
generated 225 scaffolds with a predicted genome size of 4,765 667 nucleotides. 
Phylogenetic single nucleotide polymorphism (SNP) analysis of the assembled 
genomes was performed to gain a better understanding of the genetic relationship of 
the O78 strains, as well as their relationship to other ExPEC, including APEC O1, 
APEC O2 and UPEC O6.  The SNP based phylogenetic analysis is able to detect 
non-related strains and group those that are related into one clade.  As can be seen 
in Figure 30, SAP24 and SAP44 were grouped together into one clade together with 
the reference genome APEC O78 (PC004009). In contrast, APEC O1 and APEC O2 
which belonged to different O-antigen groups are placed together in a single clade, 
as a sub-clade of UPEC. Using the genomic sequence data, it was also possible to 
perform multi locus sequence typing (MLST) to confirm the clonal complex of the test 
strains.   MLST is a typing method for bacteria based on the sequence of the internal 
fragments of seven housekeeping genes (e.g. adk, fumC, gyrB, icd, mdh, purA and 
recA). The DNA sequence of the tested strains were uploaded into the freely 
available MLST database (www.warwick.ac.uk/mlst/dbs/Ecoli) to generate the 
sequence typing number. MLST analysis clustered SAP44, SAP24 and the APEC 
O78 reference strain into the same sequence type (ST23), consistent with what had 
been found for the SNP analysis. In contrast, APEC O1, APEC O2 and UPEC O6 
were each given a different clone number, of ST95, ST140 and ST73, respectively 
suggesting that they were not so closely linked. Overall, the findings from the SNP 
and MLST analysis confirmed that SAP24, SAP44 and reference O78 strain were 
very closely related O78 strains.  
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Figure 30. Phylogenetic SNP tree of APEC O78 isolates 
 
 
 SNP Tree was used to produce a phylogenetic SNP tree: the number located on each node 
is a time scle root to 1.0, values near to 1.0 indicating the branch at the node exist with high 
probability. SAP24, SAP44 and APECO78 (reference) were placed into a single clade. 
APECO1 and APECO2 are in single clade were closely related to UPEC. 
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The scaffolds of SAP44 and SAP24 were reordered based on the genome of the 
APEC O78 reference strain (Mangiamele et al., 2013(CP004009)) using the Mauve 
contig mover. In Figure 31, regions that are shared between the three strains appear 
as blocks of the same colour whereas regions of difference are represented by 
‘white’ gaps, which were mostly a result of insertion by prophage-associated genes. 
To facilitate analysis, the differences found in the strains was investigated using a 
fully automated service for annotating bacteria genomes, Rapid Annotation 
Subsystem Technology (RAST) (www.rast.nmpdr.org).  This program detects protein 
coding regions, assigns function to genes and predicts which subsystems are 
represented in the genome.  
The reference APEC O78 strain has a chromosome which is 32 kb larger than 
that of SAP24, and 112 kb larger than that of SAP44. Within APEC O78 reference 
strain 4,644 chromosomal genes were predicted, whereas SAP24 and SAP44 were 
predicted to contain 4,584 and 4,503, respectively. The genome of APEC O1 and 
APEC O2 strains were also included in this analysis to validate the comparison 
among APEC O78 strains and to identify the common virulence genes that are 
shared by APECs. The data generated from RAST showed that the APEC O78 
genomes shared many genes normally found  in E. coli and identified several 
virulence genes associated with APECs including adhesins, invasin and iron 
acquisition systems (Table 16). (Complete list of gene functions found in APEC O78, 
SAP44 and SAP24 are listed in additional file on a CD enclosed within this thesis).            
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Figure 31.Genome comparative analysis of SAP24, SAP44 and the APEC O78 
reference strain  
  
Comparative mauve analysis between the core scaffolds of each whole genome sequence 
of SAP44, SAP24 and a reference genome, the closely related E.coli APECO78. Predicted 
sequence homology among all three genome sequences is represented by colour matching 
regions. Regions within black boxes are identified phage sequences and phage associated 
regions. Sequence below the line of SAP24 represents a predicted inversion, based on 
scaffold tiling to the APECO78 reference. 
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Table 16. General features counts of the SAP24, SAP44, APEC O78 (reference strain), APECO1 
and APECO2 
Genome features APEC O78 SAP24 SAP44 APECO1 APECO2 
Genome size (bp) 4,798,435 4,765,667 4,686,633 5,082,025 4,929,051 
Possibly missing genes 12 25 24 16 4 
G+C content 50.68% 51.1% 51.7%   
Number of coding sequence 4.644 4.584 4.503 5122 4827 
Cell wall and Capsule:      
Capsular and extracellular 
polysaccharides 
81 81 81 106 105 
Gram negative cell wall 
components 
100 96 100 102 103 
Virulence, Disease and 
defence:  
     
Adhesion  7 7 7 7 7 
Toxins and super antigens 0 0 0 6 0 
Bacteriocins, ribosomally 
synthesized antbacterial 
peptides  
12 12 12 12 12 
Resistance to antibiotics and 
toxic compounds 
74 75 76 73 77 
Invasion and intracellular 
resistance 
15 13 13 14 14 
Phages, prophages 71 48 48 218 124 
Membrane transport  202 204 203 231 233 
Iron acquisition and 
metabolism: 
     
Siderophores 15 36 15 15 14 
Iron acquisition 8 9 8 34 34 
RNA metabolism 248 247 247 253 254 
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Protein metabolism 299 291 289 299 299 
Cell Division and cycle 37 39 37 37 37 
Motility and chemotaxis 84 83 82 81 79 
Regulation and cell signalling 154 158 153 152 151 
Secondary metabolism 26 26 26 5 5 
DNA metabolism 134 127 129 134 136 
Fatty acids and lipids and 
isoprenoids  
134 135 133 138 136 
Potassium metabolism 28 28 28 30 29 
Nitrogen metabolism 75 74 74 72 72 
Respiration 193 191 191 183 179 
Stress response  190 188 189 190 191 
Metabolism of aromatic 
compounds  
27 27 27 3 3 
Amino acids and derivatives 396 397 394 419 405 
Sulfur metabolism 57 57 58 58 59 
Phosphorus metabolism 54 54 54 51 51 
Carbohydrates 774 768 768 838 837 
Cofactors, vitamins and 
pigments 
283 283 284 294 298 
Function based comparison of APEC related strains belong to the same O78 type APEC O78 
(reference strain), SAP24 (non ESBL APEC) and SAP44 (ESBL producing APEC). 
 
 
 
 
 
 
 
Strains belonging to the O78 serogroup (e.g. SAP44, SAP24 and APEC O78 
(CP004009) generally have the same number of features as defined by the RAST 
system (see Table 16). For example, SAP44, SAP24 and APECO78 contained 12 
bacteroicins each. However, almost twice as many phage and prophage features 
were found in APECO78 as compared to SAP44 and SAP24. Furthermore, the non-
ESBL-producing SAP24 isolate contained more than twice the number of 
siderophores as either SAP44 or APECO78.  
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The number of features shared by the APEC O78 serogroup isolates and 
APEC O1 / APEC O2 genomes was largely similar, with the exception of the number 
of regions related to phages, siderophores and some metabolic capabilities (Table 
16). For example, there was 3-5-fold less prophage elements in O78 than APEC O1 
and APEC O2 whereas there was 9-fold more regions related to aromatic 
metabolism compounds in O78 than APEC O1 and APEC O2.  
All the genomes contained siderophores such as enterobactin, aerobactin and 
ferrous iron transporter system, EfeUOB. In addition, APEC O1 and APEC O2 
genomes have haemin uptake and utilization systems, which are not found in the 
O78 genome strains. Interestingly, the metabolism of the isolates seemed to differ. 
For example, the degradation enzymes of the aromatic compounds, 
phenylpropionate (PP) and cinnamic acid (CA), were only found in the genome of 
O78 strains while the ribulose monophosphate pathway was only identified in the 
APEC O1 and APEC O2 genomes. CMP-N-acetylneuraminate biosynthesis was only 
identified in the genome of APECO1 and APECO2 and not in the O78 strains. 
However, other polysaccharide protein structures were predicted including 
derivatives of N-acetylneuraminate such as sialic acid metabolism.  
Few phages and prophages were detected in SAP24 and SAP44 compared to 
the O78 reference strain. However when the number of phages in APEC O78 strains 
compared to other APEC strains it showed 3 to 5 fold less which indicate that the  
genome of O78 type is much conserved than other type of APECs (Table 16).  
Given that RAST identified that the number of phage-associated regions was 
different between the APEC O78 strain genomes, the PHAST server was used to 
further annotate prophage sequences within the bacterial genomes 
(http://phast.wishartlab.com). PHAST server is a tool server to identify and annotate 
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prophage sequences from raw DNA sequence or Genbank format with 94% 
predictive value.  
  Ten phage –associated regions designated Phage Regions (A1-A10), seven 
designated (B1-B7) and 7 designated (C1-C7), were identified in APEC O78, SAP24 
and SAP44 respectively (Table 17). Three of the ten phage regions in the APEC O78 
were identified to be intact prophages by PHAST whereas just one of the seven 
SAP44 and none of the SAP24 phage regions were identified as intact.  The majority 
of these phages were composed of > 70% phage genes and some hypothetical 
genes.  Incomplete phage region A5 and B1 of APEC O78 and SAP24 respectively 
were mostly similar to lambda phage and encoded the increased serum survival 
gene, bor. Also three of the incomplete Phage regions A1, A4 and A9 of APEC O78 
along with three incomplete Phage regions C1, C6 and C7 of SAP44 were similar to 
Phage mEP460 and encoded a transcriptional activator of EaeA/BfpA expression in 
enteropathogenic E.coli. Each genome examined has at least three unique phage 
regions not found in the other organisms, but also shared at least one phage region 
between one another. Interestingly, an incomplete Stx2-converting prophage was 
identified in SAP44. The stx2 genes are usually found on the genome of lambdoid-
like bacteriophages integrated in the chromosome of their bacterial hosts (Strauch et 
al., 2001).  
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Table 17. Phage associated regions identified by PHAST. 
 
1percent identity of the region compared to the PHAST annotation. 2percentage of identified ODRs that encode phage or 
hypothetical genes. 3 PHASTs prediction of whether each prophage encodes the genes necessary for lysogeny. 
 
 
 
 
 
E.coli APEC O78 
Region Region Position (bp) Size(kb) PHAST Annotation Annotation identity1 
(phage Identity)2 
PHAST 
Prediction3 
A1  569218-590142  15.1Kb  mEp460 NC_019716 43.55% (70.5%) incomplete  
A2  648202-703555  41.3Kb  SfV NC_003444  50.43% (92.8%) intact  
A3  1813936-1847980  42.2Kb  SfII NC_021857  50.61% (89.4%) intact  
A 4  2384488-2397576  27.6Kb  mEp460 NC_019716 46.81% (75.7%) incomplete  
A 5  2797858-2811582  23.8Kb  Lambda NC_001416 45.61% (93.5%) incomplete  
A 6  3000640-3041713  16.1Kb  RE2010 NC_019488  47.40% (82.6%) incomplete  
A 7  3151597-3186778  36.6Kb  P2 NC_001895 50.44% (88.8%) intact  
A 8  569218-590142  8.3Kb  PhiCh1 NC_004084 47.43% (54.5%) incomplete  
A 9  648202-703555  49.9Kb  mEp460 NC_019716 46.05% (68.1%) incomplete  
A 10  1813936-1847980  18.6Kb  SfIV NC_022749 45.03% (75%) incomplete  
Non ESBL  APEC O78 (SAP24) 
Region Region Position (bp) Size(kb) PHAST Annotation Annotation identity1 
(phage Identity)2 
PHAST 
Prediction3 
B1  569218-590142  20.9Kb  Lambda NC_001416 49.5% (76.4%)  incomplete  
B 2  648202-703555  55.3Kb  Fels 2 NC_010463 51.1% (56.8%)  incomplete  
B 3  1813936-1847980  34Kb  L 413C NC_004745 51.5 % (85.1%) incomplete  
B 4  2384488-2397576  13Kb  RE 2010 NC_019488 49.3% (60%)  incomplete  
B 5  2797858-2811582  13.7Kb  P2 NC_001895 47.9% (61.9%) incomplete  
B 6  3000640-3041713  41Kb  SfIV NC_022749 50.9 % (76.1%) incomplete  
B 7  3151597-3186778  35.1Kb  P88 NC_026014 52 % (85.7%) incomplete  
ESBL producing APEC O78 (SAP44) 
Region Region Position (bp) Size(kb) PHAST Annotation Annotation identity1 
(phage Identity)2 
PHAST 
Prediction3 
C1  845590-865476  19.8Kb  mEp460 NC_019716 47.6 % (78.5%) incomplete  
C 2  1167076-1176957  9.8Kb  Cronob ENT39118 
NC_019934 
47.7 % (41.1%) incomplete  
C 3  1378183-1389753  11.5Kb  Stx2 converting I 
NC_003525  
46.7 % (77.2%) incomplete  
C 4  1407964-1447393  39.4Kb  Yersin L 413C 
NC_004745 
51.2 % (83.8%) questionable
  
C 5  2997477-3034017  36.5Kb  Fels 2 NC_010463 52.3 % (88.8%) intact  
C 6  3244105-3255375  11.2Kb  mEp 460 NC_019716 50.7 % (78.9%) incomplete  
C 7  3819696-3862920  43.2Kb  mEp 460 NC_019716 50.5 % (54.7%) incomplete  
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To further assess differences between the three genomes, IslandViewer software 
(Dhillon, 2015)  was used to identify putative genomic islands (GIs). Island Viewer is 
a tool server that integrates three different genomic island prediction methods: 
IslandPick, IslandPath-DIMOB, and SIGI HMM to produce a comprehensive list of 
islands (http://www.pathogenomics.sfu.ca/islandviewer/).   
The SAP44 genome was found to contain 42 genomic islands (GI-1 to GI-42) 
ranging in size from 4 kb to 30 kb whereas SAP24 contained 37 genome islands (4 
kb to 35 kb) and  the APEC O78 reference genome contained 48 genomic islands (2 
kb to 30 kb) (Figure 32 – 34).  
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                                       Figure 32. Genomic Islands in SAP44 
 
Genomic islands in SAP44 were predicted using Islandviewer software. Genomic islands are 
plotted to scale and labelled clockwise on the genome map. 
 
                                           Figure 33. Genomic Islands in SAP24 
 
Genomic islands in SAP24 were predicted using Islandviewer software. Genomic islands are 
plotted to scale and labelled clockwise on the genome map. 
 
139 
 
 
 
 
                                        Figure 34. Genomic Islands in APEC O78 
 
 
Genomic islands in APECO78 (reference) were predicted using Islandviewer software. 
Genomic islands are plotted to scale and labelled clockwise on the genome map. 
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Approximately half of the genomic islands in SAP44 and APECO78 code for 
defective prophages. Conversely, SAP24 chromosome has less prophage-related 
genes representing only 14% of the genomic islands.  Four GIs in SAP44 and 
APECO78 and 5 in SAP24 were detected to be fimbrial islands (Table 18).  EmrKY-
ToIC multidrug resistance efflux pump and the sensor kinase, EvgA involved in acid 
resistance was only found in APECO78. Genomic islands involve in transport and 
metabolism of various sugars and iron uptake system were identified in all APEC 
genomes (Table 19).  
One genomic island coding for the biofilm PgaA and PgaB synthesis 
lipoprotein was identified in both SAP24 and SAP44 genomes but not in the 
APECO78 reference. The genomic regions coding for a type 3 secretion system 
were identified in all APEC strains, in addition the SAP24 genome also contains type 
IV secretion. While GIs involved in lipopolysaccharide or capsular polysaccharide 
biosynthesis predicted in all studied genomes, less were found in SAP44 and 
APECO78 genomes.  A complete analysis of all the genomic islands and their gene 
content is beyond the scope of this thesis, however a full list of this information can 
be found on CD enclosed with this thesis.   
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Table 18. Genomic islands (GIs) in APEC strains.  
CHARACTERISTICS OR TRAIT 
ENCODED 
SAP44 SAP24 APEC O78 
(REFERENCE 
STRAIN) 
DEFECTIVE PROPHAGES  GI-12,GI-13,GI-14,GI-
15,GI-16,GI-17,GI-
18,GI-24,GI-25 
GI-18,GI-23,GI-
25,GI-27,GI-28 
GI-2,GI-4,GI-
9,GI-10,GI-13,GI-
14,GI-17,GI-
18,GI-19,GI-
21,GI-30,GI-31 
FIMBRIA ISLANDS GI-7,GI-8,GI-23,GI-31 GI-7,GI-8,GI-
17,GI-18,GI24 
GI-7,GI-11,GI-
29,GI-36 
LIPOPOLYSACCHARIDE OR CAPSULAR 
POLYSACCHARIDE BIOSYNTHESIS 
GI-30 GI-18,GI-22 GI-35,GI-47,GI-48 
EMRKY-TOIC MULTIDRUG 
RESISTANCE EFFLUX PUMP AND THE 
SENSOR KINASE,EVGA INVOLVED IN 
ACID RESISTANCE 
  GI-39 
METABOLIC ISLANDS CODE FOR 
TRANSPORT AND METABOLISM OF 
VARIOUS SUGARS 
GI-5,GI-22,GI-39,GI-
41 
GI-18,GI-31,GI-
32,GI-35 
GI-34,GI-44,GI-45 
IRON UPTAKE SYSTEM  GI-2,GI-3 GI-2,GI-18 GI-4 
BIOFILM  PGA SYNTHESIS 
DEACETYLASE PGAB  AND BIOFILM 
PGA OUTER MEMBRANE SECRETIN 
PGAA 
GI-19 GI-13  
TYPE III SECRETION SYSTEM GI-37 GI-30 GI-43 
TYPE IV SECRETION SYSTEM  GI-18  
Summary of the genomic Islands (GIs) in SAP44, SAP24 and APECO78 genomes were 
predicted using IslandViewer.   
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Table 19. Presence or absence of virulence genes in APEC isolates 
Genes Presence or absence of iron uptake 
determinant in the following APEC strain: 
SAP44 SAP24 APECO78 
Ferric citrate fecEDCBARI + + + 
 Yersiniabactin  (ybtSXQPA-irp2-irp1-ybtUTE). - + - 
Aerobactin sidrophore receptor  + + + 
Type1 fimbrial adhesin  + + - 
Putative avian haemolysin + - + 
Type 3 secretion system(T3SSs) proteins homologs to that of 
Yersinia proteins (YopD and YscJFUTQ) 
+ + - 
Type 3 secretion system(T3SSs) proteins homologs to that of 
Salmonella and Shigella  protiens (EprKJIH,EpaRQ and 
SpaSPO) 
- - + 
Type 4 secretion system (T4SSs) - + - 
N-acetyl neuraminic acid capsule + + + 
Biofilm pgaA and pgaB + + - 
Iron decitrate ABC transport and Iron uptake genes were detected in different APECO78 isolates (-) 
means the genes absent and (+) means the genes is present. 
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4.5 Discussion 
 
The overall aim of this chapter was to characterise the CTX-M plasmid found in three 
APEC strains, including one belonging to the O78 serogroup. In addition, a IncFIB 
plasmid present in one of the test strains was also characterised because APEC 
virulence genes are mostly located in large plasmids belonging to IncFIB replicon 
type. Moreover, analysis of the plasmid enables the study of the effect of two large 
plasmids within one host bacterium, a common occurrence in APEC strains. While 
plasmids may confer new phenotype(s) to the host cell, it was deemed important to 
study what effect a plasmid may have on the host genome structure. To do this, two 
avian E. coli isolates, one an ESBL-producer and one not, and belonging to the 
same O-antigen group, were compared.  
There were differences found in the number and size of plasmids harboured 
by the individual strains. SAP24 harboured at least three plasmids ranging in size 
from approximately 6 kb to 60 kb. However, PCR-based Inc typing did not identify 
the replicon types of these plasmids and as a result they were considered as ‘un-
typable’. In contrast, SAP44 harboured two large plasmids with a size greater than 
100 kb. In this study, the complete annotated sequence of the SAP44 plasmids 
(pSAP44 and pFIB44) was characterised.  The IncI1 plasmid with a size of 105,610 
bp (pSAP44) was demonstrated to carry resistance and virulence genes such as 
CTX-M-1 coding for the ESBL enzyme and Col1b coding for colicin 1b. Moreover, 
comparative analysis of pSAP44 with pC49-108 and R64 plasmids showed that 
differences in DNA content mainly with respect to the presence of mobile genetic 
elements and insertion sequences whereas regions involved in plasmid mobility, 
stability, and transfer were largely identical and conserved among IncI1 plasmids.  
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The pC49-108 plasmid showed high identity and coverage of DNA sequence 
to that of pSAP44 at 99%. However, a 5.0 kb region of the class 1 integron 
(aadA5,dftA17,IntI1) and the insertion sequence Tn1722 in pC49-18 were absent in 
pSAP44, being replaced by a 3.0 kb insertion sequence coding for tetracycline 
resistance genes.  It is believed that tetRA and adjacent genes are linked with a 
direct repeat sequence (cgcccgcagca) which might serve as a location for the 
deletion and/or insertion of new mobile elements (Chiu et al., 2005).  However, this 
feature was not detected in SAP44. Instead, the flanking region of pSAP44 and 
pC49-108 contained an inverted repeat sequence of 7 bp (tatttgc-ataaacg). The fact 
that the inverted repeat sequences flanked the same region in two separate 
plasmids belonging to the same Inc type, may suggest it plays a role in the deletion/ 
insertion of new mobile genetic elements and promote the evolution of IncI1 
plasmids.  
The CTX-M-1 genes has been found in other plasmids belonging to different 
Inc types with the ISEcp1 or other insertion elements such as IS26 in IncF,IncB/O 
and IncN (Wang, 2015). ISEcp1 has been extensively characterized and found to be 
important in the dissemination of blaESBL genes in Enterobacteriaceae, including E. 
coli strains (Poirel et al., 2008). Furthermore, it was found that ISEcp1 has dual 
function by which it can act as a transposase and also regulate the expression of the 
downstream open reading frame (ORF) (Jacoby, 2009). By comparing the nucleotide 
sequence of the ISEcp1 in the IS database (http://www-is.biotoul.fr/page-is.html), it 
was found to belong to the IS1380 family (100% identity). The IS1380 family is 
known for their ability to mobilize easily and efficiently among different bacterial 
species which may explain the high prevalence of CTX-M genes (Jacoby, 2009).  
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The traABCD genes are always found upstream of the replication region and 
are usually responsible for DNA transfer (Takahashi et al., 2011). However, traD was 
not detected in pSAP44 or pC49-108 plasmids. This was surprising as traD has 
previously been found upstream of the traABC genes and is considered part of this 
gene system (traABCD) (Sampei et al. 2010). Furthermore, one of the pil genes 
(pilJ) which is missing in pSAP44 and pC49-108. In general, the pil genes have a 
role in the formation of type IV pilus, which are important in the conjugation process 
(Sampei et al., 2010). It might be noted that the presence of traD and pilJ genes is 
not essential for the conjugation process at least in pSAP44, as this plasmid was 
able to transfer to other bacterial strains. 
The col1b gene was detected in pSAP44, showed similar homologous 
structure to that found in pC9-108 and R64. Colicins are antimicrobial peptides which 
are encoded on plasmids and regulated as part of SOS response as a result of 
cellular stress (Glazebrook et al., 1983).  The toxin is fatal for the producing cell and 
any cells in the surrounding environment that are sensitive to the colicin (Riley & 
Wertz, 2002).  The plasmid-encoded colicin gene cluster normally includes a gene 
coding for an antibacterial toxin, a gene encoding an immunity protein to protect the 
producing cells and a gene coding for a lysis protein to release the colicin from the 
producing cell (Riley & Wertz, 2002). The prevalence of colicin-producing E.coli 
strain has been well established. Colicin EI and Ia are described as the most 
commonly detected colicins in E. coli (Gordon & O’Brien, 2006). Colicin I1 is carried 
on a conjugative plasmid and is readily acquired by E. coli populations (Gordon & 
O’Brien, 2006). The same can be said to colicin B, M and V  which are mostly found 
in animal E. coli isolates, including APEC strains (Christenson & Gordon, 2009; Pinto 
Da Rocha et al.,  2002).   
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The IncFIB plasmid found in SAP44 carries several virulence genes including 
an iron uptake system (hemolysine) and a gene coding for increase serum survival.  
Replicons belonging to IncFIB and colicin-associated plasmids were found to be the 
most common Inc types among APEC isolates followed by IncI1 type (Johnson et al., 
2007).  It is believed that APEC virulence is mostly associated with virulent genes 
encoded on large conjugative plasmids such as the ColV plasmids (Johnson & 
Nolan, 2009). pFIB44 showed high identity to both ColV and ColBM plasmids. It is 
believed that ColBM plasmids evolved from ColV plasmids as their genetic content 
and organisation are highly similar (Johnson & Nolan, 2009). In general all these 
plasmids belong to IncFIB type and some of the most commonly found virulence 
genes include those coding for iron acquisition (sitABCD), serum resistance (iss), 
hemolysin protein (hlyF), putative outer membrane protease gene (ompT), and 
temperature sensitive haemagglutinin (tsh) (Johnson & Nolan, 2009).  
Although plasmid pSAP44 was readily transfered to other E. coli strains 
(section3.2.3), the pFIB44 plasmid was not detected in the recipient strains by PCR.  
Analysis of the tra region of pFIB44 revealed that several important tra genes are 
missing. Important tra genes were also missing from pAPEC-1 and this plasmid was 
only transfered to other recipient strains through the use of transfer machinery from 
other conjugative plasmids (Mellata et al., 2009). In SAP44, however it seems that 
pSAP44 could not compensate for the defective conjugation apparatus of pFIB44.   
 The genomes of two E. coli O78 strains SAP44, SAP24 and the APECO78 
reference strain showed a minor degree of genome plasticity. This plasticity was 
evident in the presence and composition of plasmids, bacteriophages and 
transposable elements (Table 16). Genomic island analysis detected that all APEC 
examined strains possess type 3 secretion systems (T3SSs) and iron uptake 
systems, but differences were found in which type of system was present. For 
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instance,SAP24 and SAP44 genomes code for T3SS with the proteins similar to that 
found in Yersinia sp such as YopD and YscJFUTQ proteins whereas APECO78 
strain codes for a T3SS with proteins similar of that found in Salmonella and Shigella 
spp, like EprKJIH,EpaRQ and SpaSPO proteins (Table 19). In addition to T3SSs, 
SAP24 was only strain found to have type 4 secretion system (T4SSs) by GIs 
analysis. T4SSs are considered a versatile attribute that has a variety of functions. 
Pathogenic Gram negative bacteria use it to translocate a wide variety of virulence 
factors into the host cell or utilize it for horizontal gene transfer (Alvarez-Martinez & 
Christie,  2009).   
Other factors required for pathogenicity is the ability to acquire iron from the 
surrounding environment when free iron is scarce. Generally, APEC has iron uptake 
systems that rely on the production of siderophores as iron chelators, to bind and 
form a complex of soluble Fe3+, which is transported back inside the bacterial cell 
(Gao et al., 2012). In this study, several types of iron uptake systems were identified 
in plasmid and chromosomal DNA. The SAP44 genome contains four iron 
acquisition systems, one located in the chromosome (fecEDCBARI encode for ferric 
citrate uptake) and three located on IncFIB plasmid (ironBCDN, sitABCD and iutA 
iucABCD) (Table 19 and Figure 28). In contrast to SAP44, the sitABCD and 
iucABCD systems were identified on the SAP24 chromosome, together with the 
yersiniabactin gene cluster.  It has been found that deletion of the chromosomal 
yersiniabactin gene cluster significantly influenced the growth of E. coli O78 in an 
iron-limited media compared to the deletion of any other plasmid-encoded iron 
uptake system (Sagi, 2015). The yersiniabactin gene cluster was absent from SAP44 
and the APECO78 reference genome. Perhaps, SAP44 could compensate for the 
absence of this gene with other unknown functional genes located on its ESBL 
plasmid (pSAP44).   
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Type 1 fimbriae were found in all APEC genomes in this study. APEC 
adherence to chicken epithelial cells and trachea are mediated by type 1 fimbriae 
which consists of major subunits such as fimA and minor subunits such as fimH  
(Mellata et al., 2003). Type 1 fimbriae are believed to play a role in the early stage of 
colonisation of the upper respiratory tract in poultry (La Ragione & Woodward, 2002). 
Another study showed that the wild type of APEC O78 strains were significantly 
better at adhering to human lung epithelial cells (A549) in an in vitro infection model 
comparing to the fimH mutant strains (Musa et al., 2009).  In a study carried out by 
Mellata et al. (2003), type 1 fimbriae type were found to protect the bacterial cell from 
being phagocytised.  
The genome of all APEC O78 strains were found to contain degradation 
enzymes for the aromatic compounds, phenylpropionate (PP) and cinnamic acid 
(CA), that were not detected in APEC O1 and APEC O2.  This could be specific 
feature of O78 strains in that they have the ability to use these compounds as a sole 
of carbon and energy source. In contrast, ribulose monophosphate (RuMP) was only 
identified in APEC O1 and APEC O2 genomes. The RuMP was originally found in 
methylotrophic bacteria which are able to utilize C1 compound as a sole of source of 
carbon and energy  (Fei et al., 2014). 
Genetic differences were largely associated with the acquisition of prophage- 
associated genes. This was confirmed by sequence alignment and RAST annotation 
tools server. Specific prophages were common between the three studied strains 
suggesting they may have been acquired prior to an evolutionary divergence. 
Incomplete lambda prophage with 23 kb in size contains bro gene was identified in 
SAP24 and the reference strain APECO78 (Table 17). This gene is associated with 
increased serum survival and has identical sequence of iss genes located on ColV 
plasmid (Lynne et al., 2007). Interestingly the Lambda prophage that carries this 
149 
 
gene was not detected in SAP44 chromosome, but instead SAP44 could 
compensate for the absence of this gene by encoding the iss gene on its IncFIB 
plasmid. Incomplete prophage-related genes with a size of 11.5 kb of the Stx2 
converting phage I were only detected in SAP44. However, having an incomplete 
prophage does not mean Shiga toxin is expressed and produced by SAP44. It is 
possible that the complete Stx2 prophage I sequence was partially lost from the 
SAP44 genome. Shiga toxin (Stx)-producing E. coli have been detected in many 
species and the toxins can be found in many serotypes including the O78 type 
(Nataro & Kaper, 1998).    
In conclusion, the presence of multiple large plasmids is a defining feature of 
the APEC (Johnson et al., 2007). However, the variability in the core genome of the 
three O78 strains studied here was limited mainly to phages and mobile element 
accessory genes. This would suggest that the APEC O78 serotype in general has a 
conserved repertoire of genes, but a flexibility to harbour multiple plasmids without a 
detrimental gene burden on the host bacterium. Analysis of IncII and IncFIB plasmids 
demonstrated that they encoded resistance and virulence genes that may have a 
role in the pathogenicity of APEC and indeed SAP44. The fact that the genomic 
islands found in the APEC genomes studied here are showed high similarity which 
suggests that these genomic islands have an influential role in the phenotype of 
APEC belong to O78 type. 
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Chapter 5: Contribution of ESBL carriage on host 
cell fitness 
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5 . Contribution of ESBL carriage on host cell fitness 
 
5.1 Introduction 
Plasmid carriage may positively, negatively or have no impact on the ‘fitness’ of a 
host bacterium. Fitness is usually defined as the ability of an organism to survive, 
proliferate and spread in a specific environment (Laurent et al., 2001). Thus fitness is 
relative and may vary depending on the environmental niche the organism occupies. 
For example, plasmids carrying antibiotic resistance genes may confer a clear 
benefit to the host bacterium when located in an infected individual undergoing 
antibiotic treatment, but appear neutral when the organism resides in the non-host 
environment or in the absence of that selection pressure. Finally, any fitness ‘cost’ 
may change over time due to changes in the plasmid or changes in the host 
bacterium (Dahlberg & Chao, 2003), and fitness-related compensatory mutations 
have been described in a number of organisms (Barrick et al.,2010; Björkman et al., 
2000; Levin et al., 2000).  
           Fitness costs related to plasmid carriage may be associated with the process 
of plasmid maintainance and/or the expression of specific genes on the plasmid 
(Dahlberg & Chao, 2003). Plasmid maintainance costs are believed to be as a result 
of the cellular activities required to maintain a plasmid in the host via the processes 
of replication and partitioning at every generation (Ebersbach & Gerdes, 2005). 
Conversely, the expression of resistance genes may interfere with bacterial growth 
or other cellular functions causing a decrease in host cell fitness (Turner et al., 
1998).        
The fitness of bacteria within a specific ecological niche and an increased 
selective advantage may occur by the acquisition of traits that are not found in other 
competitive strains. In terms of pathogenic bacteria, such as ExPEC and APEC, the 
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acquisition of resistance and virulence plasmids may increase fitness under several 
conditions (Hacker & Carniel, 2001).  
The overall aim of this chapter was to assess the contribution of the ESBL-
harbouring plasmids to the fitness of the host APEC isolates, as well as to examine 
their impact on the fitness of related avian and laboratory E. coli strains. 
Furthermore, given that APEC usually harbour several large plasmids, where 
possible using the bacterial derivatives described in chapter 3, the impact of the 
virulence plasmid (pFIB44) was also explored. These experiments tested the 
hypothesis that carriage of ESBL plasmids may decrease growth or survival of the 
host bacterium during stressful environmental conditions. As such, APEC isolates 
and their derivatives were studied under different environmental conditions including 
low iron, low pH and nutrient-poor conditions, as well as when in competition with 
other microorganisms.   
The objectives of this chapter were to: 
 Determine the impact of ESBL plasmid acquisition on host growth in rich and 
minimal media in single strain or competition growth experiments 
 Assess whether the ESBL plasmid confers a fitness cost to plasmid-
containing and plasmid-free isolates using a competitive growth assay. 
 Evaluate bacterial growth under low iron and low pH conditions in order to 
uncover additional beneficial traits associated with ESBL plasmid carriage in 
APEC 
 Assess the transmissibility of the ESBL plasmid to avian (O78) and laboratory 
E. coli K12 isolates by performing conjugation assays, under different pH 
conditions 
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 Determine the transmissibility of the ESBL plasmid in an ex vivo model of the 
chicken caecum in order to evaluate the extent of this process under more 
realistic in vivo conditions  
5.2 Impact of APEC plasmids on bacterial growth 
5.2.1  Single strain growth in nutrient-rich media 
To begin to examine whether carriage of ESBL plasmids confers a metabolic burden 
to the host bacterium, single strain growth curves were performed on the wildtype 
APEC strains and their cognate pESBL-cured derivatives. The generation time of the 
3 wildtype APEC (SAP44, SAP45 and SAP46) in nutrient-rich media was similar and 
ranged between 19 – 21 minutes. As can be seen in Table 20, loss of both plasmids 
(pSAP44 (ESBL) and pFIB44) from SAP44 did not significantly alter the generation 
time of the parental strain (see appendix I for growth curves). In addition, loss of 
ESBL-producing plasmids from the other two APEC strains SAP45 and SAP46 also 
did not affect the organisms’ growth. Finally, transfer of the pSAP44 ESBL plasmid to 
a naïve non-ESBL-producing APEC strain (SAP24) or to a laboratory E. coli K12 
strain (SAP59) did not significantly alter the generation time of the transconjugant 
compared to the plasmid-free host strain (Table 20). These results suggest that 
carriage of large plasmids including those coding for ESBLs, does not appear to 
impact the growth of the organisms under the conditions of the study. However, the 
fitness of an organism can vary under different environmental conditions (Keller & 
Surette, 2006) and hence further analysis of the strains was performed to investigate 
this in more detail. 
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Table 20 Generation time of wildtype APEC and cured derivatives. 
name serotype host / plasmid content generation 
time 
(mins) 
(mean ± 
SD) 
Significance 
level 
Strains derived from wild type APEC strains 
SAP44 O78 APEC / pSAP44 
(ESBL) + pFIB44 
19 ± 0.03 
NS 
SAP44 cured - APEC / none 20 ± 0.05 
SAP45 O7 APEC / pIncI1 (ESBL) 
+  pIncFIB + pIncFIA 
20 ± 0.07 
NS 
SAP45 cured - APEC / pIncFIB + 
pIncFIA 
20 ± 0.06 
SAP46 O15 APEC / pIncI1 (ESBL) 21 ± 0.03 
NS 
SAP46 cured - APEC / none 20 ± 0.06 
ESBL transconjugants 
SAP24 O78 APEC / multiple non-
typeable plasmids 
18 ± 0.04 
NS 
SAP140 - SAP24 / pSAP44 18 ± 0.06 
SAP59 K12 E. coli / none 22± 0.07 
NS 
SAP56 - SAP59 / pSAP44 25 ± 0.06 
 Bacteria were inoculated in LB media as single strain growth experiments performed 
at 37˚C with shaking for 8 h. Generation times were calculated based on the 
maximum rate of growth and data were compared using Student’s t test. Data are 
mean of 3 independent experiments ± standard deviation (SD).  
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5.2.2 Competitive growth experiments in defined minimal media 
Competitive growth experiments where equal numbers of organisms are mixed 
together and grown over successive days, offers a more sensitive way to detect 
differences in an organisms’ fitness (Lenski, 1998). Thus, pair-wise competitive 
growth experiments were set up to study the impact of plasmids on SAP44 (wildtype 
APEC) growth as well as that of E. coli transconjugants harbouring pSAP44. 
Changes in population size were measured by counting CFU following serial dilution 
and plating on selective media. As well as changes in population density, the data 
were expressed as Relative Fitness (RF) values which are calculated as the ratio of 
the increase of each population from time 0 to the end of the experiment at 7 days 
(Lenski, 1998). Given that sequencing revealed the ESBL plasmids of the 3 wildtype 
APEC to be identical, these studies focused on SAP44 as isogenic derivatives which 
contained one or both of the large plasmids naturally present in the organism, were 
available (see below).  Finally, pair-wise comparisons between plasmid-containing 
and naïve non-ESBL-producing APEC (SAP24) strains were carried out because 
SAP44 and SAP24 belonged to the same serogroup. 
As shown in Chapter 3 and 4, wild type SAP44 carries two large plasmids 
(named pSAP44 and pFIB44) of about 100 kb in size. Curing the ESBL plasmid 
(pSAP44) from the host strain resulted in the generation of two derivatives, 
SAP44(plasmidless) in which both plasmids had been lost and SAP44F, in which 
pSAP44 (ESBL) had been lost but pFIB44 was retained. The complemented 
derivative, SAP44C, was subsequently generated by re-introducing pSAP44 into 
SAP44-cured by conjugation. It was not possible to generate a derivative 
complemented with pFIB44 in the same way because of the lack of a selectable 
marker on this plasmid. Therefore, these 3 derivative strains of SAP44 were used to 
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investigate the impact of large APEC plasmids on the fitness on the host strain as 
well as on the fitness of a naïve non-ESBL-producing APEC (SAP24).  
 
Table 21  Relative fitness (RF) values of plasmid derivatives following pair-wise 
competitive growth experiments.  
Strain A host / plasmid 
content 
strain B host / plasmid 
content 
relative 
fitness 
(RF)1,2 
P value3 
SAP44 APEC / pSAP44 
+ pFIB44 
SAP44-
cured 
APEC / none 0.8 <0.05 
SAP44 APEC / pSAP44 
+ pFIB44 
SAP44F APEC / 
pFIB44 
1 NS 
SAP44-
cured 
APEC / none SAP44C SAP44-cured 
/ pSAP44 
1 NS 
SAP44F APEC / pFIB44 SAP44C SAP44-cured 
/ pSAP44 
0.75 <0.05 
SAP24 APEC / 
untypeable 
plasmids 
SAP140 SAP24 / 
pSAP44 + 
untypeable 
plasmids 
1 NS 
1Pair-wise competitive growth experiments were carried in DM media and values represent 
the mean of at least 3 independent experiments. 
2RF values were calculated 
3RF values were compared to a theoretical value of 1 using Z score test.  
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5.3 Competition of the wild type SAP44 (ESBL) against its cured derivative strains.  
First, wildtype SAP44 containing both plasmids (pSAP44 and pFIB44) was competed 
against the plasmidless derivative strain SAP44-cured. During the first 48 hours of 
co-culture, approximately equal numbers of the two strains were maintained in the 
population (Figure 35).  Thereafter, the number of wild type SAP44 cells significantly 
decreased by 2 logs and remained at this level for the rest of the experiment. The 
relative fitness (RF) value was 0.8 ± 0.004, which was significantly less than 1 
indicating that the plasmidless SAP44-cured strain outcompeted the wild-type (Table 
21).  
 
Figure 35.Competitive growth of wild type APEC strain SAP44 and the plasmid-cured 
derivative 
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In a competition growth assay in a minimal media (MD25) supplemented with glucose 
(25mg/ml) as a carbon source. The presence of the ESBL and FIB plasmids (pSAP44 and 
pFIB44) indicated cost fitness in the wild type strain SAP44 (WT) when co-cultured with its 
derivative plasmidless strain SAP44. The fitness impact was estimated as <1.0 by 
calculating the selection rate constant from at least three biological and two technical 
repeats. 
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Next, in order to find out which plasmid contributed to the change in fitness, wild type 
SAP44 was first competed against SAP44F, the pESBL-negative but pFIB44-
containing SAP44 derivative.  There was no fitness cost detected in this competitive 
assay as the RF value was approx. 1.0 (Figure 36). This suggests that pESBL had 
no detrimental effect on the organisms’ growth. Consistent with this finding, a 
competitive growth experiment between the plasmidless strain, SAP44-cured, and 
the complemented strain harbouring pSAP44 (SAP44C), gave rise to an RF value 
close to 1 (Figure 36). Finally, when SAP44F (which contains pFIB44) was competed 
against SAP44C (which contains pSAP44), SAP44C outcompeted SAP44F with a 
relative fitness cost <0.75 (Table 21). When taken together these results indicate that 
the fitness deficit associated with the native strain was attributable to carriage of 
pFIB44 rather than the ESBL-producing plasmid, pSAP44.  Unfortunately, the lack of 
a selectable marker on pFIB44 precluded direct testing of SAP44F against SAP44-
cured in the competitive growth assay.  
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Figure 36. Competitive growth assay of SAP44WT and its derivative strains. 
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In a competition growth assay in a minimal media (MD25) supplemented with glucose 
(25mg/ml) as a carbon source. A:The presence of the ESBL and FIB plasmids (pSAP44 and 
pFIB44) did not indicate cost fitness in the wild type strain SAP44 (WT) when co-cultured 
with its derivative strain SAP44F (containing only pFIB44). B: The plasmidless strain 
complemented with ESBL plasmid SAP44C (pSAP44) did not indicate cost fitness when co-
cultured with its ancestor plasmidless strain. The fitness impact was estimated as =1.0 by 
calculating the selection rate constant from at least three biological and two technical 
repeats. 
 .   
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5.4 Competition of the wild type SAP24 (non-ESBL) against its derivative SAP140 
(ESBL). 
To investigate whether the ESBL-producing plasmid (pSAP44) affects the fitness of 
a naïve non-ESBL-producing APEC strain, pSAP44 was introduced by conjugation 
into SAP24. The resultant cefotaxime resistant transconjugant was designated 
SAP140.  Co-cultures of SAP24 and SAP140 were subject to the competitive growth 
assay as described above. As can be seen in Figure 37, there was no significant 
fitness cost associated with carriage of pSAP44 as similar numbers of SAP24 and 
SAP140 colonies were recovered in both nutrient-rich and defined minimal media. 
Consistent with this, the mean RF value in the two different media was approx. 1.0. 
(Table 21).In summary, these studies indicate that carriage of SAP44, a large ESBL 
plasmid, had no significant impact on the growth of APEC under the conditions used 
in these experiments.    
Figure 37.Competitive growth assay of non-ESBL SAP24 and its derivative strain.  
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In a competition growth assay in LB broth media, the presence of the ESBL plasmid 
(pSAP44) in SAP140 did not indicate a fitness cost when co-cultured with its ancestoral non 
ESBL strain SAP24 (A). The same also can be said in a competition growth assay in minimal 
media (MD25) supplemented with glucose (25 mg/ml) as a carbon source (B).The fitness 
impact was estimated as =1 by calculating the selection rate constant from at least three 
biological and two technical repeats. 
 .  
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5.5 ESBL plasmids enhance the growth of APEC O78 type in iron-limited media 
In chapter 4, one difference noticed between pFIB44 and pSAP44 was that the 
former contained genes which coded for an ABC iron uptake locus eitABCD (Figure 
28). Since available iron is often limiting in the environment as well as in the intestine 
of humans and animals (Fischbach et al., 2006), it was postulated that the different 
plasmids may affect the ability of organisms to scavenge iron and grow in iron-limited 
environments. Therefore, the impact of each plasmid on APEC fitness was examined 
in single strain growth experiments performed under iron-limited (minimal media + 
1.5 uMFeSo4 + 100 uM 2,2-dipyridyl) or iron-replete conditions (minimal media + 1.5 
uM FeSO4). As previously, SAP24 and the ESBL-producing transconjugant SAP140, 
were included in order to examine the impact of pSAP44 in a related but different 
strain background. 
Compared to growth in iron-replete M9 media (see Figure 38 ), SAP44 grew 
slowly and reached a final cell density (107 cfu/mL) that was approx. 100-fold lower 
(Figure 38). The plasmidless derivative SAP44-cured followed a similar growth 
kinetic during the early stages of growth, but after 38 hrs incubation, cell numbers 
steadily increased to reach ~108 cfu/mL. The presence of either pFIB44 or pSAP44 
increased the growth of strains in the iron-limited environment although each 
derivative exhibited different growth kinetics (Figure 39). While SAP44F, which 
contains pFIB44, increased the rate of growth throughout the incubation period, 
SAP44C, which contains pSAP44, only resulted in increased growth from approx. 20 
hrs. Thus while the presence of both plasmids reduced the growth of SAP44, the 
presence of either plasmid conferred a growth advantage.  
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In order to verify the effect of pSAP44 on organism growth under iron-limiting 
conditions, single strain growth experiments were also carried out using SAP24 and 
the ESBL-producing transconjugant, SAP140. As found previously, the presence of 
pSAP44 significantly (p<0.05) increased the growth of the host bacterium after ~20 
hrs in iron-limited media (Figure 39).  Similar experiment could not be performed with 
pFIB44 due to the lack of appropriate derivative strains. When taken together, these 
results suggest that pSAP44 confers a fitness advantage to APEC O78 strains in 
environments where available iron is scarce. Further analysis is required to identify 
the genes encode for iron uptake in pSAP44. To our knowledge, this is the first 
report would shows that an IncI1 plasmid carrying ESBL/CTX-M-1 genes able to 
enhance the growth of E. coli strains particularly APEC strains belonging to O78 
group.  
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Figure 38. Single strain growth curve of wildtype APEC (SAP44) or its derivatives in 
iron-limited growth media. 
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Comparison of growth curve of SAP44WT (containing pFIB44 and pSAP44 plasmids) and its 
derivatives, SAP44F (containing pFIB44plasmid), SAP44C (containing ESBLpSAP44 
plasmid) and SAP44-(plasmidless cured stain) in iron-restricted media containing 2,2-
dipyridyl (- iron)100 µM and  supplemented with FeSO4(1.5 µM).  Varaiability in growth was 
observed in different time point from at least three biological and two technical repeats. 
.  
 
Figure 39.Single strain growth curves of non-ESBL APEC (SAP24) or the ESBL-
producing transconjugant (SAP140) in iron-limited growth media.  
t im e  in  h o u r
L
o
g
 o
f 
C
F
U
/m
l
0 2 0 4 0 6 0
5
6
7
8
9
1 0
1 1
S A P 2 4
S A P 1 4 0
 
p  <  0 .0 5
 
Comparison of growth curve of SAP24 and its derivative SAP140 (containing ESBL pSAP44 
plasmid) in iron-restricted media containing 2,2-dipyridyl (- iron)100 µM and  supplemented 
with FeSO4(1.5 µM). The growth kinetics of each strains using at least three biological and 
two technical repeats indicated that SAP24 carries the ESBL plasmid (pSAP44) grew 
significantly after 24 h of incubation while the non ESBL wildtype strains remined in 
stationary phase from the same time point (24 h).  
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Figure 40. Single strain growth curve of wild type APEC (SAP44) or its derivatives in 
media supplemented with iron (1.5µM). 
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Comparison of growth curve of SAP44WT (containing pFIB44 and pSAP44 plasmids) and its 
derivatives, SAP44F (containing pFIB44plasmid), SAP44C (containing ESBLpSAP44 
plasmid) and SAP44-(plasmidless cured stain) in M9 minimal media supplemented with 
FeSO4 (1.5 µM).  Variability in growth was observed in different time point from at least 
three biological and two technical repeats. 
 
Figure 41. Single strain growth curves of non-ESBL APEC (SAP24) or the ESBL-
producing transconjugant (SAP140) in media supplemented with iron (1.5µM). 
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Comparison of growth curve of SAP24 and its derivative SAP140 (containing ESBL pSAP44 
plasmid) in M9 minimal media supplemented with FeSO4 (1.5 µM). The growth kinetics of each 
strains using at least three biological and two technical repeats indicated that SAP24 carries the ESBL 
plasmid (pSAP44) grew significantly and reached the stastionary phase after 6 h of incubation while 
the non ESBL wildtype strains had long lag phase for a period of 12 h. 
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5.6 ESBL plasmid has a burden cost fitness on APEC strains to acid shock tolerance  
Acid resistance is an important attribute of organisms that contributes to their fitness 
in the intestinal tract (Kanjee & Houry, 2013).  In this series of single strain growth 
experiments, the impact of the plasmids on the ability of APEC to survive in low pH 
was tested. SAP44, SAP24 and their derivatives were used and their survival in LB 
media adjusted to pH 2.5 determined at various times post-incubation. Data are 
expressed as the percentage reduction from the number of viable bacteria at the 
start of the incubation. None of the strains grew (increased in numbers) during the 
experiment, but the decrease in the number of cells was time and strain-dependent. 
Twenty-four hours after incubation, no significant differences between the survival of 
plasmid-containing and plasmidless SAP44 were detected. However, by 36 hours 
incubation, there was a significantly greater reduction in the number of viable cells 
recovered for the strain SAP44-cured than for the wildtype strain SAP44 (Figure 42).  
The presence of the ESBL plasmid (in SAP44C) did not abrogate this effect, 
however, when pFIB44 was present in the cell (in SAP44F) survival was significantly 
higher (2 fold). This finding may suggest that the APEC strains carrying pFIB44 
plasmids have a better tolerance to acid condition whereas carrying ESBL plasmid 
pSAP44 showed a cost fitness when exposed for a long time to acidic conditions.    
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Figure 42.Acid tolerance assay in APEC O78 carrying ESBL plasmids. 
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Percentage acid survival of APEC strains belong to O78 type .SAP44 wild type strain 
(containing pSAP44 and pFIB44) and its derivative strains, SAP44F (pFIB44), SAP44C 
(pSAP44) and SAP44-(plasmidless). Non ESBL wild type strain SAP24 and its derivative 
strain SAP140 (pSAP44). APEC O78 strain survive better with pFIB44 plasmid. The effect of 
ESBL plasmids was only significant in the wild type strains harbouring both plasmids. P < 
0.05. But strains did not harbour the pFIB44 plasmid the reduction was significantly high. P 
<0.05. Data are displayed as a mean of three separate expermints all performed with three 
technical repeats.  
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5.7 Transfer of ESBL plasmid in APEC  
In addition to different environmental conditions affecting the survival of APEC, it is 
likely that the rate of plasmid transfer between cells is also altered, which may have 
significant consequences for the spread of the resistance plasmids. The results 
obtained in chapter 3 demonstrate that the ESBL plasmid transmits readily to other 
E.coli strains during filter mating (section 3.2.3). In order to more accurately quantify 
this process, plasmid transfer between different APEC O78 strains was determined. 
In these experiments, wild type SAP44 (containing both pSAP44 and pFIB44 
plasmids), SAP44C (cured strain complemented with pSAP44) and the pSAP44-
harbouring naïve APEC strain (known as SAP140) were used as donors whereas 
two streptomycin resistant O78 APEC  strains (SAP44cured and SAP24) were used 
as recipients. Streptomycin-resistant derivatives were needed in order to facilitate 
selection of putative transconjugants. Conjugation experiments were performed on 
filters placed on LB agar plates. Each experiment was repeated at least three 
different occasions. 
As can be seen in Figure 43, the rate of pSAP44 transfer to SAP44 SmR was 
significantly greater (P<0.05) for SAP44C than for either the wild type APEC strain 
SAP44 or the recent transconjuant, SAP140. A similar pattern of response was seen 
when the naïve non-ESBL-harbouring strain SAP24 was used as a recipient (see 
part B of figure). One possible explanation for this pattern is that pSAP44 was 
present in a higher copy number in the cured strain compared to the wild type or 
recent transconjugant strain. Other explanations could be the plasmid was quickly 
adapted by the cured strain facilitating more plasmid transfer to recipients. 
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Figure 43. Conjugation frequency of ESBL plasmid among APEC O78 strains. 
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The graph bars show the rate of ESBL plasmid transfer in APEC O78 strains. The rate of 
pSAP44 transfer to SAP44 SmR (A) and SAP24SmR (B) was significantly higher for SAP44C 
(SAP44 cured strain complemented with pSAP44) than for wild type SAP44 or recent 
transconjugant SAP140. P < 0.05. The ESBL conjugation frequencies were measured from 
donor strains during 4 h period from at least three separate experiments. 
 
In the previous section, the rate of plasmid transfer was determined under optimal 
conditions, however these conditions poorly resemble the natural environment of the 
chicken intestine. The pH of the chicken intestinal tract contents increases towards 
the caecal site from pH 4.5 in the crop, to pH 5.7–6.0 in the duodenum/jejunum, to 
pH 6.3–6.4 in the ileum/rectum and finally up to pH 7.0 or higher in the caecum 
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(Siragusa, 2008). Thus, a series of experiments were set up to investigate if acidic 
conditions influenced the rate of ESBL plasmid transmission. 
ESBL plasmid transmission was studied using acid pre-stressed SAP44 (WT) 
as a donor and acid pre-stressed SAP24 as a recipient strain in order to more 
closely replicate the conditions experienced by the organisms in the chicken 
intestine.  Figure 44 showed that at low pH the transfer frequency for pSAP44 
plasmid was significantly lower than that found in more alkaline environments. The 
frequency of plasmid transfer from one APEC to another increased with pH, from 
1.0x10-4 to 5.0x10-4, but was below the detection limits of the assay at pH 4.0. The 
plasmid transfer in this condition was 5 times less than that found previously in non-
stress strains in non-stress condition. Thus, conditions in the chicken caecum pH 
5.7-6.0 are conducive to ESBL transfer and are correlated with the findings found in 
the acid shock tolerance assay.   
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Figure 44. Conjugation frequency of ESBL plasmid transfer between stressed donor 
(SAP44WT) and stressed recipient (SAP24).  
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Rate of transfer of pSAP44 ESBL plasmid from pre-stressed donor ESBL SAP44 (WT) to 
pre-stressed recipient non ESBL SAP24 (WT) related strain in low pH condition range from 
4.3 to 7.0 mimic the pH of chicken intestinal tract contents. P < 0.05. The ESBL conjugation 
frequencies were measured from donor strains during 4 h period on at least three separate 
experiments. 
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5.8  ESBL plasmid transmission in an in vitro chicken caecum model.  
In addition to low pH, the gut microbiota may exert a significant influence on the 
transfer of conjugative plasmids.  In order to investigate this further and to better 
mimic the conditions of the chicken intestine, a model of the chicken ceacal 
environment was developed.  The model was set up as a continuous flow bioreactor 
model, where chicken faecal material was used as a starting inoculum. By adjusting 
the medium in-flow and the waste outflow in the bioreactor and keeping growth 
conditions such as temperature and pH, constant the growth rate of bacteria was 
tightly controlled (see methods and materials section 2.8.3 for more information). 
The inoculum of chicken faecal contents (2mL) injected directly into the bioreactor 
via a syringe at the start of the experiment. Then 24 hours later, a 1:1 mixture of 
donor (SAP44) or (SAP140) and recipient cells (SAP24 SmR) or (SAP44 SmR) were 
added to the media. The inoculum was tested for the presence of bacteria with ESBL 
resistance phenotype before adding the tested strains. Samples from the bioreactor 
were taken as follow: one sample was removed at 0 hour immediately after adding 
the starting inoculum; a second sample was collected at 8 hours (first cycle) and a 
third sample at 24 hours.  After injecting the tested strains, the samples were taken 
in the same manner for the first cycle, but then continue every 24 hours for 10 days 
to monitor the plasmid mobility and the trans-conjugant strains for a long period of 
continuous growth. The total number and ratio of recipient, donor and trans-
conjugant cells was determined by plating an appropriate dilution on antibiotic 
selective agar.  
In general all tested recipient strains SAP44 and SAP24 acquired the pSAP44 
ESBL plasmid in the model from the first cycle which indicates that the plasmid is 
able to transfer easily even in the complex microbiome of the chicken caeca. The pH 
condition in this experiment was fixed at pH 5.8 to mimic the average condition of 
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chicken intestine. In previous section the pSAP44 transfer increase by pH with 4.0 x 
10-4 transfer rate which is 4 times more than its transfer in low pH.  However, there 
was a decline in the growth of the trans-conjugant cells in parallel with the decline in 
the recipient cells over a long period of continuous growth (Figure 45). This reduction 
was not observed in the donor strains throughout the experiment.   
Figure 45. Conjugation frequency of ESBL pSAP44 plasmid in APEC O78 strains. 
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Transfer of pSAP44 plasmid in APEC O78 strains in a chicken gut model. Donor and 
recipient cells were mixed in a ratio 1:1 and immediately injected into the media which was 
inoculated previously with a microbial population obtained from a chicken ceacal contents. 
(A) SAP44 (WT) was used as a donor and SAP24SmR as a recipient. (B) SAP140 (SAP24 
derivative strain transconjugate with pSAP44) was used as a donor and SAP44SmR cured 
strain as a recipient. The ESBL conjugation frequencies were calculated from three separate 
experiments. 
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5.9 Discussion 
Plasmids frequently impose a fitness burden on their host cells (Dahlberg & Chao, 
2003) and the relative fitness of bacteria containing plasmids has usually been 
assessed by comparing its growth rate and generation time with its derivative 
plasmid-free strains in pure culture as an indicator of bacterial fitness if difference in 
growth kinetics were detected (Lenski, 1998).This simplistic assay fails to 
recapitulate the complexities of the physical, chemical and biological interactions 
encountered by organisms in the real world. However, it offers a starting point from 
which to ask questions relating to the impact of plasmids on the host bacterium.  
           In this study, the fitness burden of ESBL plasmids on avian and laboratory E. 
coli was assessed by comparing their growth kinetics. In rich media, carriage of the 
ESBL plasmid had no significant effect on the generation times of the strains. These 
results are in agreement with  Fischer et al. (2014) who found no difference in 
estimated growth parameters between donors, recipients and transconjugants 
containing a plasmid belonging to the IncI1 carrying blaCTX-M-1 plasmid. In addition, 
as APEC strains harbour more than one plasmid, it is perhaps not surprising that 
ESBL plasmids did not confer any fitness impact on APEC when strains were grown 
in rich media. However it was interesting to note that the plasmid also had no effect 
on a naïve host organism, like E. coli K12. This data contradicts the statement “that 
the plasmid will initially have a growth burden to a naïve host” (Lenski, 1998). It is 
possible that ESBL plasmids conferred a low growth burden to the host that is not 
detectable by the growth curve experiments performed in this thesis. 
Because no differences in growth were found in rich media, competitive 
growth assays in minimal media were used to further test the comparative fitness of 
the APEC O78 isolates. Growth competitions between isogenic bacteria provides a 
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more sensitive measurement for determining the relative fitness since the two strains 
compete for resources in the same media (Lenski, 1998).In these experiments 
SAP44 showed a fitness cost when competed against the plasmidless derivative 
SAP44-cured. This cost could be associated with carriage of either one or both of the 
large plasmids carried by this isolate. Pair-wise comparison growth experiments 
showed differences in growth when the plasmid-free strain was competed against 
the ESBL-producing derivative nor when SAP44 was competed against the pFIB44-
containing derivative. Interestingly, a fitness cost occurred when the single plasmid 
derivatives of SAP44 were competed against each other. When taken together, the 
data would suggest that the cost is not associated with carriage of the ESBL plasmid 
but rather is associated with carriage of the pFIB44 plasmid.  
Thus the ESBL plasmid had no effect on the ‘fitness’ of APEC O78 isolates 
under these conditions.Starikova et al. (2013) indicated that any cost associated with 
newly-acquired plasmids encoding antibiotic resistance can be rapidly compensated 
for, even in the absence of the selective antibiotic pressure. Alternatively, SAP44 
may already be ‘primed’ to carry multiple plasmids as this natural isolate harbours 
two such plasmids. Technical reasons precluded direct comparison of pFIB44 in the 
recipient strains, however if possible, this would have added further support to its 
impact on host cell fitness.  
    Many studies equate ‘fitness’ with the growth of the organism in replete, 
defined growth media, however, an impact on other cellular functions such as 
metabolic function or virulence, following incubation under less-than-optimal growth 
conditions, has received much less attention(Vogwill & MacLean, 2015). In the 
environment the level of free iron has been estimated to be very low (10-18M) 
whereas bacteria need iron concentrations of approximately 10-7 to 10-5 M to survive 
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(Mellata et al., 2009). In chapter 4, iron acquisition systems were identified in the 
genome of the APEC O78 isolates, SAP44 and SAP24. In addition, the pFIB44 
plasmid of SAP44 contains three iron acquisition systems namely, iroBCDN, 
sitABCD and iutA iucABCD. These systems have been previously described to play 
a role in the growth and virulence of APEC O78 (Dozois et al., 2003). The ESBL 
plasmids do not appear to contain known iron acquisition genes and to our 
knowledge, there are no reports of iron acquisition genes being found on ESBL-
producing IncI1 plasmids.  However, the significant proportion of genes of unknown 
function does not preclude this possibility. Therefore, in this study, the role of ESBL 
plasmid in iron acquisition by APEC O78 isolates was assessed in iron-limited 
media. Surprisingly, carriage of pSAP44 enhanced the growth of the strain in both 
iron-replete and iron-limited minimal media. However, when both SAP44 plasmids 
were present in the same cell, this growth phenotype was supressed. This could be 
as a result of conflict between the two plasmids, each expressing genes which put a 
burden on host growth or because gene expression in one plasmid interferes with 
those expressed by the other plasmid. Further experiments are required to dissect 
this phenomenon. 
Survival in low pH is an essential pre-requiste of bacteria residing in the 
intestine. The ability of APEC to persist in poultry facilities is associated with its 
capacity to survive in an acidic environment found in the avian intestine (La Ragione 
& Woodward, 2002). Carriage of the pFIB44 plasmid and not the ESBL plasmid 
(pSAP44) significantly enhanced survival of APEC O78 isolates under low pH 
conditions. Variable results have been reported in the literature. For example, Ji et 
al. (2007) found that plasmid-cured strains survived better in acidic conditions than 
isogenic wild type strains. In contrast, however, Mellata and colleagues found that a 
single plasmid (pChi7122-3 belongs to IncI2, 57 kb) increased the survival of the 
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isogenic plasmid-free APEC isolate, although this study did not identify any genes 
which may be responsible for this phenotype (Mellata et al.,2009). A number of 
studies have linked the iron regulatory gene (fur) with acid tolerance in 
Enterobacteriaceae (Bearson et al., 1998 ; Zhu et al., 2002). Fur is a regulatory 
protein that able to sense either iron or pH independently (Foster & Hall. 1992). 
Bearson et al. (1998) found that Fur mutants of Salmonella challenged by low pH 
media were acid sensitive compared to the wild type. In addition, Zhu et al. (2002) 
stated that fur is involved in acid tolerance in APEC but not essential in the APEC 
virulence. In this study, pFIB44 plasmid harboured by SAP44 was found to have 
three iron acquisition system (iroBCDN, sitABCD and iutA iucABCD). The aerobactin 
operons, iucABCD and iutA are regulated by fur proteins (Litwin & Calderwood,1993) 
and could explain the contribution of the FIB plasmid to acid tolerance in SAP44.  
            The spread of resistant bacteria is also linked to the transfer of resistant 
determinants within and between bacterial species.  ESBL plasmids were readily 
transferred to other strains of E. coli, including another avian isolate and a laboratory 
K12 strain. Somewhat unexpectedly, recently transformed recipients were then 
better able to transfer the plasmid to new recipients than the original host strain. This 
may help explain the rapid spread of ESBL-producing plasmids.  Furthermore, 
plasmid transfer occurred in acidic conditions and in an in vitro chicken caecal 
model, indicating that the chicken intestine may represent a ‘hotpsot’ for conjugation. 
     In conclusion, this chapter described how ESBL plasmids can affect the growth of 
the host bacterium under a range of environmental conditions, and began to explore 
the transmissibility of these resistance determinants under more realistic 
environmental conditions. However, the impact of the plasmid on non-growth-related 
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properties of the bacterium has not been considered and this will be addressed in 
chapter 6.  
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Chapter 6: Impact of ESBL plasmids on the 
metabolic fingerprint of APEC 
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6 .  Impact of ESBL plasmids on the metabolic fingerprint of APEC 
 
6.1 Introduction 
Differences in the ability of the bacterium to utilise various carbon, nitrogen, 
phosphorus and/or sulphur substrates could confer a fitness benefit to the organism 
over and above that related to the acquisition of antibiotic resistance.  This may 
enable resistant bacteria to outcompete sensitive variants in different ecological 
niches or environments, where nutrient supplies are variable and/or limiting. Thus, 
the metabolic ‘fingerprint’ of ESBL-producing and non-ESBL-producing strains were 
compared using a commercially-available phenotypic microarray.  
Biolog™ phenotyptic microarrays, a high throughput screening assay were 
used to examine the metabolic profiles of wild type APEC. Biolog™ microarrays 
enable the investigation of a large number of cellular phenotypes in a single 
experiment using four different microarray plates (PM1 to PM4) and provides a 
metabolic ‘fingerprint’ for each organism. The plates PM1 and PM2 contain 190 
different carbon sources while PM3 contains 95 different nitrogen sources and PM4 
contains 59 and 35 different phosphorus and sulfur sources, respectively. In total, 
these plates facilitate the analysis of 379 different metabolic activities (Bochner et al., 
2001). Biolog™ microarrays has been used previously to study the metabolic 
changes associated with resistance genes in Salmonella Typhimurium LTL where a 
sensitive strain indicated better utilisation of 10 and 5 carbon and phosphorus 
sources respectively than the resistant strain (Zheng et al., 2011).  
The aim of this chapter was to: 
 Study the impact of ESBL plasmid acquisition to the host metabolism using 
Biolog phenotypic microarray. 
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 Test and compare any significant data generated by Biolog using limited 
media growth and viable counts. 
 
In order to explore the influence of the plasmids on APEC metabolism, plasmid-
cured and plasmid-complemented derivatives generated in chapter 3 were examined 
using Biolog™ phenotypic microarrays. All Biolog™ microarray tests were performed 
in triplicate over 48 hours. However, all data using the PM3 plates were 
subsequently excluded from the study because respiratory activity was found in the 
negative control wells. Data from E. coli K12 strains was also excluded from further 
analysis because of the weak (low) respiratory activity found  on most plates. Data 
were recorded using the Omnilog PM Software and transferred into Microsoft Excel 
for statistical analysis by one-way analysis of variance (ANOVA) and Tukey Honestly 
Significant Difference (HSD) test. Data were expressed in ‘heat’ maps, a colour 
density representation of the amount of substrate utilised by each strain after 48 h. In 
the heat maps, the colours correspond to substrate utilisation ranging from none 
(blue colour) to low (green/yellows) to high (bright orange colour).  A difference 
between the strains was considered significant when the p value ≤ 0.05. 
6.2 Carbon utilisation profile of wild type APEC O78 (SAP44)    
As evident by the blocks of orange colour in Figure 47, SAP44 was able to respire 
approx. 50% (94/190) of the carbon substrates present on the PM1 and PM2 plates 
(Graphs in appendix II). Curing SAP44 of both plasmids (pSAP44 and pFIB44) 
resulted in marked differences in respiration for approximately 6% (6/94) of the 
utilised carbon sources, as evident by the differences in colour coding between 
SAP44W and SAP44 (plasmidless) (Figure 46).. Despite these differences, cluster 
analysis performed by the heat map aligned wildtype APEC SAP44 and the 
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plasmidless derivative into a single closely related cluster (see Figure 46) (left hand 
edge of heat map).   
In general, the single plasmid-containing derivatives, SAP44C and SAP44F, 
showed lower levels of respiration than either the wild type (SAP44W) or the 
plasmid-free derivative (colours tend to be yellow and light orange rather than bright 
orange) (Figure 46). Moreover, cluster analysis placed the two single plasmid-
containing derivatives in a single group, distinct from SAP44 or the plasmid-free 
derivative. Closer examination of the data revealed that 78% (74/94) and 66% 
(62/94) of the carbon sources were more poorly utilised by the SAP44 derivatives 
carrying a single plasmid. However, the two single plasmid-containing derivatives 
were significantly better able to utilise some carbon sources than their respective 
parental strains. For example, SAP44F, which contains pFIB44, was significantly 
(P<0.05) better able to respire pectin, D-fucose and L-alaninamide whereas 
SAP44C, which contains pSAP44, showed significantly (P<0.05) higher rates of 
respiration on formic acid, α-keto glutaric acid and mono-methyl succinate (Table 
22). Notably, both SAP44F and the plasmid-free cured derivative were no longer 
able to utilize formic acid as a carbon source. Given that SAP44C which contains 
pSAP44, utilised formic acid as well as the wild type APEC strain, this indicates that 
factors required for the regulation or utilisation of formic acid may be carried on the 
ESBL plasmid. Taken together, the findings suggest that APEC plasmids harbour 
factors that enhance the utilisation of some substrates by the bacterium. An 
alternative explanation is that conflict(s) in gene expression that occurs when both 
plasmids are present in the same bacterium, are resolved in the single plasmid-
bearing derivatives allowing enhanced utilisation of certain substrates. An example 
of this is seen for D-malic acid. Loss of both plasmids significantly (P<0.05) 
increased the utilisation of D-Malic acid compared to derivatives carrying only a 
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single plasmid. It is possible that factors present on both plasmids normally interfere 
with the utilisation or regulation of malic acid metabolism in E. coli.   
 
Cluster heat map showing respiratory activity of SAP44W and its various derivatives.  
Bacterial strains were incubated for 48 h in the presence of 190 different carbon sources on 
Biolog™ PM1 and PM2 plates. The cumulative levels of respiration are colour-coded, with 
blue indicating no utilisation, low levels indicated by green/yellows and dark orange 
indicating high levels of utilisation. Carbon sources are identified by their position on the 96-
well plate (letter and number format) as listed in appendix III. Curing wildtype APEC of both 
plasmids resulted in some changes to carbon utilisation patterns. Single-plasmid containing 
derivatives (SAP44C and SAP44F) showed less intense colours than the parental strains.  
 
Figure 46. Cluster heat map showing the single values of SAP44WT and its derivative strains obtained 
from 190 different carbon sources.  
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Table 22 . Differences in carbon utilisation between wild type APEC and their derivatives. 
Strains No. of carbon 
sources where the 
strain respire less 
than the parent 
No. of carbon 
sources where 
the strain 
respires more 
than parent 
Name of components where the strain 
respire bettera or lessb than the parent 
SAP44 
(plasmidless) 
6% (6/94) 1% (1/94) D-Malic acida 
SAP44C(pSAP44) 79% (74/94) 3% (3/94) (Formic acid,α-glutaric acid, 
monomethyl succinate)a 
SAP44F(pFIB44) 66%(62/94) 3% (3/94)  (pectin,, D-fucose and L-Alaninamide )a 
SAP24 0 0 - 
SAP140(pSAP44) 0 0 - 
SAP45(cured) 7%(7/98) 1% (1/98) m-Tartaric Acida , (D-Glucuronic Acid, α-
Keto-Glutaric Acid, m-Tartaric Acid, D-
Threonine, Fumaric Acid, L-Threonine)b 
The table shows the number of significant differences which were found in carbon utilisation 
between parent and its derivative strains with and without ESBL plasmids.Footnote: a, name 
of components where the strain respired better than the parent strains. b, name of 
components where the strains respire less than the parent strains. 
 
6.3 Confirmation of Biolog data using growth assays 
As evident in Table 22(above), Biolog™ assays revealed many differences in carbon 
utilisation between SAP44 and the various plasmid-containing derivatives. While it is 
beyond the scope of this thesis to investigate all the differences revealed when 
comparing the strains, one carbon substrate (α-keto glutaric acid) was selected for 
further study. α-keto glutaric is known to contribute to the a variety of metabolic 
process including tricarboxylic acid cycle (TCA) (Seol & Shatkin, 1991). In these 
experiments, M9 minimal media broth supplemented with 10 µM α-keto glutaric acid 
was used to provide independent confirmation of the Biolog data and verify a role for 
this substrate in the growth (versus respiration) of the bacteria. 
Wild type SAP44 grew slowly in M9 media, exhibiting a long lag phase but 
finally reached a cell density of >109 cfu/mL after approximately 72 h (Figure 47).  
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Loss of both plasmids did not alter the length of the lag phase but slowed the growth 
of the organism and significantly (P≤0.01) reduced the final cell density by 
approximately 1 log. Re-introduction of pESBL to the cured strain to yield SAP44C 
restored the organism’s growth, in agreement with the results found in the 
microarrays. This provides independent validation for a role for the ESBL plasmid in 
α-ketoglutaric acid metabolism in APEC.  
 
Figure 47. Growth of SAP44WT and its derivative strains in minimal media 
supplemented with α-keto glutaric acid as a sole carbon source.   
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Growth of wild type APEC SAP44 and its derivatives in minimal media supplemented with α-
keto glutaric acid as a sole carbon source. Bacteria were grown in M9 minimal media 
supplemented with 10µM α-keto glutaric acid for 7 days at 37°C with shaking. The graph 
shows the ability of plasmid-free SAP44 derivative to respire as well as the wildtype 
organism after complementing with the ESBL plasmid, pSAP44 (P≤0.01). Data are displayed 
as a mean of three separate experiments. 
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6.4  Influence of ESBL plasmids on other APEC isolates  
6.4.1 Impact on O78 APEC 
As described in chapter 3 and 4, SAP44 and SAP24 are APEC, which belong to the 
O78 serogroup and share 99% nucleotide identity, whereas SAP45 and SAP46 are 
APEC, which belong to differing serogroups (O7 and O15, respectively) but harbour 
identical ESBL plasmids, to SAP44. Therefore, it would be interesting to compare the 
effects of the ESBL plasmid on the metabolism of the other APEC strains described 
in this study. Prior to these experiments, the carbon utilisation fingerprint of the 
plasmid-free host bacterium (SAP24) was examined and compared to that of the 
plasmid-free SAP44 derivative. The analysis revealed that SAP24 utilised 8 
additional substrates compared to the plasmid-free SAP44 strain (Figure 48). 
Interestingly, SAP24 respired α-ketoglutaric acid even in the absence of the pESBL 
plasmid (P<0.005). Furthermore, acquisition of pESBL did not abrogate this activity 
suggesting that all the factors required for α-ketoglutaric acid respiration are located 
on the chromosome rather than the possibility that plasmid-borne factors are 
repressing this activity. However, chapter 3 revealed that SAP24 contained multiple 
plasmids that were not type-able by PCR-based typing. It is possible that the 
presence of these untypeable plasmids may enhance the strain’s ability to respire α-
keto glutaric acid. While pESBL was linked to changes in the utilisation of 3% (3 out 
of 94) of carbon substrates for SAP44, there were no significant differences in 
substrate utilisation in the presence or absence of pESBL for SAP24.  
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6.4.2  Impact on non-O78 APEC  
To examine if the ESBL plasmid affected the carbon metabolism of APEC belonging 
to different serogroups, wildtype and plasmid-free derivatives of SAP45 and SAP46 
were compared using Biolog™. As described previously (chapter 3), SAP45 and 
SAP46 belong to O7 and O15 serogroups, respectively, but harbour identical ESBL 
plasmids to SAP44.  
Curing the strains of their ESBL plasmids using pCURE resulted in significant 
changes to the host bacterium’s ability to respire on the different carbon substrates. 
Unfortunately, the Biolog™ data obtained for the SAP46 plasmid-cured derivative 
had to be excluded from further analysis. The data were of poor quality due to the 
very low levels of respiration exhibited by the cured strain. It is possible that the 
curing process had adverse effects on the host bacterium.  
However, significant differences in respiratory activity were found for 7% (7 
out of 98) of carbon substrates used by SAP45 compared to its plasmid-free 
derivative (see Table 22). Most differences reflected a reduced ability of the plasmid-
free strain to utilise certain substrates. For example, similar to SAP44, respiration of 
α-keto glutaric acid was enhanced in the presence of the ESBL plasmid. This finding 
indicates that this may be a general response applicable to other APEC and is 
attributable to the ESBL plasmid examined in this thesis. It would be interesting to 
explore this further by testing the plasmid in a wider range of APEC isolates. 
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Figure 48. Differences in carbon utilisation by non-ESBL SAP24 and SAP44 (plasmidless). 
 
 
Differences in carbon utilisation between non ESBL APEC O78 strains SAP44 (plasmidless) 
and SAP24. SAP24 utilised 8 additional substrates (listed beside the graph) compared to the 
plasmid free SAP44. 
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6.5 Phosphorus and sulphur utilisation profiles of SAP44 
While carbon is a key substrate required for microbial growth, the ability of strains to 
utilise different phosphorus or sulphur sources can also have a significant impact on 
an organism’s fitness. Thus, strains were incubated in PM4 Biolog™ plates which 
contain an array of phosphorus or sulphur substrates, and the response of plasmid-
containing and plasmid-free derivatives compared as before.  
As evident by the heat map (Figure 49), SAP44 attained high levels of 
respiratory activity on the majority of phosphorus substrates but respired less well on 
many of the sulphur sources (note: the predominance of orange colour for wells 
containing phosphorus substrates). However, closer examination of the data 
revealed that SAP44 exhibited significantly higher levels of respiration than the 
negative control for 51 of 59 phosphorus sources and 30 of 35 sulphur sources, 
indicating that SAP44 was able to utilise the majority of P or S substrates to some 
extent. 
Curing both plasmids from SAP44 resulted in significantly reduced levels of 
respiration on 2 phosphorus substrates (Adenosine- 3’,5’-cyclic monophosphate  and 
Cytidine- 3’,5’-cyclic monophosphate).In contrast, the cured strain exhibited 
significantly (P≤0.05) higher levels of respiratory activity for triethyl phosphate 
compared to the wild type strain. While neither the wild type strain nor the plasmid-
free derivative were able to utilise O-phospho-D-serine, both of the single plasmid-
containing derivatives, SAP44C and SAP44F, were able to respire on this substrate.  
When SAP44 strains carry pSAP44 or pFIB44 plasmid as a single carrier 
were examined in the Biolog, approximately between 47%-60% of the the strains 
respired the sulphur compounds better compared to the plasmidless and wild type 
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strains (Table 23).  As was the case for the carbon utilisation, no differences in 
phosphorus or sulphur utilisation could be attributed to the ESBL plasmid (pSAP44) 
in the SAP24 genetic background.  
Similar to the findings observed for carbon utilisation, analysis of the data for 
phosphorus and sulphur utilisation also suggested that the plasmids harbour factors 
that enhance the utilisation of certain components in the host bacterium, but only 
when carried singly. Likewise the alternative explanation that points to conflicts in 
gene expression may be true. An example of this may be the increased utilisation of 
triethyl phosphate by the plasmid-free strain compared to the wild type organism. 
Thus, whether considering carbon, phosphorus or sulphur ulitisation profiles, there is 
evidence to suggest that the plasmids, either singly or in combination, exhibit a 
physiological effect on SAP44 metabolism. One important caveat to these studies, 
however, is the need to verify any effects by measuring the growth and not just the 
respiratory activity of the organism. 
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Figure 49. Cluster heat map showing the single values of SAP44WT and its derivative strains obtained from different phosphorus and 
sulphur sources.  
 
 
 Cluster heat map showing the signal values of SAP44W and its derivative strains obtained from 95 biochemical tests using PM4 for phosphorus 
(59 test)and sulphur sources (35 test), with blue showing no utilisation through to dark orange showing high levels of utilisation. As it can be seen 
SAP44C and SAP44F strains are clustered in one group as they respire better with pSAP44 and pFIB44 plasmids in sulphur sources whereas 
SAP44W and plasmidless strains respire less in sulphur sources. 
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Table 23 Effect of plasmid carriage on the metabolism of SAP44 strains in 
phosphorus and sulphur sources. 
 
The table shows the percentage utilaisation of phosphorus and sulphur substrates and 
significant differences were found among SAP44 strains when compared to the wild strain 
SAP44W and free plasmidless strain SAP44 (plasmidless). aThe phosphorus and sulphur 
sources are designated by number and letters adapted from biolog labelled names. A6: 
Triethyl Phosphate, A11: Adenosine- 2’,3’-cyclic monophosphate, B2: Dithiophosphate,B5: 
Carbamyl Phosphate,B8: Guanosine- 2’-monophosphate,B9: Guanosine- 3’-
monophosphate, C6: D-Glucosamine-6-Phosphate, C7: 6-Phospho-Gluconic Acid, C9: 
Cytidine- 3’- monophosphate, C10 :Cytidine- 5’- monophosphate, C11: Cytidine- 2’,3’-cyclic 
monophosphate, D1: D-Mannose-1-Phosphate,D2:D-Mannose-6-Phosphate, D3: 
Cysteamine-S-Phosphate, D5: O-Phospho-D-Serine, D6: O-Phospho-L-Serine, D7: O-
Phospho-L-Threonine,D8: Uridine- 2’- monophosphate, D11: Uridine- 2’,3’- cyclic 
monophosphate, E10: Thymidine-5’-
monophosphate,E11:InositolHexaphosphate,F2:Sulfate,F3:Thiosulfate,      
F5:Thiophosphate,F6:Dithiophosphate,F8:D-Cysteine,F9:L-Cysteinyl-Glycine,F10:L-Cysteic 
Acid,F11:Cysteamine,F12:L-Cysteine Sulfinic Acid, G2:S-Methyl-L-
Cysteine,G3:Cystathionine,G4: Lanthionine,G5: Glutathione,G6: D,L-Ethionine,G7: L-
Methionine,G8:D-Methionine,G9: Glycyl-L-Methionine,G10: N-Acetyl-D,L-Methionine,G11:L- 
Methionine Sulfoxide,G12:L-Methionine Sulfone, H1:L-Djenkolic Acid,H2:Thiourea,H3:1-
Thio- -D-Glucose,H5:Taurocholic Acid,H7: Hypotaurine, H11: Methane Sulfonic 
Acid,H12:Tetramethylene Sulfone. 
 Phosphorus substrates Sulphur substrates 
Strains No. of 
substrates 
utilised 
(59) 
Higher 
respiration 
compared to 
SAP44Wa 
Higher 
respiration 
compared to 
SAP44 
(plasmidless) 
No. of 
substrates 
utilised 
(35) 
Higher 
respiration 
compared to 
SAP44W 
Higher 
respiration 
compared to 
SAP44 
(plasmidless) 
SAP44W  86% 
(51) 
- 0 86% 
(30) 
- 1% 
(1/30) 
G11 
SAP44 
(plasmidless) 
88% 
(52) 
1% 
(1/51) 
 A6 
- 86% 
(30) 
0  
SAP44C 
(pSAP44) 
88% 
(52) 
8% 
(4/52) 
B5,D1,D5,E10 
4% 
(2/52) 
D5,E10 
89% 
(31) 
16%  
(5/30) 
F5,F9,G4, 
G6,H2 
47% 
(14/30) 
F2,F3,F6,F8,G2,
G3,G4,G5,G6,G
11,G12,H1,H2, 
H11 
SAP44F 
(pFIB44) 
88% 
(52) 
89% 
(31) 
(too many to 
list) 
4%  
(2/52) 
 D1,D5 
6% 
(3/52) 
A11,B5,D5 
47% 
(14/30) 
F5,F6,F9,F12,
G4,G8,G9,G10
,G11,G12,H3,
H5,H11,H12 
60% 
(18/30) 
F2,F3,F6,F8,F9,F
10,F12,G3,G4,G
7,G8,G9,G11,G1
2,H1,H3,H7,H12 
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6.6 Discussion: 
The aim of this chapter was to investigate whether ESBL plasmid carriage conferred 
a metabolic benefit to the host bacterium. There were three carbon compounds for 
which the ESBL plasmid had a positive impact - formic acid, α-ketoglutaric acid and 
mono-methyl succinate. Respiratory activity was restored to wild type levels for these 
compounds when the cured strain was complemented with the plasmid. However, 
introducing the plasmid into non-ESBL avian E. coli O78 isolate (SAP24) showed no 
alteration in its carbon utilisation profile, which means that this response is specific to 
SAP44.  Interestingly, curing an identical ESBL plasmid from an unrelated APEC 
isolate (SAP45) also resulted in reduced utilisation of α-ketoglutaric acid, although 
plasmid complementation studies were not included for this organism. These 
findings suggest that in some E. coli genetic backgrounds, the plasmid positively 
contributes to the metabolic capacity of the organism.  
Somewhat surprisingly, the plasmidless SAP44-cured strain respired better in 
the absence of any plasmids for one carbon compound, D-malic acid. Increased 
carbon utilisation has also been reported following deletion of an transcriptional 
regulator linked to antimicrobial resistant in Salmonella Typhimurium (Zheng et al., 
2011). Similarly, it is possible that some genes present on the ESBL plasmid may 
regulate genes involved in metabolic pathways.  
Fumaric and malic acid can be used as ‘acidulents’ to improve the feed 
conversion ratio of broiler chickens when used as a supplement in poultry feed 
(Skinner et al., 1991).These compounds have the ability to reduce the pH of the crop 
and gizzard contents of chickens (Cengiz et al., 2012), thereby, reducing the load of 
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pathogenic bacteria which prefer the higher pH of the digestive system (Rocha et al., 
2011). Organic acids have been put forward as a potential alternative to replace 
antibiotic growth promotors because of the fears of antibiotic resistance and the 
consequences for human health (Hassan et al., 2010). It is tempting to speculate 
that acidification of the chicken crop is counteracted by the conversion of these weak 
organic acids into neutral compounds (Leonhartsberger et al., 2002). Alternatively, 
reduced growth of ESBL-producing organisms in the presence of malic acid may act 
as a signal to the organism that it is not in the correct niche in the chicken intestine. 
Moreover, it seems that protein expression of genes on the ESBL plasmid does not 
occur optimally at low pH. For example, the frequency of APEC conjugation 
increased in parallel with increasing pH (see chapter 5) and ESBL-producing SAP44 
was less able to survive in acidic environments than non-ESBL-producing derivatives 
(i.e. those carrying pFIB44 or the cured derivative). In addition, investigation of the 
genome annotations generated by RAST (see Chapter 4), revealed that genes 
coding for transcription regulators of these compunds (e.g. succinate, malate and 
fumarate) are found in APEC genomes. When taken together, there appear to be 
many ways through which the plasmid affects the global metabolic capability and 
growth of the host bacterium.    
For most sulphur compounds, the presence of either the ESBL or the FIB 
plasmid had a positive impact on the respiratory capacity of the host strain. In fact, 
plasmid-free strains respired less than the other three (plasmid-containing) strains on 
over 60% of the sulphur sources. This is in contrast to when single-plasmid 
derivatives of SAP44 are tested on different carbon sources, when these strains 
194 
 
 
 
 
respired significantly less in nearly 70% of the sources tested. SAP44 wild type and 
plasmid-free derivative respire less in two and four phosphorus compounds 
respectively when compared to SAP44F and SAP44C (D-mannose-1-phosphate, o-
phospho-D-serine, carbamyl phosphate and thymidine-5’-monophosphate) 
comparing to the derivative strains. Further analysis in the genome annotations also 
revealed several clusters of sulphate and phosphate regulons are located in the 
bacterial genome which again emphasises the plasmid potential influence on the 
bacterial metabolic regulation system.  
The metabolic burden of plasmid carriage has been attributed to the 
consumption of limiting intracellular metabolites and the need for extra ATP for 
plasmid maintenance (Diaz-Ricci et al., 1995). This idea was based on evidence 
which indicates that plasmids maintain enhanced gene expression in the host cells.  
The authors measured cyclic adenosine monophosphate (cAMP) gene expression to 
determine metabolic processes. Higher levels of glucose were taken up in the strains 
carrying plasmids compared to those without plasmids. The same study emphasised 
that this phenomenon of the plasmid and host interaction has to take into account 
the genetic background of the host and this effects was independent of the type and 
number of plasmids. Furthermore, it has long been recognised that high plasmid 
copy number in E. coli HB101 causes increases in the level of enzymes involved in  
the tricarboxylic acid (TCA) cycle, including succinate dehydrogenase (Birnbaum & 
Bailey, 1991). Plasmids may also affect cellular metabolism by increasing  ATP 
synthesis necessary for the expression of resistance genes (Rozkov et al., 2004).   
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The metabolic burden found in carbon metabolisms could be related to the 
expression of plasmid gene products interfering with the regulation of carbon 
metabolism in E. coli, while there is no metabolic stress found harbouring them as a 
single plasmid in sulphur sources may suggest exchange roles between plasmid 
DNA and bacterial genome in sulphur metabolisms.   
In conclusion, carriage of large ESBL-producing plasmids are associated with 
both positive and negative impacts on the respiratory activity of the host bacterium 
when grown on different carbon, phosphorus and sulphate substrates. While such 
studies are useful for obtaining an overview of the metabolic ‘fingerprint’ of 
organisms, ultimately, within the host, bacteria are exposed to a complex mix of 
substrates as well as competition from other members of the microbiota. It is only by 
considering the organism’s fitness within the context of the host that a more accurate 
picture emerges and this is the focus of the next chapter. 
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Chapter 7: Impact of ESBL plasmid on APEC 
virulence 
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7 . Impact of ESBL plasmid on APEC virulence 
 
7.1 Introduction 
APEC strains belong to  O78, O1 and O2  group  cause infection outside of the 
gastrointestinal tract (extra-intestinal pathogenic E. coli, ExPEC), are the causative 
agent for 80% of colibasillosis in poultry (Dziva & Stevens, 2008). The pathogenicity 
of APEC is mostly associated by harboring virulence genes found on bacterial 
genome or plasmids (Janßen et al., 2001). Most known virulence genes detected in 
APEC in Chapter4 such as iss, IbeA, iroBCDN and tsh were carried on IncFIB 
plasmids. The virulence properties of such genes include adhesion, invasion, iron 
uptake system, serum resistance and toxins (Mellata et al., 2009). Plasmids 
belonging to Inc1 type have previously been detected in pathogenic E. coli of avian 
and human origin and commonly belong to the E. coli subtypes ExPEC and InPEC.   
The plasmids are commonly found as integrative plasmids and or free plasmids.  
However, few plasmid sequences of this type have been deposited in public 
databases.  Interestingly, the plasmids are  similar to pSAP44 in that they contain  a 
transfer region, transposon-like element and genes encoding ColIb proteins 
(Johnson & Nolan, 2009).  With the exception of the colonization factors and 
resistance genes found in pSAP44, the characterization of the plasmid DNA in 
Chapter4 did not detect most known virulence genes that have been reported in 
avian pathogenic E. coli isolates. However, 45 unidentified functional genes were 
detected in the plasmid and these may play a role in APEC pathogenicity. This led to 
hypothesis that ESBL plasmids found in the APEC strains examined in this thesis 
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may have certain genes of unknown functions, but with properties that may enhance 
APEC virulence. Therefore, the aim of this chapter was to investigate the impact of 
ESBL plasmid carriage on the virulence of APEC strains. In order to achieve this, the 
following assays were performed; 
 Study the impact of ESBL plasmid acquisition in biofilm formation at different 
temperatures representative of the poultry unit, human and chicken intestine, 
respectively  
 Study the impact of ESBL plasmid acquisition in adherence and invasion in 
avian and human macrophage–like cell lines. 
 Study the impact of ESBL plasmid acquisition in adherence and invasion in 
human intestinal epithelial cell line (Caco-2) 
 Utilise the Galleria mellonella model to study the contribution of ESBL 
plasmids to virulence.        
 
7.2 Impact of ESBL plasmid carriage on APEC biofilm formation    
To study the role of ESBL plasmid in biofilm formation, wild type APEC strain SAP44, 
the naïve non-ESBL APEC strain SAP24 and their respective derivatives were tested 
using the crystal violet biofilm assay. The effect of the ESBL plasmid on APEC 
strains belonging to different O serogroups was also included in this study. Each 
strain was tested in quadruplicate and biofilm development after 5 days was studied 
at three different temperatures 30˚C, 37˚C and 42˚C to simulate temperatures found 
in commercial poultry production units, the human and chicken intestines, 
respectively.    
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Generally, wild type APEC (with the exception of SAP45 which formed poor 
biofilms under all conditions), formed larger biofilms at 30˚C than at 37 ˚C or 42 ˚C 
(Figure 50, A and B).  However, the amount of biofilm formed was not correlated with 
serotype as APEC strains of the same serotype (e.g. SAP44 and SAP24) formed 
significantly (p<0.05) different amounts of biofilm. In contrast to APEC, laboratory E. 
coli K12 (SAP59 and its derivative SAP56) formed larger biofilms at 42 ˚C compared 
to 30˚C or 37˚C, perhaps the biofilm formation at 42oC was stimulated by non-plasmid 
related features. 
The role of the APEC plasmids on biofilm formation was investigated using 
the APEC derivatives described previously (section 3.2.4).  Curing wild type APEC 
SAP44 of both its plasmids did not significantly alter the amount of biofilm formed by 
the organism. Loss of the ESBL plasmid from SAP46, the APEC O15 isolate, 
significantly (P<0.05) reduced the amount of biofilm formed by the organism when 
grown at 30˚C. This finding however, was not supported by plasmid complementation 
as biofilm formation was not restored to the original levels when the plasmid was re-
introduced to the cured strain.  
The re-introduction of pSAP44 into the cured strain gave surprising results. 
The complemented strain SAP44C made significantly (P<0.05) less biofilm at 30˚C 
than the cured strain from which it was derived. However, the inverse was found at 
37˚C and 42˚C, where SAP44C formed significantly (P<0.05) larger biofilms than the 
cured strain. These conflicting results may suggest a temperature-dependent role for 
pSAP44 in biofilm formation. In order to test this further, pSAP44 transconjugants 
derived from the naïve APEC strain (SAP24) or from laboratory E. coli K12 were 
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tested for their ability to form biofilms. The presence of the plasmid had no significant 
effect on biofilm formation by either strain at any of the temperatures. When taken 
together, it is clear that further studies are needed to elucidate a role, if any, for 
ESBL-harbouring plasmids in biofilm formation by APEC. 
 
Figure 50. Biofilm formation of APEC with and without ESBL plasmids in different 
temperatures.  
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The effect of ESBL plasmids and temperature on biofilm formation. Biofilm formation by different APEC 
strains and their cured and complemented derivative strains were compared at different temperatures 
(30Co, 37Co and 42Co). SAP44(WT) and its derivative strains : SAP44 (plasmidless strain), SAP44C ( 
plasmidless strain complemented with ESBL pSAP44 plasmid) and SAP44F (non ESBL but  
containing FIB plasmid) ; SAP24(WT) and its derivative strain SAP140(containing ESBL pSAP44 
plasmid) (A) ,  E.coli k12 (SAP59) and its derivative SAP56(containing ESBL pSAP44 plasmid), 
SAP45 (WT) and its derivative cured strain SAP45(cured), SAP46(WT) and its derivative cured strain 
SAP46(cured) (B).Data are calculated from at least three biological and two technical repeats. When 
P-value < 0.05 is considered significant which is displayed as a star symbol. 
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7.3 APEC adherence and invasion of macrophage-like cells. 
APEC causes systemic disease in poultry, however it is not clear where or how 
APEC reaches the bloodstream (Dziva and Stevens, 2008). Uptake by macrophages 
represents a possible route of dissemination (Antão et al., 2008). In order to 
investigate the role of the ESBL plasmid on APEC interactions with macrophages, in 
vitro cell-based assays were set up to measure bacterial adherence, invasion and 
survival in the chicken macrophage–like cell line HD11.The numbers of intracellular 
APEC were determined using the gentamicin protection assay and the number of 
extracellular (adherent) bacteria derived by difference between the total numbers of 
APEC recovered prior to gentamicin treatment minus any intracellular organisms. 
The ability of APEC to survive inside macrophages was calculated after an additional 
4 h incubation. The invasive isolate Sallmonella.Typhimurium SL1344 strain and low-
invasive E. coli DH5α K12 strain were used as positive and negative controls, 
respectively. Wild type ESBL-producing APEC and naïve non-ESBL-producing 
APEC and their various derivatives were tested in this study.   
7.3.1 Avian macrophage-like cells (HD11) 
Regardless of plasmid content, all APEC isolates adhered to the HD11 
macrophage cell line as well as the positive control strain SL1344 (Figure 51 and 
Figure 52). In all cases, the numbers of recovered bacteria were approximately 1 log 
higher than for the negative control strain (P<0.05). In contrast, the non-APEC E. coli 
strains SAP59 and its plasmid-containing derivative (SAP56) adhered significantly 
(P<0.05) less well than APEC, at a level similar to the negative control strain (Figure 
52). These results indicate that while the ESBL plasmid has no impact on the ability 
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of APEC isolates to adhere to HD11 cells, in general APEC are able to adhere more 
effectively than laboratory E. coli.   
By 4 h post infection, the numbers of intracellular bacteria for SAP44 and its 
derivatives were similar to that of the negative control indicating very low levels of 
invasion had occurred. No effect of the ESBL plasmid on invasion was found. In 
contrast, approximately 100-fold more intracellular bacteria were recovered from 
assays using the positive control strain SL1344 (p-value <0.05) (Figure 51, chart B) 
indicating the HD11 macrophage cells were functioning as expected.  While the 
ESBL plasmid of SAP44 and SAP45 had no effect of APEC invasion, curing the 
plasmid from the third APEC strain, SAP46, gave rise to significantly (P<0.05) higher 
numbers of intracellular bacteria than the parental strain (Figure 52, chart B). This 
was manifest despite no difference in adherence evident for these two strains. 
Overall, it seems that the ESBL plasmid has no effect on the adherence and only a 
marginal effect on the invasion of one APEC isolate (SAP46 cured strain).  
In general, similar numbers of intracellular bacteria were recovered for wild 
type SAP44 and its derivatives, and the negative control strain at 8 h post infection. 
The one exception to this was found for the ESBL transconjugant (SAP44C) in which 
significantly (P<0.05) higher numbers of intracellular bacteria were recorded than for 
the strain from which it was derived (SAP44cured).  In contrast, the other two APEC 
isolates were better able to survive inside the macrophage than the negative control, 
with 5 to 10-fold higher numbers of intracellular bacteria recovered. For one of these 
isolates (SAP45), loss of the ESBL plasmid significantly increased survival (Figure 
51 and Figure 52, chart C). In summary, it appears that APEC are better able to 
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survive inside avian macrophages than laboratory E. coli, but the impact of the ESBL 
plasmids on this process is minimal.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
HD11 assays (A: Adherence, B: Invasion and C: survival after 8 hours (P.I: post infection) of 
APEC SAP44 (WT) and SAP24 (WT) strains with their derivatives (see table ) compared 
with highly virulent S. Typhimurium SL1344 and the low invasive control strain E. coli K12 
over time.  Chart A shows the number of bacteria adhered 2h P.I (calculated by numbers of 
viable counts associated minus numbers invaded). Chart B shows the number of bacteria 
invaded at 4 h P.I following the addition of 100µg/ml gentamicin to kill any extra cellular 
bacteria prior to disrupting the cells. (P.I = post infection). Chart C shows the numbers of 
gentamicin protected intracellular bacteria surviving at 8h P.I.  Note that the scale of the y-
axis is logarithmic. Each assay was performed in duplicate for each strain with 3 biological 
repeats. The probability level for significance was regarded as P <0·05.  
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Figure 51. The ability of APEC O78 strains carrying the ESBL plasmid to 
adhere, invade and survive in HD11 cells. 
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HD11 assays (A: Adherence, B: Invasion and C: survival after 8 hours (P.I: post infection) of 
APEC SAP45, SAP46 and K12 SAP59 strains with their derivatives (see table ) compared 
with highly virulent S. Typhimurium SL1344 and the low invasive control strain E.coli K12 
over time.  Chart A shows the number of bacteria adhered (calculated by numbers of viable 
counts associated minus numbers invaded). Chart B shows the number of bacteria invaded 
at 4 h P.I following the addition of 100µg/ml gentamicin to kill any extra cellular bacteria prior 
to disrupting the cells. (P.I = post infection). Chart C shows the numbers of gentamicin 
protected intracellular bacteria surviving at 8h P.I.  Note that the scale of the y-axis is 
logarithmic. Each assay was performed in duplicate for each strain with 3 biological repeats. 
The probability level for significance was regarded as P <0·05.  
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Figure 52. The ability of APEC strains (SAP45 and SAP46) and K12 E.coli 
carrying the ESBL plasmid to adhere, invade and survive in HD11 cells. 
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7.3.2 Human macrophage-like cells (THP1)    
APEC are well-established pathogens of birds and recent evidence suggests that 
this group of organisms may also be pathogenic to human (Mellata, 2013). For 
example, the genomic sequences of  human pathogenic E. coli strains and APEC 
are very similar (Johnson et al., 2007). In addition, the IncI1 type ESBL plasmid 
found in APEC strains, are also commonly found in human pathogenic E. coli strains 
(Johnson & Nolan, 2009). Thus, the ability of APEC to adhere, invade and survive in 
the human macrophage cell line THP-1 was examined.  In addition, the influence of 
the ESBL plasmid on these processes was examined. The assay protocols used 
here mimicked those already described for the HD11 assays (adherence, invasion 
and survival).  
In general, approximately 10-fold more SAP44 cells adhered to THP-1 cells 
than compared to the negative control strain (P<0.05) (Chart A in Figure 53). Yet 
despite an increased number of SAP44 organisms attaching to the THP-1 cells, the 
level of invasion found for SAP44 was similar to that for the poorly invasive negative 
control strain. Furthermore, once SAP44 gained entry to the cells, there was no 
evidence that it was not better able to survive than the negative control. Loss of both 
plasmids from SAP44 did not significantly alter the ability of the strains to adhere, 
invade or survive under these conditions. Only SAP44C, the SAP44 strain 
complemented with the ESBL plasmid showed a different response. This strain 
appeared to invade and survive in THP-1 cells better than all other SAP44 
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derivatives. For example, approximately 3 fold more intracellular cells were 
recovered compared to the cured strains at 4 h post infection. By 8 h post-infection 
the number of SAPP44C cells found within the macrophage was nearly 1 log higher 
than for wild type SAP44 (Chart C in Figure 53 ). These findings may indicate that 
recent acquisition of the ESBL plasmid suggest a role for conferring virulence 
phenotype, but may be induced by different host cell line.  
On the other hand, other APEC of different types harbouring ESBL plasmid did not 
show the same pattern of variation that seen in SAP44 derivatives in invasion or 
survivability into THP-1 cells.  Indeed, one APEC isolate, SAP46 adhered at levels 
even higher than the positive control strain, SL1344. The invasiveness of SAP45 WT 
(O7) and its derivative SAP45 cured strains was less than the positive control 
SL1344 but was remarkably more than the poorly invasive control E.coli K12 strain 
and SAP46, SAP24 and their derivatives P-value ˂ 0.05 ( Chart B in Figure 54). 
However, reduction in the survivability was equal to the E. coli, K12  and other tested 
strain when compared to the positive control SL1344 with a P-value ˂ 0.05 (Chart C 
in Figure 54). 
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Figure 53. The ability of APEC O78 strains carrying the ESBL plasmid to adhere, 
invade and survive in THP-1 cells. 
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THP-1 assays (A: Adherence, B: Invasion and C: survival after 8 hours (P.I: post infection) of 
APEC SAP44 (WT) and its derivatives (see table) compared with highly virulent S. 
Typhimurium SL1344 and the low invasive control strain E. coli K12 over time. Chart A 
shows the number of bacteria adhered (calculated by numbers of viable counts associated 
minus numbers invaded). 2h P.I. Chart B shows the number of bacteria invaded at 4 h P.I 
following the addition of 100µg/ml gentamicin to kill any extra cellular bacteria prior to 
disrupting the cells. (P.I = post infection). Chart C shows the numbers of gentamicin 
protected intracellular bacteria surviving at 8h P.I.  Note that the scale of the y-axis is 
logarithmic. Each assay was performed in duplicate for each strain with 3 biological repeats. 
The probability level for significance was regarded as P <0·05. 
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Figure 54. The ability of APEC strains (SAP45 and SAP46) and K12 E.coli carrying the 
ESBL plasmid to adhere, invade and survive in THP-1 cells. 
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THP-1assays (A: Adherence, B: Invasion and C: survival after 8 hours (P.I: post infection) of 
APEC SAP45, SAP46 and SAP24 strains with their derivatives compared with highly virulent 
S. Typhimurium SL1344 and the low invasive control strain E. coli K12 over time.  Chart A 
shows the number of bacteria adhered (calculated by numbers of viable counts associated 
minus numbers invaded).2h P.I. Chart B shows the number of bacteria invaded at 4 h P.I 
following the addition of 100µg/ml gentamicin to kill any extra cellular bacteria prior to 
disrupting the cells. (P.I = post infection). Chart C shows the numbers of gentamicin 
protected intracellular bacteria surviving at 8h P.I.  Note that the scale of the y-axis is 
logarithmic. Each assay was performed in duplicate for each strain with 3 biological repeats. 
The probability level for significance was regarded as P <0·05.  
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7.4 APEC interactions with human intestinal Caco2 epithelial cells 
As well as interacting with macrophages, it is likely that APEC come into contact with 
intestinal epithelial cells when transmitting through the intestine and this may 
represent an alternative route of infection (Dziva & Stevens, 2008). In order to 
examine the role of the plasmids on APEC interactions with intestinal epithelial cells, 
adherence and invasion studies were also performed using Caco2 cells. As before, 
the different APEC strains as well as the E. coli K12 transconjugants were included 
to enable comparative analysis. 
Approximately 10-fold more SAP44 cells adhered to the Caco2 epithelial cells 
than the E. coli negative control strain. Indeed, the level of adherence was not 
significantly different to that achieved by the positive control strain. However, SAP44 
were much less able to invade Caco-2 cells than SL1344. The number of 
intracellular SAP44 bacteria detected was of an intermediate level of approximately 
103 cfu/mL compared to the positive (105) and negative (<102 cfu) controls, 
respectively (Figure 55). The loss of both or one of the plasmids present in SAP44 
had no significant impact of any of the parameters tested.  
Both of the other wildtype APEC strains adhered effectively to Caco2 cells, 
with SAP46 adhering at a level significantly higher than the positive control strain 
(SL1344). However, compared to SL1344, this strain was poorly invasive, with 103 
cfu fewer intracellular bacteria being found at 4 h post infection. Carriage of the 
ESBL plasmid appeared to promote cellular invasion in this strain as significantly 
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fewer cells were recovered in assays using the cured strain compared to the wild 
type. Of the three APEC isolates, SAP45 invaded Caco2 cells to the greatest extent 
with 105 cfu/ml found (Figure 56, chart B). No significant difference in adherence or 
invasion was found in E. coli K12 (SAP59) following acquisition of the ESBL plasmid 
(SAP 56), although both strains adhered significantly more (1 log) than the negative 
control strain (Figure 56).   
These results suggest that the ability of APEC O78 strains to adhere and invade to 
Caco2 is not associated with the ESBL plasmid, but more likely due to the carriage 
of host-specific virulence factors. It is also possible that the ESBL plasmid may play 
a different role in APEC belonging to different O serogroups and/or at different stage 
of the infection process. 
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CACO2 assays (A: Adherence, and B: Invasion) of APEC SAP44 (WT) and SAP24 (WT) 
strains with their derivatives compared with highly virulent S. Typhimurium SL1344 and the 
low invasive control strain E. coli K12 over time. Chart A: shows the number of bacteria 
adhered (calculated by numbers of viable counts associated minus numbers invaded). Chart 
B shows the number of bacteria invaded at 4 h P.I following the addition of 100µg/ml 
gentamicin to kill any extra cellular bacteria prior to disrupting the cells. (P.I = post infection).  
Note that the scale of the y-axis is logarithmic. Each assay was performed in duplicate for 
each strain with 3 biological repeats. The probability level for significance was regarded as P 
<0·05.  
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Figure 55. The ability of APEC O78 strains carrying the ESBL plasmid to 
adhere, invade CACO2 cells. 
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CACO2 assays (A: Adherence and B: Invasion) of APEC SAP45, SAP46 and K12 SAP59 
strains with their derivatives compared with highly virulent S. Typhimurium SL1344 and the 
low invasive control strain E.coli K12 over time.  Chart A: shows the number of bacteria 
adhered (calculated by numbers of viable counts associated minus numbers invaded). Chart 
B: shows the number of bacteria invaded at 4 h P.I following the addition of 100µg/ml 
gentamicin to kill any extra cellular bacteria prior to disrupting the cells. (P.I = post 
infection).Note that the scale of the y-axis is logarithmic. Each assay was performed in 
duplicate for each strain with 3 biological repeats. The probability level for significance was 
regarded as P <0·05.  
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Figure 56. The ability of APEC strains (SAP45 and SAP46) and K12 E.coli 
carrying the ESBL plasmid to adhere, invade CACO2 cells. 
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7.5 Colonisation and lethality of Galleria mellonella infected with APEC  
 Previous studies using Galleria mellonella as an in vivo model indicated how the 
levels of virulence factors carried by UPEC isolates associated with the degree of 
lethality to the larvae which makes it a good tool to investigate the virulence of a 
range of bacteria (Alghoribi et al., 2014). Here, it was used to assess the differences 
between APEC containing ESBL plasmid and their derivative cured strains. Galleria 
mellonella larvae were infected with each strain with a dose of 104 CFU of bacterial 
cells or PBS (as a negative control) in 10 µl in the right foreleg using a Hamilton 
syringe. All larvae were incubated at 37oC for 24 hours to determine the rate of 
survival and macroscopic appearance.   
Injection of 104 cfu of SAP44 resulted in the death of most larvae with only 
10% still alive by 12 h (Figure 57, Table 24). In contrast, nearly 100% of 
uninoculated or PBS-inoculated larvae present in the control groups survived. With 
the exception of SAP44C, all other SAP44 derivatives regardless of plasmid content 
caused a similar percentage of larvae death as the wild type. In contrast only 40% of 
larvae infected with SAP44C died giving rise to a significant difference in the survival 
caused by these strains (two tailed t test (P<0.05) (see the table in appendix IV).  
The number of bacteria recovered in the larvae at different times post infection is 
shown in Figure 58 . While the number of bacteria recovered for most SAP44 
derivatives increased over the course of the infection, this was not the case for 
SAP44C. The number of SAP44C cells recovered declined over 3 logs before rapidly 
increasing between 5 and 10 h post infection. The percentage of viable larvae 
following injection with the naïve O78 isolate (SAP24) or its ESBL-harbouring 
derivative SAP140 was similar at about 10%. Whereas the survival following 
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injection with the non-APEC E. coli K12 strain (SAP59) or its ESBL-harbouring 
derivative (SAP56) was slightly higher at 15%. Overall, APEC isolates appear slightly 
more virulent in the larvae model than laboratory E. coli K12 strains, although 
carriage of APEC plasmids does not appear to play a role in this phenotype.  
 
 
Figure 57. The ability of bacterial hosts carrying ESBL plasmid to cause infection in 
Galleria mellonella. 
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Figure 58. Number of bacteria (cfu/ml) recovered from larvae infected with APEC at various 
times post infection.  
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 P <0.05 
 
 
Larvae were injected with 104 cfu of APEC isolate SAP44 or its various plasmid-
bearing derivatives. Haemolymph from representative viable larvae at various times 
post infection was collected and the number of viable bacteria enumerated by serial 
dilution and plating on selective media. As it can be seen SAP44C showed significant 
reduction in CFU after 5 hours post infection while other SAP44 strains remain 
increasing in cfu during infection period. P <0.05. 
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7.6  Discussion 
APEC are implicated in a complex of systemic infections in poultry which can result 
in high morbidity and mortality (Pourbakhsh et al., 1997). The high genome 
homology between APEC and other ExPEC of human and animal origin draw 
attention to the potential zoonotic risk of APEC  (Mellata, 2013).  In this study the 
potential contribution of ESBL plasmid to APEC virulence was assessed using 
biofilm formation and three different cell cultures lines (HD11, THP1 and CACO2). 
Furthermore, an in vivo, Gallaria mellonella larvae virulence model was also used.  
In general, APEC strains belonging to the O78 serotype with and without the 
ESBL plasmid formed better biofilms at 30˚C than 37˚C and 42˚C. However, 
variability in the level of biofilm formation was significant. The wild type strain SAP44 
(O78) and its derivatives produce more biofilm when compared to wild type strain 
SAP24 (O78) and its derivative SAP140. Interestingly, when SAP44 (O78) carrying 
the ESBL plasmid as a single plasmid the production of biofilm was reduced 
compared to the wild type and the other derivative strains at 30˚C . However, at 
different temperatures that mimic the host temperature of humans and poultry at 
37˚C and 42˚C, respectively the ESBL plasmid significantly enhanced the biofilm 
production, whereas the wild type and derivative strains were not able to form 
biofilms at these conditions. A correlation between ESBL production and biofilm 
formation was also observed in E. coli strains by other researchers (Subramanian et 
al., 2012).  Interestingly, the plasmid did not seem to have any significant effect on 
K12 E.coli, SAP45 and SAP46 and their derivatives in all test conditions. The biofilm 
produced by the plasmid-cured strains (SAP44 plasmidless) was high at 30˚C , is 
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probably induced by non-plasmidic genes being expressed only at 30˚C  such as 
curli required for development of biofilm and adhesions at the early stage of biofilm 
formation (Kikuchi et al., 2005).   
The analysis of the ESBL plasmid DNA from APEC in the previous chapter 
(Figure 22) showed that it contains genes encoding type IV pili mediate conjugal 
transfer of this plasmid. These genes have been shown to be essential in adherence 
to and invasion of epithelial cells (Zhang et al., 2000). In this study, the carriage of an 
ESBL plasmid by K12 E.coli strains did not confer any virulence advantage over a 
plasmid-less strain, even though the plasmid contains the IV pili genes. APEC 
strains with and without ESBL plasmids were able to adhere to tissue culture cells in 
the same pattern as the positive control Salmonella strain (SL1344). This may also 
confirm that the IV pili is not essential in the bacterial adherence. These results 
comes in agreement with Srimanote et al. (2002) who stated that, the  pili in plasmid 
PO113 belong to IncI has no role in adhesion to the epithelial cells.  However, recent 
acquisition of ESBL plasmid by APEC O78 strain as a single plasmid showed ability 
to invade human macrophage cells and to survive in both avian and human 
macrophages. The results were consistence with the ability to this strain to form 
biofilm in conditions that mimic the temperature in human and chicken host.  
The tissue culture data generated for APEC strains of other O groups, SAP45 
and SAP46 were rather complex. For example, the wild type SAP45 (O7) and its 
cured strain showed ability to adhere and invade the THP-1 and Caco2 cells, but 
only the cured strain was able to survive in HD11 cells. Likewise, the wild type APEC 
SAP46 (O15) showed ability to adhere toTHP-1 cells significantly more than its cured 
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strains and other APEC tested strains, but were not able to invade or survive in 
HD11 cells. It seems that the elimination of the plasmid that encoded the ESBL 
production did not influence the ability of strains to adhere or invade the cells, 
indicating that the adherence or invasion of these APEC strains is chromosomal 
rather than plasmid mediated.  
In this study, the Galleria mellonella virulence model was employed to further 
assess the difference between APEC O78 strains carrying the ESBL plasmid and 
their respective cured strains. Galleria mellonella, the larvae of the Greater wax moth 
were infected with each strain to evaluate the ability to kill the larvae. This model has 
been used previously to assess the virulence of different bacterial species including 
ExPEC strains (Alghoribi et al., 2014; Senior et al., 2011; Mukherjee et al., 2010). 
Almost all of uninfected larvae and larvae infected with PBS were alive at 
12hr, but the survival rate of larvae infected with K12 and APEC O78 strains with 
and without the ESBL plasmids was reduced compared to the control. In addition, 
SAP44C strains contains ESBL plasmid as a single plasmid was less efficient at 
killing the larvae and was attenuated compared to the wild type SAP44 (contains two 
plasmids:pSAP44 and pFIB44) and plasmid cured strains indicating that the plasmid 
may has attenuated the bacteria virulence.  This result was also confirmed by the 
level SAP44C strain in the larvae during the infection time which was 5 times less 
than the parent and derivative strains. The difference in in vivo growth was not seen 
in the in vitro growth rates of isolates with and without ESBL plasmid in rich media. It 
seems that the majority SAP44C was killed in the first 5 hours and may be 
persistence bacterial cells start to multiply after the 5 hours of infection or the 
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bacterial cells has a long lag phase before they reach the exponential growth phase. 
However, from the virulent model experiments the effect of the absence or presence 
the ESBL plasmid in APEC O78 strains was less clear as the cured plasmid was still 
able to kill the larvae as the wild type and other strain, but in different background 
harbouring the plasmid (K12, E. coli).     
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Final Discussion 
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8 .Final Disccussion 
 
The increased prevalence of ESBL producing E. coli represent a significant concern 
in human and veterinary health (Smet et al., 2010). The emergence of community-
acquired ESBL E. coli infections and their detection in livestock has increased in 
recent years, indicating the successful transmission of this resistance determinant 
outside of the clinical disease setting (Guenther et al., 2011). Molecular 
epidemiological studies have indicated that certain conjugative plasmids such as 
IncI1, are associated with prevalent ESBL types in particular the CTX-M allele, in E. 
coli and ExPEC in particular  (Johnson et al., 2012; Smet et al., 2010; Hopkins et al., 
2006; Cantón et al., 2012). Plasmids belonging to the IncI1 replicon are thus viewed 
as ‘epidemic plasmids’ responsible for the dissemination of CTX-M resistance genes 
across different bacterial species in human and animals (Hopkins et al., 2006). For 
example, in recent years ESBL types such as CTX-M-1, CTX-M-2 and CTX-M-14, 
has been found in E. coli poultry isolates from many European countries (Cantón et 
al., 2012). 
A wide range of virulence genes have been reported for APEC, several of 
which are associated with large plasmids, such as the Col V plasmid (Mellata et al., 
2009). Plasmid-encoded virulence genes enhance the ability of APEC to exploit the 
host, promoting its spread and persistence in the bacterial community (Pitout, 2012). 
However, there are limited studies on the role of common plasmids such as the IncI1 
rep type, in APEC. Most studies highlight the epidemiological prevalence of drug 
resistant and/or virulence plasmids in isolates of E. coli from human and poultry 
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origins (Ben Sallem et al., 2014; Accogli et al., 2013; Johnson et al., 2012). However, 
fewer consider the impact of plasmid acquisition on APEC virulence, or how multiple 
large plasmids function together inside the host bacterium. This is surprising given 
that several studies indicate that the zoonotic risk of APEC is linked to the presence 
of these mobile genetic elements (Stehling et al., 2003). Thus, in order to better 
understand the reasons for the widespread dissemination of ESBL plasmids, this 
thesis examined the advantages and disadvantages of ESBL plasmid carriage in 
APEC, including the impact of such plasmids on the co-existing plasmids that are 
characteristic of this pathotype.    
In this study, four wild type APEC strains were selected for detailed 
phenotypic and genotypic investigations. Three of the isolates were confirmed as 
ESBL-producers, whereas the fourth was a non-ESBL-producing APEC O78 strain. 
In chapter 3 and 4 of this thesis, the selected strains and their plasmids were 
characterised phenotypically and genetically. Cured and plasmid-complemented 
derivatives of these strains were generated and used in chapters 5, 6 and 7 to study 
the impact of ESBL plasmid carriage on the phenotype of APEC strain in a variety of 
in vitro and in vivo assays.  
While the ESBL-producing isolates examined in this study belonged to 
different O-antigen types and phylogenetic groups, all harboured an identical ESBL 
plasmid belonging to the IncI1replicon type and containing the blaCTX-M-1 gene. The 
plasmid (herein named pSAP44) was 105,610 bp in size and encoded all three 
genes inc, repY and repZ that are essential for replication maintenance and control 
of the plasmid copy number in the host bacterium (Sampei et al., 2010). Sequencing 
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revealed the presence of several virulence genes in addition to another antibiotic 
resistance element (tetracycline resistance cassette). The IncI1 plasmid was 
transferable via conjugation and mobilised to other APEC strains in conditions that 
mimic the chicken caeca.  
 Further analysis of the region adjacent to blaCTX-M-1 identified that the insertion 
sequence ISEcp1 was located downstream of the gene. Previous data from 
molecular epidemiology studies has shown that ISEcp1 is associated with the 
prevalence of CTX-M-1(Jacoby, 2009). Interestingly, the plasmid also encoded 
resistance genes to tetracycline (tetRA); therefore persistence and spread of the 
IncI1 plasmid could also be driven by antibiotic pressure from non-β-lactam drugs. 
This is particularly relevant for APEC because tetracycline was a commonly used 
antimicrobial growth promoter (AGP) prior to the 2006 EU ban on their use in food 
producing animals.  The ban was initiated through the European Common Market in 
the mid-1970s as a result of increased antimicrobial resistance in bacteria isolated 
from animal and farm workers (Marshall & Levy, 2011).  
In epidemiological studies, IncI1 plasmids have been related to a number of 
ESBL types such as CTX, SHV and TEM-encoding β-lactamases (Bortolaia et al,. 
2010; Ben Sallem et al., 2014; Accogli et al., 2013; Johnson et al., 2012). In addition, 
IncI1 plasmids harbouring ESBL genes have been detected in different isolates of 
Enterobacteriaceae (Dolejska et al., 2013).These data suggest that IncI1 plasmids 
are common in bacterial pathogens isolated from humans and animals. 
Compared to other CTX-M-1-encoding IncI1 plasmids (e.g. pC49-108(Wang et al., 
2014)), pSAP44 showed few differences in DNA content. However, regions of 
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difference were found in mobile elements and insertion sequences, including the 
presence of an inverted repeat sequence of 7 bp (tatttgc-ataaacg) downstream of the 
replicon region. These sequences flanked the tetR-tetA-pecM gene cluster in 
pSAP44, whereas in pC49-108, they flanked a class 1 integron.  
Therefore, this inverted repeat sequence located downstream of the replicon 
region may act as a ‘hotspot’ for the deletion and insertion of new mobile elements. 
In addition, two genes were absent in pSAP44, traD, which usually forms part of the 
traABCD operon responsible for transfer expression, and pilJ, one of the pil genes 
which are involved in formation of the type IV pilus involved in conjugation (Sampei 
et al., 2010). Given that pSAP44 readily transferred to recipient cells, the data 
suggests that these two genes are not essential for the conjugation process.  
Examination of the sequence data revealed that pSAP44 contained a large 
number of genes of unknown function (hypothetical proteins) compared to the co-
resident pFIB virulence plasmid present in the organism. Therefore, it would be 
interesting to study the functional and role of these predicted proteins, as many 
appear to be conserved in IncI1 plasmids.   
        The impact of ESBL-producing plasmids on strain fitness has been investigated 
by a number of investigators (Yates et al., 2006; Humphrey et al., 2012; Vogwill & 
MacLean 2015; Starikova et al., 2013; Enne et al., 2005). However, to date most 
have overlooked the fact that other plasmids co-exist in the same host bacterium. 
Yet such plasmids may have a profound impact on ESBL gene expression and/or on 
the fitness ‘cost’ or ‘benefit’ associated with carriage of resistance elements. This 
significant gap in knowledge was investigated in this thesis.  
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        In addition to pSAP44, plasmids belonging to the IncFIB replicon type were 
present in all the ESBL-producing APEC isolates examined. In fact, the IncFIB 
plasmid type is prevalent in APEC strains and most virulence genes found in APEC 
have been associated with this element (Johnson & Nolan, 2009). The FIB plasmid 
from the APEC O78 isolate SAP44 was chosen for further study. This plasmid 
(pFIB44) was 97, 245 bp in size and shared significant DNA identity to the Col V 
plasmid (pAPEC-1(Mellata et al., 2009)). At least 80 kb of pFIB44 coded for 
virulence factors which were similar to the factors harboured in previously 
sequenced IncFIB plasmids of APEC origin (Mellata et al., 2009). The virulence 
genes found on the IncFIB plasmid included three iron acquisition systems 
(iroBCDN, sitABCD and iutA iucABCD), a colicin V operon (cvi and cva ABC), 
temperature sensitive haemagglutinin (tsh), haemolysin protein (hlyF), macrolide 
resistant genes (etsABC), increased serum survival (iss), and the outer membrane 
protease gene (ompT). Interestingly, pSAP44 and pFIB 44 both encode colocin 
proteins, but of different classes, Col1b and ColV, respectively. The presence of two 
colicin types may provide a competitive advantage for survival and persistence in the 
poultry intestinal tract (Johnson et al., 2010).    
Comparative genomic analysis of the ESBL-producing and non-ESBL-
producing APEC O78 isolates revealed only minor differences in their content, 
mainly  to do with the number of plasmids, bacteriophages and other transposable 
elements they harbour. The O78 strains (SAP44 and SAP24) contained fewer 
bacteriophages and transposable elements than other unrelated APEC strain such 
as APEC O1 and APEC O2, perhaps suggesting that APEC O78 serogroup 
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harbours mostly conserved genes. Regardless, this does not rule out that the 
plasmids affect bacterial physiology and metabolism. As evident from the carbon 
utilisation data, the acquisition of pSAP44 enhanced the respiratory capability of the 
host bacterium compared to that of the cured host derivative. Specifically the ESBL-
complemented strain (SAP44C) was better to utilise formic acid, α-keto glutaric acid 
and mono-methyl succinate than the cured strain. Conversely, the cured strain 
exhibited better utilisation of D-Malic acid than derivatives harbouring either the FIB 
or IncI1 plasmid. In general, the single plasmid-containing derivatives exhibited 
decreased respiratory activity when exposed to 78% of the carbon sources whereas 
there was increased respiratory activity when they were exposed to approximately 
50% of the sulphur compounds compared to the wild type and plasmid-less strains. 
This may be due to the plasmid interfering with chromosomally-encoded genes that 
are involved in carbon metabolism in E. coli, which may be less likely for the sulphur-
containing compounds.  A study examining the metabolic changes in resistant 
Salmonella Typhimurium LTL found reduced utilisation of 10 and 5 carbon and 
phosphorus sources, respectively, compared to the sensitive strain (Zheng et al., 
2011). Both findings suggest there is an alteration in the metabolic processes of the 
cell due to the presence of antibiotic resistance genes.  
                Many virulence genes are controlled by the carbon catabolic repression 
which means that the expression of these genes is linked to the supply of carbon in 
the cell (as reviewed by Fuchs et al., 2012). In addition, virulence genes may have 
dual function a part from its main role in virulence. For example, iron uptake systems 
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is not only involved in iron acquistion but also for expression of other virulence genes 
in pathogenic E. coli strains (as reviewed by Fuchs et al., 2012).   
The fitness of ESBL-producing and non-ESBL-producing APEC isolates and 
transconjugants was determined by single strain and competitive growth assays. 
There was no significant difference in the phenotypic growth rate in APEC strains 
harbouring the ESBL plasmid. Moreover, no significant cost was observed when the 
plasmid was introduced into a non-ESBL wild type APEC (SAP24). This may be 
because the non-ESBL strain used in this thesis harbours multiple plasmids and so 
the strain was able to adapt to the newly-introduced plasmid with no effect in its 
growth rate. ESBL plasmid carriage in APEC O78 showed no fitness impact during 
the longterm competitive growth assays. These results are different from those 
reported by others. For example, plasmid RP1 belonging to IncP containing the 
blaTEM-2 and tet genes conferring resistance to 1st generation β-lactams and 
tetracycline respectively, caused a fitness deficit in five unrelated host strains 
(Humphrey et al., 2012). However, Lenski et al. (1994) found in their study that the 
tetracycline resistance gene (tetC) increased the fitness of the strains when the 
plasmid was present in a co-evolved host. Although, the pSAP44 (ESBL plasmid) 
contains tetracycline resistance genes, a fitness enhancement by these genes was 
not detected. This would suggest that the role of tetracycline resistance gene in 
increasing plasmid fitness was not significant.  
Interestingly, the fitness cost in the wild type SAP44 (O78) strain was 
associated with the presence of another plasmid belonging to the IncFIB replicon 
during longterm competitive assays. Although, the overall size of pFIB44 (97.245bp) 
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was determined to be reduced compared to pSAP44 (IncI1 plasmid: 105,610bp), the 
fitness burden could be attributed to the continual virulence gene expression by the 
FIB plasmid compared to the IncI1 plasmid.  On the other hand, pSAP44 (IncI1) 
showed a fitness burden on its host carriage in different conditions. In low pH, 
pFIB44 showed better acid tolerance for SAP44 whereas carrying ESBL plasmid 
pSAP44 showed a cost fitness when exposed for a long time to acidic conditions. 
The acid effect was also evident when the conjugation frequency of IncI1 plasmid 
was increased in proportional with the increase in pH (from 4.3 to 7.0) which may 
suggest that pSAP44 plasmid is not functional properly in low acid environment. Acid 
tolerance in the presence of FIB plasmid may explain the association and prevalence 
of this replicon type in APEC. Despite an apparent role for iron acquisition system in 
FIB plasmid in APEC (Mellata et al., 2012), it was also evident in this study that 
pSAP44 (IncI1) plasmid enhanced the growth of APEC O78 strains in iron limited 
media. Further work is necessary to identify the genes required for iron acquisition in 
pSAP44 (IncI1). The above findings may suggest that these plasmids play different 
role in APEC’s ability to persist in the poultry intestinal tract and virulence, but in 
different conditions.    
The results of the virulence experiments showed variability among APEC 
invasion and survivability in in vitro infection assays using HD11, THP-1 and Caco-2 
cell lines. However, when cured plasmid-less O78 strains complemented with 
pSAP44 plasmid, the virulence increased with regard to invasion and survival in 
human and chicken macrophages. Furthermore, when the cured plasmid-less O78 
strains complemented with pSAP44 plasmid were tested, the biofilm production was 
229 
 
 
 
 
enhanced at 37oC and 42oC which mimic the human and chicken temperature, 
respectively. The IncI1 plasmid carrying CTX-M-1 has been reported in E. coli strains 
isolated from human patients and in poultry suggesting the potential link between 
these human and animal settings (da Silva & Mendonça, 2012). In this study 
sequence analysis identified type IV pili genes in IncI1 plasmid. These genes were 
described previously to contribute to the adhesion and invasion of Shiga-toxigenic E. 
coli (da Silva & Mendonça, 2012).  The results presented in SAP44 O78 strain may 
not always apply to other strains. This was evident when the cured strain 
complemented with pSAP44 showed less invasion rate at the early hours (post 
infection) in G. mellonella model comparing to the cured, wildtype strains and SAP24 
related O78 strain. 
 In conclusion, this thesis suggests that the pSAP44 (IncI1) plasmid 
harbouring CTX-M-1 is prominent among avian pathogenic E. coli strains of different 
O and phylogenetic groups. The epidemiological success of this plasmid could be 
attributed to chromosomal and/or specific plasmid elements rather than one 
particular attribute. These beneficial elements may include the stability and 
persistence in a broad range of hosts within the family Enterobacteriacae, the ability 
to efficiently mobilise plasmids in both the chicken gut model and on solid media at 
different pHs, and the lack of a fitness burden to new host strains following 
stabilisation. However, further research is still required to understand the interactions 
between the plasmid and the genome of the host bacterium. Thus, the original 
hypothesis of this thesis that carriage of ESBL plasmids confers a burden to the host 
bacterium is not as straightforward as expected. In particular a neglected area is the 
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interaction of ESBL plasmids with other plasmids and how these may interact with 
bacterial host gene expression and affect the phenotype of the host bacterium. Thus, 
the studies presented in this thesis have laid sound foundations for the further 
investigation of the contribution of plasmids to APEC fitness and future studies 
should investigate other APEC serotypes and plasmids of different replicon types.     
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Future perspectives 
The emergence of ESBL-producing isolates in human and animal populations 
remains problematic and is unlikely to slow in coming years. Added to this, the 
possibility that zoonotic transmission of isolates between these two populations may 
act to means to re-supply the ESBL plasmid pool is of grave concern. The findings 
from this study have led to the identification of several areas of further study: 
1. Distribution of CTX-M-1-harbouring plasmid in APEC population. This study 
revealed that all three ESBL-producing isolates harboured identical blaCTX-M-1 
containing plasmids. It would be interesting to explore in a larger number of isolates 
and/or at different geographical locations how widespread this particular plasmid is in 
APEC. It may also be interesting to examine if a similar plasmid has been detected 
in human ExPEC isolates. 
2. Role of the insertion element ISEcp1 in transmission of the resistance 
plasmid. The ISEcp1 element was found to lie immediately upstream of the blaCTX-M-1 
gene in the plasmid. Previous studies suggest a role for the element in the 
dissemination of the plasmid. It would be interesting to explore the mechanistic basis 
of this interaction with the idea of finding small molecule inhibitors that interfere with 
its function and potentially abrogate ESBL plasmid transmission. 
3.  Role of host microbiota as a reservoir for resistance plasmids. In this 
study, the ESBL plasmid readily transferred to other E. coli isolates, however, it 
would be interesting to explore whether this plasmid was capable of transferring to 
other species commonly found in the host intestine (e.g. Lactobacillus) . As such, it 
may be that the normal host microbiota (of chickens or humans) acts a reserviour for 
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resistance plasmids. Ideally this would need to be assessed using a culture-
independent method as most of the intestinal microorganisms are not readily 
cultured in the laboratory.  
4.  Impact of multiple large plasmids on plasmid biology and transmission. In 
this study, often contrasting results were obtained when the target (resistance) 
plasmid was present singly or in the presence of other plasmids in the host 
bacterium.  Further studies are required tease apart this phenomenon and 
investigate how multiple plasmids function together within a single cell. To date, this 
represents a largely unstudied aspect of plasmid biology, certainly in the context of 
antimicrobial resistance. 
5. The fitness advantage of ESBL plasmid in APEC O78 growth in iron limited 
media. In these studies, the ESBL plasmid was beneficial to APEC O78 growth in 
iron-limited media. It would be interesting to explore the genes that encode iron 
transporters that are related to those found in the IncFIB plasmid. 
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10 .Appendix 
 
 
Appendix I. Growth curve of the wildtype strains and their derivatives with and without ESBL 
plasmid in LB broth media.  
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Growth curve of SAP59 (k12, E.coli strain) and SAP59 strain carry CTX-M plasmid 
represented by SAP56 grew on LB broth media. The growth kinetics of each 
bacterial strain using three biological and tow technical repeats. No significant 
difference was found between the strains although SAP59 carry the ESBL plasmid 
gave generation time of 25 min/generation which was a bit higher than the parent 
strain which was 22 min/generation. 
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Growth curve of non ESBL APEC SAP24 and SAP24 strain transformed with ESBL 
plasmid represented by SAP140 on LB broth media. The growth kinetics of each 
bacterial strain using three biological and tow technical repeats. The graph shows no 
significant difference was found among the tested strains using a student’s T test. 
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Growth curve of ESBL APEC wild type strain SAP44 and its derivative strains 
(SAP44C: cured strains complemented with ESBL plasmid, SAP44: plasmidless 
strains and SAP44F: carries FIB plasmid) on LB broth media. The growth kinetics of 
each bacterial strain using three biological and tow technical repeats. The graph 
shows no significant difference was found among the tested strains using a student’s 
T test. 
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Appendix II. Kinetic curve respiration of SAP44W and its derivatives utilising different 
carbon sources.  
 
 
 
 
The difference pattern of respiration kinetics by wild type ESBL SAP44 (black curve 
line) and its derivative strains (SAP44C (yellow curve line): cured strains 
complemented with ESBL plasmid, SAP44 (white curve line): plasmidless strains and 
SAP44F (blue curve line): carries FIB plasmid) utilizing the sole carbon source in 
PM1. The growth kinetics of each bacterial strain using three biological and tow 
technical repeats. 
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The difference pattern of respiration kinetics by wild type ESBL SAP44 (black curve 
line) and its derivative strains (SAP44C (yellow curve line): cured strains 
complemented with ESBL plasmid, SAP44 (white curve line): plasmidless strains and 
SAP44F (blue curve line): carries FIB plasmid) utilizing the sole carbon source in 
PM2. The growth kinetics of each bacterial strain using three biological and tow 
technical repeats. 
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Appendix III. Biolog PMs with component names   
                        PM1  MicroPlate™ Carbon Sources 
A1  
Negative Control  
A2  
L-Arabinose  
A3  
N-Acetyl-D-
Glucosamine  
A4  
D-Saccharic 
Acid  
A5  
Succinic Acid  
A6  
D-Galactose  
A7  
L-Aspartic 
Acid  
A8  
L-Proline  
A9  
D-Alanine  
A10  
D-Trehalose  
A11  
D-Mannose  
A12  
Dulcitol  
B1  
D-Serine  
B2  
D-Sorbitol  
B3  
Glycerol  
B4  
L-Fucose  
B5  
D-Glucuronic 
Acid  
B6  
D-Gluconic 
Acid  
B7  
D,L- -
Glycerol- 
Phosphate  
B8  
D-Xylose  
B9  
L-Lactic Acid  
B10  
Formic Acid  
B11  
D-Mannitol  
B12  
L-Glutamic 
Acid  
C1  
D-Glucose-6-Phosphate  
C2  
D-Galactonic 
Acid- -
Lactone  
C3  
D,L-Malic 
Acid  
C4  
D-Ribose  
C5  
Tween 20  
C6  
L-Rhamnose  
C7  
D-Fructose  
C8  
Acetic Acid  
C9  
-D-Glucose  
C10  
Maltose  
C11  
D-Melibiose  
C12  
Thymidine  
D-1  
L-Asparagine  
D2  
D-Aspartic 
Acid  
D3  
D-
Glucosaminic 
Acid  
D4  
1,2-
Propanediol  
D5  
Tween 40  
D6  
-Keto-
Glutaric Acid  
D7  
-Keto-
Butyric Acid  
D8  
-Methyl-D-
Galactoside  
D9  
-D-Lactose  
D10  
Lactulose  
D11  
Sucrose  
D12  
Uridine  
E1  
L-Glutamine  
E2  
m-Tartaric 
Acid  
E3  
D-Glucose-1-
Phosphate  
E4  
D-Fructose-6-
Phosphate  
E5  
Tween 80  
E6  
-Hydroxy 
Glutaric Acid-
-Lactone  
E7  
-Hydroxy 
Butyric Acid  
E8  
-Methyl-D-
Glucoside  
E9  
Adonitol  
E10  
Maltotriose  
E11  
2-Deoxy 
Adenosine  
E12  
Adenosine  
F1  
Glycyl-L-Aspartic Acid  
F2  
Citric Acid  
F3  
m-Inositol  
F4  
D-Threonine  
F5  
Fumaric Acid  
F6  
Bromo 
Succinic Acid  
F7  
Propionic 
Acid  
F8  
Mucic Acid  
F9  
Glycolic Acid  
F10  
Glyoxylic 
Acid  
F11  
D-Cellobiose  
F12  
Inosine  
G1  
Glycyl-L-Glutamic Acid  
G2  
Tricarballylic 
Acid  
G3  
L-Serine  
G4  
L-Threonine  
G5  
L-Alanine  
G6  
L-Alanyl-
Glycine  
G7  
Acetoacetic 
Acid 
G8  
N-Acetyl- -D-
Mannosamine  
G9  
Mono Methyl 
Succinate  
G10  
Methyl 
Pyruvate  
G11  
D-Malic Acid  
G12  
L-Malic Acid  
H1  
Glycyl-L-Proline  
H2  
p-Hydroxy 
Phenyl Acetic 
Acid  
H3  
m-Hydroxy 
Phenyl Acetic 
Acid  
H4  
Tyramine  
H5  
D-Psicose  
H6  
L-Lyxose  
H7  
Glucuronami
de  
H8  
Pyruvic Acid  
H9  
L-Galactonic 
Acid- -
Lactone  
H10  
D-
Galacturonic 
Acid  
H11  
Phenylethyl-  
amine  
H12  
2-
Aminoethanol  
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PM2A MicroPlate™ Carbon Sources 
 
Negative Control  A2 Chondroitin 
Sulfate C  
A3  
-Cyclodextrin  
A4  
-Cyclodextrin  
A5  
-Cyclodextrin  
A6  
Dextrin  
A7  
Gelatin  
A8  
Glycogen  
A9  
Inulin  
A10  
Laminarin  
A11  
Mannan  
A12  
Pectin  
B1  
N-Acetyl-D-Galactosamine  
B2  
N-Acetyl-
Neuraminic 
Acid  
B3  
-D-Allose  
B4  
Amygdalin  
B5  
D-Arabinose  
B6  
D-Arabitol  
B7  
L-Arabitol  
B8 Arbutin  B9 2-Deoxy-D-
Ribose  
B10  
i-Erythritol  
B11 D-Fucose  B12 3-0- -D-
Galacto-
pyranosyl-D-
Arabinose  
C1 Gentiobiose  C2  
L-Glucose  
C3 Lactitol  C4 D-
Melezitose  
C5 Maltitol  C6 a-Methyl-D-
Glucoside  
C7  
-Methyl-D-
Galactoside  
C8 3-Methyl 
Glucose 
C9  
-Methyl-D-
Glucuronic 
Acid  
C10  
-Methyl-D-
Mannoside  
C11  
-Methyl-D-
Xyloside  
C12  
Palatinose  
D1 D-Raffinose  D2  
Salicin  
D3 
Sedoheptulosan  
D4  
L-Sorbose  
D5 Stachyose  D6 D-Tagatose  D7 Turanose  D8 Xylitol  D9 N-Acetyl-D-
Glucosaminitol  
D10  
-Amino 
Butyric Acid  
D11  
-Amino 
Valeric Acid  
D12  
Butyric Acid  
E1 Capric Acid  E2  
Caproic Acid  
E3  
Citraconic Acid  
E4 Citramalic 
Acid  
E5 D-
Glucosamine  
E6 2-Hydroxy 
Benzoic Acid  
E7  
4-Hydroxy 
Benzoic Acid  
E8  
-Hydroxy 
Butyric Acid  
E9  
-Hydroxy 
Butyric Acid  
E10  
a-Keto-Valeric 
Acid  
E11  
Itaconic Acid  
E12  
5-Keto-D-
Gluconic Acid  
F1  
D-Lactic Acid Methyl Ester  
F2  
Malonic Acid  
F3  
Melibionic 
Acid  
F4  
Oxalic Acid  
F5  
Oxalomalic 
Acid  
F6  
Quinic Acid  
F7 D-Ribono-
1,4-Lactone  
F8 Sebacic 
Acid  
F9  
Sorbic Acid  
F10  
Succinamic 
Acid  
F11  
D-Tartaric 
Acid  
F12  
L-Tartaric 
Acid  
G1  
Acetamide  
G2  
L-Alaninamide  
G3 N-Acetyl-L-
Glutamic Acid  
G4 L-Arginine  G5 Glycine  G6 L-Histidine  G7 L-
Homoserine  
G8 Hydroxy-L-
Proline  
G9 L-
Isoleucine  
G10 L-Leucine  G11  
L-Lysine  
G12  
L-Methionine  
H1  
L-Ornithine  
H2  
L-
Phenylalanine  
H3  
L-Pyroglutamic 
Acid  
H4  
L-Valine  
H5  
D,L-Carnitine  
H6  
Sec-Butylamine  
H7 D.L-
Octopamine  
H8  
Putrescine  
H9 Dihydroxy 
Acetone  
H10  
2,3-Butanediol  
H11 2,3-
Butanone  
H12  
3-Hydroxy 2-
Butanone  
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PM4A MicroPlate™ Phosphorus and Sulfur Sources 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A1 Negative Control  A2 Phosphate  A3  
Pyrophosphate  
A4  
Trimeta-phosphate  
A5  
Tripoly-phosphate  
A6  
Triethyl Phosphate  
A7  
Hypophosphite  
A8  
Adenosine- 2’-
monophosphate  
A9  
Adenosine- 3’-
monophosphate  
A10  
Adenosine- 5’-
monophosphate  
A11 Adenosine- 
2’,3’-cyclic 
monophosphate  
A12  
Adenosine- 3’,5’-
cyclic 
monophosphate  
B1  
Thiophosphate  
B2  
Dithiophosphate  
B3  
D,L- -Glycerol 
Phosphate  
B4  
-Glycerol 
Phosphate  
B5  
Carbamyl 
Phosphate  
B6  
D-2-Phospho-
Glyceric Acid  
B7  
D-3-Phospho-
Glyceric Acid  
B8 Guanosine- 2’-
monophosphate  
B9 Guanosine- 3’-
monophosphate  
B10  
Guanosine- 5’-
monophosphate  
B11 Guanosine- 
2’,3’-cyclic 
monophosphate  
B12 Guanosine- 
3’,5’-cyclic 
monophosphate  
C1 Phosphoenol Pyruvate  C2  
Phospho- Glycolic 
Acid  
C3  
D-Glucose-1-
Phosphate  
C4 D-Glucose-6-
Phosphate  
C5 2-Deoxy-D-
Glucose 6-
Phosphate  
C6 D-Glucosamine-
6-Phosphate  
C7 6-Phospho-
Gluconic Acid  
C8 Cytidine- 2’- 
monophosphate  
C9  
Cytidine- 3’- 
monophosphate  
C10  
Cytidine- 5’- 
monophosphate  
C11 Cytidine- 2’,3’-
cyclic 
monophosphate  
C12  
Cytidine- 3’,5’-
cyclic 
monophosphate  
D1 D-Mannose-1-Phosphate  D2  
D-Mannose-6-
Phosphate  
D3 Cysteamine-S-
Phosphate  
D4  
Phospho-L-
Arginine  
D5 O-Phospho-D-
Serine  
D6 O-Phospho-L-
Serine  
D7 O-Phospho-L-
Threonine  
D8 Uridine- 2’- 
monophosphate  
D9 Uridine- 3’- 
monophosphate  
D10 Uridine- 5’- 
monophosphate  
D11  
Uridine- 2’,3’- 
cyclic 
monophosphate  
D12  
Uridine- 3’,5’- 
cyclic 
monophosphate  
E1 O-Phospho-D-Tyrosine  E2  
O-Phospho-L-
Tyrosine  
E3  
Phosphocreatine  
E4 Phosphoryl 
Choline  
E5 O-Phosphoryl-
Ethanolamine  
E6 Phosphono 
Acetic Acid  
E7  
2-Aminoethyl 
Phosphonic Acid 
E8  
Methylene 
Diphosphonic Acid  
E9  
Thymidine- 3’-  
monophosphate  
E10  
Thymidine- 5’-  
monophosphate  
E11  
Inositol 
Hexaphosphate  
E12  
Thymidine 3’,5’- 
cyclic 
monophosphate  
F1  
Negative Control  
F2  
Sulfate  
F3  
Thiosulfate  
F4  
Tetrathionate  
F5  
Thiophosphate  
F6  
Dithiophosphate  
F7 L-Cysteine  F8 D-Cysteine  F9  
L-Cysteinyl-
Glycine  
F10  
L-Cysteic Acid  
F11  
Cysteamine  
F12  
L-Cysteine Sulfinic 
Acid  
G1  
N-Acetyl-L-Cysteine  
G2  
S-Methyl-L-
Cysteine  
G3 Cystathionine  G4 Lanthionine  G5 Glutathione  G6 D,L-Ethionine  G7 L-Methionine  G8 D-Methionine  G9 Glycyl-L-
Methionine  
G10 N-Acetyl-D,L-
Methionine  
G11  
L- Methionine 
Sulfoxide  
G12  
L-Methionine 
Sulfone  
H1  
L-Djenkolic Acid  
H2  
Thiourea  
H3  
1-Thio- -D-
Glucose  
H4  
D,L-Lipoamide  
H5  
Taurocholic Acid 
H6  
Taurine  
H7 Hypotaurine  H8  
p-Amino Benzene 
Sulfonic Acid  
H9  
Butane Sulfonic 
Acid  
H10  
2-Hydroxyethane 
Sulfonic Acid  
H11 Methane 
Sulfonic Acid  
H12  
Tetramethylene 
Sulfone  
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Appendix IV. The macroscopic appearance of infected larvae was illustrated in 
the table below. 
 
 
APEC strains/control Macro-
colour 
(0-3) 
Number of 
Galleria  
Diarrhoea or 
pellet 
Mean Galleria 
survival (%) 
Control?unifected larvae 0 
1 
2 
3 
49/50 
1/50 
0/50 
0/50 
Normal feacal 
pellet 
100 
Control/PBS infected larvae 0 
1 
2 
3 
49/50 
0/50 
0/50 
1/50 
Green/yellow 
pellet 
98 
ESBL APEC O78,SAP44(WT) 0 
1 
2 
3 
0/50 
2/50 
3/50 
45/50 
No feacal pellet  10 
SAP44 cured(plasmidless) 0 
1 
2 
3 
0/50 
2/50 
6/50 
42/50 
No feacal pellet 10 
SAP44F(p44FIB,FIB plasmid) 0 
1 
2 
3 
0/50 
3/50 
3/50 
44/50 
No feacal pellet 10 
SAP44C (pSAP44,ESBL 0 30/50 Few larvae 60 
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APEC strains/control Macro-
colour 
(0-3) 
Number of 
Galleria  
Diarrhoea or 
pellet 
Mean Galleria 
survival (%) 
plasmid) 1 
2 
3 
2/50 
5/50 
13/50 
present 
diarrhea but not 
all over the 
plate 
Non-ESBL APEC O78,SAP24 0 
1 
2 
3 
0/50 
5/50 
0/50 
45/50 
No feacal pellet 10 
SAP140 (pSAP44,ESBL 
plasmid) 
0 
1 
2 
3 
0/50 
3/50 
2/50 
45/50 
No feacal pellet 10 
SAP59(K12) 0 
1 
2 
3 
0/50 
8/50 
1/50 
41/50 
No feacal pellet 15 
SAP56(pSAP44,ESBL plasmid) 0 
1 
2 
3 
0/50 
10/50 
5/50 
35/50 
No feacal pellet 16 
 
Macroscopic evaluation of G. mellonella larvae following APEC strains infection in terms of 
colour and presence of diarrhoea. APEC infected and uninfected larvae were incubated at 
37oC. A score of 3 refers to fatality. Cream, score 0; beige score 1; dark beige to dark brown 
score 2; black score 3. Based on 5 replicates of group (10 larvae per group). 
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Appendix V. Media  
 
A. Media  
All culture media were obtained from Oxoid (Basingstoke) and prepared using 
distilled water. Sterilization was carried out by autoclaving at 121ºC for 15 minutes at 
15 pounds per square inch (p.s.i). The media plates were stored at 4ºC. 
LB broth media  
Tryptone  5g 
Yeast Extract 2.5g 
NaCl   5g 
Distilled water  500 ml 
 
LB agar 
Tryptone   5g 
Yeast extract   2.5g 
Sodium chloride  5g 
Agar    6g 
Distilled water  500 ml 
Iso-Sensitest Media  
Iso-Sensitesy agar  15.7 g 
Distilled water  500 ml 
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B. Davise minimal media 
Potassium Phosphate (dibasic) K2HPO4  MW 228.17    3.5 g 
Potassium Phosphate (monobasic) KH2PO4  MW 136.07 1 g 
Ammonium Sulfate (NH4)2 SO4  MW 132.08 0.5 g 
Sodium Citrate (trisodium, dihydrate) Na3C6H5O7 (H2O)2  MW 294.10  0.25 g 
Distilled water  500 ml 
After autoclaving the following stock solutions were added: 
0.5ml of 10% (w/v) Magnesium Sulfate MgSO4 (separately autoclaved stock) 
0.5ml of 0.2% (w/v) Thiamine (vitamin B1) (filter sterilized) 
125 µl of 10% (w/v) glucose 
 
C. M9 minimal media 
Sodium phosphate, Na2HPO4    6 g   
Potassium phosphate, KH2PO4  3g 
Sodium chloride, NaCl   05g 
Ammonium chloride, NH4Cl  1.0 g 
After autoclaving the following stock solutions were added: 
1 ml of 1M Magnesium sulfate, MgSO4 
1 ml of 0.1M Calcium chloride CaCl2 
10 ml of 10% (w/v) glucose (or other carbon source) 
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D. VLA media 
Beef extract 2.5 g 
Yeast extract 5.0 g 
Glucose 2.5 g 
Tryptose 10 g 
L-cysteine HCL 0.6 g 
NaCl 5.0 g 
Buffer solutions 1.0/ L 
Buffered solutions was adjusted at pH of 5.8 by adding the following soultions: 
118 ml of 1M citric acid  
382ml of 1M sodium citrate 
 
 
 
 
 
 
 
